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 Light chain amyloidosis (AL) is an acute systemic amyloid disease in which the overexpression 
and misfolding of immunoglobulin light chains leads to the formation of insoluble fibrils at critical organs 
in the body. The typical prognosis for AL patients is extremely severe—usually less than three years of 
diagnosis—but in the case of cardiac involvement, this is reduced to under a year. As a result of the 
complex and diverse nature of the disease, our understanding of how it onsets and imparts its devastating 
effects remains elusive, consequently delaying progress on the identification of robust diagnostic and 
therapeutic strategies. To address this deficiency, we investigate the structural and dynamical properties 
of the fibrils involved in a severe case of cardiac AL disease, formed from the light-chain variable domain 
(VL) patient-derived protein, AL-09. We performed these studies through the use of solid-state nuclear 
magnetic resonance (SSNMR) spectroscopy, which have revealed new insights on specific features of the 
fibril species. First, we report our findings on the 13C and 15N chemical shift assignments and sequence 
involvement of AL-09 VL fibrils, followed by subsequent investigations on the predominant secondary 
structure and relative dynamics across the protein sequence. In addition, we present a comparison of AL-
09 VL fibrils (prepared in vitro) with ex vivo amyloid deposits of another AL protein fibril (HIG) obtained 
from human spleen tissue using 1D 13C SSNMR analysis. Next, we describe the development and 
implementation of 4D 13C-detected SSNMR experiments that combine non-uniform sampling with band-
selective J-decoupling pulses to enable the resolution of previously unassignable resonances while 
maintaining high sensitivity. Last, we introduce an improved program and strategy for the 
computationally-aided assignment of protein chemical shifts that incorporates peak intensity and 
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CHAPTER 1: INTRODUCTION 
Amyloid diseases encompass a broad group of disorders that are characterized by the misfolding 
and aggregation of proteins in the body and their subsequent deposition as elongated, insoluble fibrils at 
various organs. The way these diseases are typically classified is based on the location at which the fibrils 
involved deposit in the body. In general, they can be separated into two main categories: 
neurodegenerative amyloid diseases, in which fibril formation occurs in the brain tissue of patients, and 
non-neuropathic amyloid diseases, in which fibrils deposit at other organs of the body apart from the 
neural tissue1,2. The pathology that occurs in the class of neurodegenerative diseases is presented in cases 
such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, as well as many other prevalent 
disorders3. For non-neuropathic amyloid diseases—more generally known as amyloidoses—this 
pathology can manifest as either localized amyloidosis, in which fibril build-up occurs specifically at the 
tissue where the protein is produced, or systemic amyloidosis, in which multiple organs and tissues can be 
targeted4. 
A significant amount of research, especially in the past few decades, has been directed at 
improving our understanding of the underlying mechanisms of amyloid fibril formation in these diseases, 
as well as how to more effectively diagnose and treat them5. To capture a complete picture of the 
determinants driving the progression of amyloid diseases, researchers have applied a wide array of 
techniques to study them from many different angles, ranging from genetic regulation of the precursor 
protein6,7, mathematical modeling of fibril formation kinetics8, thermodynamics of protein folding9,10, 
cellular toxicity assays11-13, and continuing onto their testing in animal models14 and eventually clinical 
drug trials15. Each of these methods provides a different insight into the amyloid formation process. One 
technique that is particularly well-suited for studying both the molecular-level structure and dynamics of 
amyloid fibrils is magic-angle spinning (MAS) solid-state nuclear magnetic resonance (SSNMR) 
spectroscopy, in which there is no inherent molecular size limitation and is specifically equipped to study 
insoluble materials. Indeed, MAS SSNMR has been applied to the cases of many disease-related fibrils, 
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and has enabled the elucidation of the three-dimensional structure for multiple amyloid systems in only 
the past few decades, including those involved in neurodegenerative diseases such as Alzheimer’s disease 
and Parkinson’s disease16-22, localized amyloidoses such as that often presented in type II diabetes 
mellitus23,24, as well as localized or systemic dialysis-mediated amyloidosis25,26. The availability of these 
structures has provided foundational insight into the unique conformational fold that each fibril structure 
exhibits, the types of interactions that hold the fibril core together, as well as the intermolecular 
interactions that support the structural integrity of the extended fibril27. Furthermore, the elucidation of 
these structures can also provide a basis on which the design of molecules that can bind to specific sites 
on the fibril of interest can be investigated. Indeed, relatively recent work has already shown that this can 
be done using a library of compounds to computationally sample and score their binding to the -amyloid 
fibril structure28,29. Clearly, there is tremendous value in having access to this structural information, 
especially when combined the details obtained from all of the other methods. As such, we now turn to the 
case of systemic amyloidoses, which comprise the group of amyloid diseases which has received notably 
less attention from structural pursuits, in which we apply and further develop several of the techniques 
used for the fibril systems described above. 
The most common form of systemic amyloidosis is presented by the disease light chain 
amyloidosis (AL)4. AL is an acute systemic disease in humans that is described by the overexpression of 
immunoglobulin light-chain proteins throughout the bloodstream which—upon misfolding—form into 
insoluble fibrils and deposit at critical organs of the body, culminating in tissue damage and death30. The 
average prognosis for patients suffering from AL disease is generally within two to three years of 
diagnosis, but is reduced to under a year if the afflicted organ is the heart, which is presented by 
approximately 50% of all AL cases31-33. Due to the highly variable nature of immunoglobulin light chain 
sequences and wide range of possible tissue sites for fibril deposition, the search for a working animal 
model as well as effective diagnostic and therapeutic strategies for AL has remained largely limited4. 
These efforts have been further hindered by the absence of a full understanding of the molecular 
mechanisms governing the fibril formation process as well as the three-dimensional fibril structure, both 
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of which would inform the rational design of new treatments or diagnostic tools34-36. Accordingly, here 
we present our collection of investigations on the structural determinants of cardiac AL disease, including 
studies of both the fibril structure and dynamics, as pursued through MAS SSNMR spectroscopy. 
 The work described in the following chapters is concentrated on the light-chain variable domain 
(VL) of the protein, AL-09, which represents one particularly severe case of cardiac AL disease31,37. AL-
09 VL is a 108 amino acid residue protein that contains seven mutations relative to the I O18/O8 
germline sequence from which it is derived37. Of these mutations, Y87H, N34I, and K42Q are non-
conservative and are known to contribute the most to the overall increased propensity and rate of fibril 
formation30,38. To explore the involvement of these residues and other residues in the fibril structure, our 
initial studies involved the acquisition and analysis of a series of multidimensional SSNMR 13C and 15N 
correlation spectra on uniformly [13C,15N]-labeled AL-09 VL fibrils. In addition to enabling site-specific 
chemical shift assignments to be made for nearly half of the backbone and side chain atoms in AL-09 VL 
(via a sequential backbone walk), our data reveal that approximately 70 residues of sequence in total are 
observed to be structured in the fibril species39. Further, the secondary chemical shift trends and backbone 
torsion angle predictions determined from these assignment data revealed that the structured residues of 
AL-09 VL fibrils assume a predominantly -sheet conformation39,40. Subsequently, we proceeded to 
investigate the dynamics of the fibril structure level through the use of 1H-13C dipolar recoupling 
experiments (via 2D T-MREV41,42 and 3D R-symmetry43 pulse sequences), allowing for the measurement 
of the scaled 1H-13C dipolar-coupling values at both the sequence-wide and site-specific levels. Our 
results indicated that AL-09 VL fibrils exhibit high rigidity across the majority of the protein sequence, 
and moreover that this rigidity is particularly evident for residues near the N- and C-termini40. Together, 
these data suggest that the N- and C-terminal regions are primarily involved in maintaining the rigid fibril 
structure, while the more central regions of the sequence—i.e., where most of the mutation sites occur—
may play a larger role in destabilizing the native protein structure to allow the initial misfolding event and 
fibril formation to occur. 
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To assess whether the structural features we observe for AL-09 VL fibrils (prepared in vitro) are 
common to other AL fibrils, we compared the 13C 1D spectrum to that acquired for an ex vivo AL 
amyloid sample (obtained from post-mortem human spleen tissue; HIG). Interestingly, the samples 
demonstrate qualitatively similar spectral features and secondary chemical shift trends, while the presence 
of several unique peaks in HIG spectrum are indicative of the presence (and likely association) of tightly 
bound glycosaminoglycans from the extracellular matrix of the spleen tissue40. These results will serve as 
a framework on which the structural study of isotopically-enriched and seeded HIG fibrils can be 
performed.  
 In parallel with our above studies, we also describe the design and application of two new 
methods for SSNMR data collection and analysis. The first is the implementation of 13C-detected 4D 
experiments that provide internuclear correlation information between the i and i-1 residues (via 13Ci-
15Ni-13C’i-1-13CXi-1 transfer) or i and i+1 residues (via 13C’i-1-15Ni-13Ci-13C’i transfer)44, combined with 
band-selective J-decoupling pulses on the indirect 13C-dimensions to deliver further resolution 
enhancement without compromising sensitivity45. Furthermore, we have implemented these experiments 
with the use of non-uniform sampling (NUS), a technique in which only a subset of the hypercomplex 
data points are collected and—when combined with powerful data reconstruction tools such as 
SMILE46—allow for efficient acquisition of high-dimensionality spectra with enhancements to both 
resolution and sensitivity47,48. Following initial performance testing of the pulse sequence with GB1, we 
proceed to apply this to the case of AL-09 VL fibrils and demonstrate the ability to resolve and assign 
chemical shift resonances that were previously inaccessible at lower dimensionality, in addition to 
reducing the total experiment time by a factor of 50 or more. Moreover, our results on AL-09 VL also 
reveal that several residues the central region of the protein sequence are also partially structured in the 
fibril form and exhibit a unique set of chemical shifts, suggesting that they may adopt a distinct 
conformation relative to the rest of the AL-09 VL fibril structure. This work comprises the primary focus 
of Chapter 4. 
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 The second method we introduce (which forms the topic of Chapter 5), is an improved program 
for computationally-assisting the assignment of chemical shifts in protein SSNMR data. Specifically, we 
have incorporated peak intensity and frequency overlap information as a new objective within the Monte 
Carlo and multi-objective approach to identifying optimal assignment solutions which have been reported 
previously49-51. Through this, we essentially provide a method of scaling the overall quality of a given 
assignment solution based on an additional aspect of experimental data, which we demonstrate offers a 
significant improvement to the robustness of the program relative to the previous programs. In particular, 
when provided with data containing many inter-residue cross-peak correlations within the same spin 
systems (e.g., a list of frequencies representing a single residue, plus several non-representative 
frequencies), our program consistently performs with a much higher probability of success than previous 
programs. Furthermore, we present several additional computational tools that streamline the preparation 
of input to the new assignment program directly from the data processing step, without requiring time-
consuming manual analysis of the acquired spectrum. In addition to applying this strategy to GB1 with 
nearly perfect assignment success, we apply it to the challenging case of AL-09 VL fibril data and show 
that the program is able to accurately assign the majority of the residues which have previously been 
assigned manually with moderate consistency, even with minimally analyzed data sets. 
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CHAPTER 2: Solid-state NMR Chemical Shift Assignments for AL-09 VL Immunoglobulin 
Light Chain Fibrils 
2.1. NOTES AND ACKNOWLEDGEMENTS 
This chapter is adapted with permission from Springer Science and Business Media: 
Biomolecular NMR Assignments. Solid-state NMR chemical shift assignments for AL-09 VL 
immunoglobulin light chain fibrils, volume 11, 2017, pages 45-50, authors: Dennis W. Piehl*, Luis M. 
Blancas-Mejía*, Marina Ramirez-Alvarado, Chad M. Rienstra. *These authors contributed equally to this 
work. This research is supported by the University of Illinois (Centennial Scholars Award to C.M.R.), 
R01-GM075514 (to M.R.A.), the Mayo Foundation, and the generous support of amyloidosis patients and 
their families. D.W.P. is an American Heart Association Predoctoral Fellow (15PRE25100008). We thank 
Marcus D. Tuttle and Alexander M. Barclay for help with SSNMR data acquisition and processing. 
 
2.2. ABSTRACT 
 Light chain (AL) amyloidosis is a systemic disease characterized by the formation of 
immunoglobulin light-chain fibrils in critical organs of the body. The light-chain protein AL-09 presents 
one severe case of cardiac AL amyloidosis, which contains seven mutations in the variable domain (VL) 
relative to its germline counterpart, ϰI O18/O8 VL. Three of these mutations are non-conservative—
Y87H, N34I, and K42Q—and previous work has shown that they are responsible for significantly 
reducing the protein’s thermodynamic stability, allowing fibril formation to occur with fast kinetics and 
across a wide-range of pH conditions. Currently, however, there is extremely limited structural 
information available which explicitly describes the residues that are involved in supporting the misfolded 
fibril structure. Here, we assign the site-specific 15N and 13C chemical shifts of the rigid core residues of 
AL-09 VL fibrils by solid-state NMR, reporting on the regions of the protein involved in the fibril as well 




2.3. BIOLOGICAL CONTEXT 
Light chain (AL) amyloidosis is an acute systemic disease in humans that is described by the 
formation of immunoglobulin light-chain fibrils in the extracellular matrix of critical organs of the body1. 
AL patients typically die within two to three years of diagnosis, and this expectancy is reduced to under a 
year if the affected organ is the heart—which comprises approximately 50 % of all AL cases2-4. Currently, 
there are only a limited number of therapies that exist which can marginally extend this outlook1,4. The 
light chains that compose these fibrils originate from abnormally proliferative monoclonal plasma cells, 
which secrete a large amount of the amyloidogenic protein into the bloodstream5. Although these proteins 
are natively innocuous, they can become toxic in the blood upon misfolding, providing the nucleation 
event for fibril elongation and deposition to occur1. Although the exact reason for the misfolding of these 
proteins is not completely understood, studies on the thermodynamic stability of patient-derived light 
chains reveal that the introduction of particular somatic (non-inherited) mutations within the VL of the 
germline sequence can predispose them to forming amyloidogenic fibrils1,6.  
One particularly severe case of AL arises from the protein AL-09 (from patient AL-09)7. The AL-
09 VL domain is a 108 amino acid residue protein composed of primarily β-sheet secondary structure that 
contains seven mutations relative to its non-amyloidogenic germline counterpart, I O18/O8 (Figure 
2.1a–b)1,6,8. Notably, AL-09 is observed to form fibrils spontaneously and with fast kinetics at a 
physiological pH of 7.4, whereas I O18/O8 requires the addition of a pre-formed fibril to initiate the 
aggregation reaction (yet, both proteins spontaneously form fibrils at a pH of 2.0) (Figure 2.1c)5-7. 
Interestingly, restorative mutational analyses for AL-09 have revealed that the three non-conservative 
mutations are responsible for a significant amount of the destabilizing effect—Y87H, N34I, and K42Q (in 
decreasing order of influence)1,5,8. However, due to a lack of high-resolution structural or chemical shift 
information of the fibrillar species, the exact influence that these mutations are suspected to have on 
increasing the fibril-forming propensity of AL-09 relative to I O18/O8 remains unclear1,5. Accordingly, 
in this study, the sequence composition and secondary structure of the rigid regions for AL-09 VL fibrils 
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were investigated by magic-angle spinning (MAS) SSNMR spectroscopy, revealing an extensive and 
highly ordered fibril core that involves residues of both the N- and C-terminus.  
 
Figure 2.1. a. Sequence alignment for AL-09 and ϰI O18/O8 VL (residues in red indicate mutations; 
those in blue are purification artifacts). b. X-ray structures of AL-09 and ϰI VL dimers in their native 
forms (PDBs: 2Q1E and 2Q20, respectively)8. c. TEM images of [13C, 15N]-labeled AL-09 fibrils used for 
SSNMR studies. 
2.4. METHODS AND EXPERIMENTS 
Protein Expression and Purification. AL-09 VL is a patient-derived variable domain proteins 
belonging to the ϰI O18/O8 germline gene product (also known as IGKV 1-33)2. Uniformly [13C, 15N]-
labeled AL-09 VL protein was expressed using a modified version of the protocol described by Marley et 
al. 2001. Briefly, Escherichia coli BL21 (DE3) Gold competent cells (Stratagene, La Jolla, CA) were 
transformed with pET12a-AL-09 VL and grown in 1 L of 2XYT media at 37 ºC and 250 rpm. Upon 
reaching an A600nm of 0.6, cells were pelleted for 20 min at 4,000 g, and subsequently washed and re-
pelleted (20 min, 4,000 g) using an M9 salt solution10 that excluded all nitrogen and carbon sources. The 
cell pellet was resuspended in 250 mL of isotopically labeled M9 minimal medium containing [13C]-
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glucose and [15N]-ammonium chloride (Cambridge Isotope Laboratories, Tewksbury, MA) as the sole 
carbon and nitrogen sources, and incubated for 1 h at 37 ºC and 250 rpm to allow for recovery of growth. 
Cells were induced by adding isopropyl -D-1-thiogalactopyranoside (IPTG) for a concentration of 0.8 
mM and then grown at 25 °C and 100 rpm for 12 h before harvesting by centrifugation at 8,000 rpm for 
20 min.  
Extraction of uniformly [13C, 15N]-labeled AL-09 VL protein was accomplished by osmotic shock, as 
follows. Harvested cell pellets were resuspended in 100 mL (each) of cold phosphate-buffered saline 
(PBS), incubated on ice for 10 min, and pelleted for 20 min at 4,000 g. Subsequently, cell pellets were 
resuspended in 100 mL of 20% sucrose solution, incubated on ice for 10 min, and pelleted for 20 min at 
8,000 g. Upon resuspension in 100 mL of 10 mM Tris–HCl buffer, pH 7.4, each pellet was sonicated 
three times for 10 s at 35% amplitude (with 1 min intervals of incubation on ice), using a Misonix S-400 
sonicator (Osonica, Newtown, CT). Sonicated cells were pelleted for 20 min at 8,000 g, followed by 
resuspension in 100 mL of 5 M urea, incubation on ice for 30 min, and re-centrifugation for 1 h at 20,000 
g. The resulting pellets were discarded and the urea supernatant was dialyzed overnight against 4 L (per 
pellet) of 10 mM Tris–HCl buffer, pH 7.4. Uniformly [13C, 15N]-labeled AL-09 VL monomer was purified 
under the same buffer conditions by size exclusion chromatography with a HiLoad 16/60 Superdex 75 
column on an AKTA FPLC system (GE Healthcare, Piscataway, NJ).  
Protein purity and homogeneity were determined by SDS-PAGE. Protein concentration was 
determined by UV absorption at 280 nm using an extinction coefficient of  = 13,610 M-1 cm-1 for AL-09 
VL, calculated from the amino acid sequence. Pure protein was flash frozen and stored at −80 °C. As a 
quality control measurement, far UV circular dichroism (CD) spectroscopy was used to confirm that the 
protein retained the native secondary structure previously reported at the beginning of the fibril formation 
reaction. Far UV-CD spectra from 260–200 nm (1 nm bandwidth) were acquired at 4 °C, on a Jasco 
Spectropolarimeter 810 (JASCO Inc., Easton, MD) using a 0.2 cm path-length quartz cuvette. All samples 
were prepared with 20 M protein in 10 mM Tris–HCl pH 7.4. 
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Mass Spectrometry. The molecular mass of uniformly [13C, 15N]-labeled AL-09 VL protein was 
determined using MALDI-TOF. The average molecular weight was measured to be 12776 Da, indicating 
~99 % [13C, 15N] incorporation relative to the calculated masses for unlabeled and 100 % [13C, 15N]-
labeled protein (11933 Da and 12789 Da, respectively). 
In vitro Fibril Formation. Uniformly [13C, 15N]-labeled AL-09 VL fibril samples were prepared from 
protein monomer solutions, according to previously reported protocols6. Briefly, purified protein was 
thawed at 4 ºC, filtered using 0.45 m membranes and subjected to ultracentrifugation at a speed of 
90,000 rpm (645,000 g) for 3.3 h in a NVT-90 rotor on an Optima L-100 XP centrifuge (Beckman 
Coulter, Brea, CA), to remove any pre-formed aggregates formed during the thawing of the soluble 
protein. 
Ultracentrifuged protein samples were prepared on ice at a final concentration of 20 M in 10 mM 
Acetate Borate Citrate (ABC) buffer pH 2.0, containing 150 mM NaCl, 10 M Thioflavin T (ThT), and 
0.02 % NaN3 in 1.5 mL low binding microcentrifuge tubes (1.0 mL total volume). Fibril formation 
reactions were conducted in triplicate using sealed, black 96-well polystyrene plates (Nunc, Roskilde, 
Denmark; Greiner, Monroe, NC) with 260 µL reaction mixture per well and incubating at 37 °C with 
continuous orbital shaking (300 rpm) in a New Brunswick Scientific Innova40 incubator shaker until 
fibril formation was complete. Fibrillation progress was monitored by the change in enhanced 
fluorescence intensity of ThT, and the presence of fibrils was subsequently confirmed by transmission 
electron microscopy (TEM). On average, the time required for fibrillation to conclude for AL-09 VL 
fibrils is ~2 days (50 hours). 
Transmission Electron Microscopy (TEM). To confirm the presence of fibrils, a 3 µL fibril sample 
was placed on a 300 mesh copper formvar/carbon grid (Electron Microscopy Science, Hatfield, PA), and 
excess liquid was removed. The samples were negatively stained with 2 % uranyl acetate, washed twice 
with H2O, and air-dried. Grids were analyzed on a Philips Tecnai T12 transmission electron microscope 
at 80 kV (FEI, Hillsboro, OR). 
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Preparation of Fibrils for SSNMR Studies. Fibril samples were transferred to polypropylene 
microfuge tubes (Item #: 357448) and pelleted in a table-top ultracentrifuge with a TLA-100.3 (Beckman 
Coulter) rotor and microfuge tube adapters (Item #: 355919), for 1 hr at 4 ºC and 55,000 rpm (or 
~100,000 g, accounting for the shorter radius of the microfuge tubes). Following the removal of the 
fibrillation buffer, fibril pellets were washed twice with deionized water using homogenization and 
subsequent ultracentrifugation. Washed fibril pellets were dried completely under nitrogen gas by 
monitoring the mass of the sample until it remained unchanged. Dried AL-09 VL fibril samples were 
packed into either 3.2 mm (outer-diameter) standard-wall rotor or 3.2 mm thin-wall rotor (Agilent 
Technologies, Santa Clara, CA), and hydrated to a level of 50 % water by mass. Kel-F and rubber spacers 
were used to retain hydration level of sample. 
Solid-State NMR Spectroscopy. MAS SSNMR spectra of AL-09 VL fibrils were acquired at 11.7 T 
(500 MHz 1H frequency) and 17.6 T (750 MHz) on VNMRS (Agilent Technologies) spectrometers with a 
3.2 mm Balun or BioMAS 1H-13C-15N probe as well as at 14.1 T (600 MHz) on an InfinityPlus 
spectrometer using a 3.2 mm Balun or T3 probe. For all multidimensional experiments, the MAS rate was 
set to 11.111 kHz (500 MHz), 12.5 kHz (750 MHz), or 13.333 kHz (600 MHz), and a variable-
temperature (VT) stack was used to provide a constant flow of -10 ºC, 0 ºC, or 10 ºC air, for a sample 
temperature of -5 to 15 ºC (due to heating caused by MAS and 65–80 kHz 1H SPINAL-6411 decoupling 
power). Multidimensional SSNMR experiments performed on AL-09 VL fibril samples include: 13C-13C 
(CC) 2D, 15N-13C (NCA) 2D, 15N-13C' (NCO) 2D, 15N-(13C)-13CX (N(CA)CX) 2D, 15N-(13C')-13CX 
(N(CO)CX) 2D, 15N-13C-13CX (NCACX) 3D, 15N-13C’-13CX (NCOCX) 3D,  13C-15N-13C' (CANCO) 
3D, 13C-15N-(13C')-13CX (CAN(CO)CX) 3D, and 13C-13C-13C (CCC) 3D. One-bond 13C-13C correlations 
were achieved using either dipolar-assisted rotational resonance (DARR; τmix = 25–90 ms)12 or 
supercycled POST-C7 (SPC-7; τmix = 0.9 ms or 1.2 ms)13 for magnetization transfer, and one-bond 15N-
13C or 13C-15N correlations were accomplished using SPECIFIC-CP14. Further experimental details are 
summarized in Table 2.1. 
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Solid-State NMR Data Processing and Analysis. All SSNMR data were processed with forward 
or backward linear prediction, zero filling, and Lorentzian-to-Gaussian apodization using NMRPipe15. 
Peak assignments, signal-to-noise ratio (SNR) measurements, and linewidth measurements were 
performed using Sparky16. Secondary structure analysis of site-specifically resolved residues was 
performed using TALOS-N17.  
 
2.5. ASSIGNMENTS AND DATA DEPOSITION 
 The number of residues involved in the structured region of uniformly [13C, 15N]-labeled AL-09 
VL fibrils was assessed by the acquisition and analysis of multidimensional MAS SSNMR spectra (Figure 
2.2). Specifically, a count of the number of peaks observed in initial 2D 13C-13C (CC) spectra allowed for 
an approximation of >50 spin-systems at a signal threshold of 10 times the noise floor, σ. This process 
was facilitated by the focus on Ala and Thr spin-systems, which exhibit highly resolved side-chain peaks 
in 13C-13C 2D spectra (Figure 2.2b–c). This estimate was further improved by repeating the process for 
higher resolution 3D data sets—specifically, NCACX, NCOCX, and CAN(CO)CX spectra (at a signal 
threshold of 8)—which consistently revealed the presence of 70 ± 15 spin-systems. Notably, as there are 
five alanine residues in the AL-09 VL sequence, the observation of no more than five alanine 13C-13C 
peaks in the CC 2D (Figure 2.2b) and 3D spectra provided initial support for the existence of a 
homogenous fibril conformation. Furthermore, the majority of the resolved cross-peaks between the α- 
and β-carbons in each residue are indicative of a primarily β-sheet secondary structure (Figure 2.2a–c). 
Together, these data reveal that approximately 70 residues of the 110 total in the AL-09 sequence are 




Figure 2.2. a. 13C-13C 2D SSNMR spectra of [13C, 15N]-labeled AL-09 VL fibrils collected at 750 MHz 
and 0 ºC using 40 ms 13C-13C DARR (dipolar) mixing and 12.5 kHz MAS. Labels indicate a subset of 
site-specific residue assignments and spectral regions unique to specific amino acid types. b. Expansions 
of the Ala 13Cα-13Cβ region and c. Ser/Thr 13Cβ-13Cα region illustrate the extent of assignments and 
predominantly β-sheet secondary chemical shift trends. 
 
To pursue the site-specific identification of the residues involved in the highly structured fibril 
region, chemical shift assignments were made via a backbone-walk using a set of NCACX, NCOCX, and 
CAN(CO)CX 3D spectra (experimental details for each are described in Table 2.1). This analysis enabled 
the complete backbone assignments of 48 residues site-specifically within the AL-09 sequence, as well as 
partial assignments for an additional 8 residues (Figure 2.3 and 2.4). Furthermore, we have also made 
tentative assignments for residues I34, R61–G66, and S76–S77 (9 total); however, because the sensitivity 
of these spin-systems was relatively limited in the 3D data sets we could not confidently confirm the 
connectivity between these residues and their neighbors, and thus opted to exclude these assignments 
here. Interestingly, the majority of the assigned resonances are located within the first 35 and last 20 
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amino acids of the N- and C-termini, respectively. In addition, TALOS-N predictions of the secondary 
structure and order parameters (based on the chemical shift values of the assignments) support the 
existence of a highly ordered and β-sheet rich fibril structure (Figure 2.3)17.  
 
 
Figure 2.3. Secondary structure and extent of chemical shift assignments for AL-09 VL fibrils. TALOS-N 
predicted backbone dihedral angles psi (closed squares) and phi (open circles) are plotted a function of 
residue number; error bars correspond to the standard deviation of the averaged TALOS-N matches. AL-
09 residues for which chemical shifts have been assigned are labeled in blue; those in bold are 
unambiguous and have resonances assigned to all three backbone atoms. Highlighted residues indicate the 
location at which mutations occur; those that are underlined are non-conservative 
 
Overall, our results reveal that approximately 70 of the 110 residues in the AL-09 VL sequence 
are involved in the highly ordered fibril with β-strand secondary structure. Moreover, we observed that 
the majority of these rigid residues are located in the N- and C-termini of the AL-09 VL sequence and 
generally demonstrate strong and well-resolved backbone signals. By contrast, the residues located 
between the two termini (i.e., those immediately following N30 and preceding L94) exhibit relatively 
weaker signal intensities and/or chemical shift degeneracy, consequently leading to ambiguity. 
Nevertheless, the majority of these spin-systems were able to be assigned by amino acid type based on 
comparison with empirical chemical shift statistics. Further, the cross-peak intensities exhibited by these 
spin-systems were observed in most cases to range from 60–130% relative to the average peak intensity 
of site-specifically assigned residues. Together these observations provide support for the existence of a 
19 
 
single conformation of the AL-09 VL fibrils, as the distribution of total intensity between several different 
conformations of a single spin-system would lead to a substantial reduction in the intensity of each cross-
peak. Finally, one interesting correlation underlying the extent of chemical shift assignments reported 
here is that all seven mutations are positioned in the central portion of the AL-09 VL sequence, and only 
two of which have assignments for all backbone atoms (N30 and L83). Although a detailed understanding 
of the interactions engaged by the non-conservative mutations within the fibril structure will require 
completion of all chemical shift assignments, it is nonetheless noteworthy that the mutations are not the 
sole constituents of the ordered fibril core. 
 
2.6. ACCESSION NUMBERS 
Chemical shift assignments for AL-09 VL fibrils can be accessed on the BioMagResBank 
(BMRB) under entry number 26879. The GenBank accession number for the light chain cDNA of AL-09 
VL is AF490909. 
 
2.7. SUPPORTING INFORMATION 
Figure 2.4. Strip-plot of all unambiguously assigned residues for [13C, 15N]-labeled AL-09 VL fibrils. 
Sequential backbone and/or side-chain chemical shift assignments are illustrated using 3D NCACX (red), 
NCA(CB)CO (positive peaks, red; negative peaks, green), NCOCX (blue), and CANcoCX (black) spectra 
for residues a. S(-1)–D1, and S7–N30, as well as b. A51–S52, S67–T69, L83–T85, and L94–I106. Strips 
from the NCA(CB)CO 3D data were used in place of NCACX 3D strips for instances when the latter 
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3.2. ABSTRACT 
 Light chain-associated (AL) amyloidosis is a systemic disorder involving the formation and 
deposition of immunoglobulin light-chain fibrils in various bodily organs. One severe instance of AL 
disease is exhibited by the patient-derived variable domain (VL) of the light-chain AL-09, a 108 amino 
acid residue protein containing seven mutations relative to the corresponding germline protein, I O18/O8 
VL, from which it is derived. Previous work has demonstrated that the thermodynamic stability of native 
AL-09 VL is greatly lowered by two of these mutations—Y87H and N34I—while a third mutation, K42Q, 
further increases in the kinetics of fibril formation. However, detailed knowledge regarding the residues 
that are responsible for stabilizing the misfolded fibril structure is lacking. In this study, we show using 
solid-state NMR spectroscopy that the majority of the AL-09 VL sequence is immobilized in the fibrils 
and that the N- and C-terminal portions of the sequence are particularly well structured. Thus, AL-09 VL 
forms an extensively ordered and β-strand-rich fibril structure. Furthermore, we demonstrate that the 
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predominantly β-sheet secondary structure and rigidity observed for in vitro prepared AL-09 VL fibrils are 
qualitatively similar to those observed for AL fibrils extracted from post-mortem human spleen tissue, 
suggesting that this conformation may be representative of a common feature to AL fibrils. 
 
 
Figure 3.1. Table of contents and abstract graphic. 
 
3.3. INTRODUCTION 
Light chain (AL) amyloidosis is a severe form of systemic amyloidosis arising from the 
misfolding and deposition of immunoglobulin light chains as fibrils in the extracellular matrix of major 
organs throughout the human body, targeting sites such as the heart, kidneys, liver, spleen, and peripheral 
nerves.1 The average prognosis for AL disease patients varies depending on which organ is affected, 
generally ranging between two to three years but dropping to below a year if the site of fibril deposition 
occurs at the heart.2-4 Further, recent work has shown that the accumulation of AL fibrils around 
cardiomyocytes cultured in vitro may lead to cellular internalization of the fibrils and subsequent cell 
death by interrupting cell growth,5 possibly through affecting normal metabolic function.6 Devastatingly, 
the number of cardiac-inflicted AL patients accounts for approximately 50% of all AL disease cases, and 
despite ongoing efforts to more effectively hinder light-chain aggregation,7-9 the availability of therapy 
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options remains severely limited and primarily targets the plasma cell population secreting the pathogenic 
protein.1-4 
Light chain misfolding in AL disease presents a particularly interesting case of amyloidoses in 
that the fibril-forming light chain generally differs by a few mutations between each patient, due to the 
natural introduction of somatic mutations during the process of generating a wide variety of antibodies.10 
The variable domain (VL) of light-chain protein AL-09 (from patient AL-09)2 represents one severe 
instance of cardiac AL disease, which differs from its germline counterpart (ϰI O18/O8 VL) by seven 
somatic mutations (Figure 3.2.A).11 Three of these mutations are non-conservative—Y87H, N34I and 
K42Q—and are found to promote the propensity and rate of fibril formation at least in part by 
contributing a significant destabilizing effect on the native, soluble dimer form of AL-09 VL.10 In 
addition, previous studies on the soluble dimer structures of AL-09 VL and κI O18/O8 VL have 
demonstrated that the interface of AL-09 VL is twisted by 90º relative to the germline dimer interface and 
is the site at which the three non-conservative mutations are located (Figure 3.2.C–D).1,11 Indeed, these 
observations strongly suggest that the presence of these non-conservative mutations in AL-09 VL 
contribute to the protein’s amyloidogenicity by distorting the VL-VL interface of the soluble dimer 
structure. Further, solution-state nuclear magnetic resonance (NMR) studies on closely related VL 
domains have demonstrated that the residues located at the dimer interface are predisposed to exhibiting 
greater conformational flexibility relative to most regions outside the interface, particularly under 
destabilizing conditions, thus implying that increased dynamics also contributes to the fibril forming 
propensity.12,13 However, there remains limited knowledge on the extent and manner of influence that the 
different regions of the light-chain VL have on stabilizing the final fibril form. 
In pursuit of this interest, here we investigate the secondary structure and relative dynamics of 
AL-09 VL fibrils at the residue-specific level by magic-angle spinning (MAS) solid-state NMR (SSNMR) 
spectroscopy. Specifically, we demonstrate that the majority of the residues in AL-09 VL fibrils are highly 
rigid and exhibit a primarily -strand secondary structure, through chemical shift and dipolar coupling 
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analyses. Moreover, our results reveal that most of the uniquely-assigned rigid residues are located near 
the N- and C-termini (i.e., before N30 and after L94) and maintain a high degree of structural order and 
homogeneity at a site-specific level. These observations also demonstrate notable structural differences 
between the fibril and soluble forms of AL-09 VL, such as residues Y32–Q38 and K45–D50 which are 
ordered as a -sheet in the dimer crystal structure (Figure 3.2.D) but are not observed site-specifically in 
the fibril form (Figure 3.2.A–B). By contrast, residues S12–V15 and L94–T97 are observed as -strands 
in the fibril form, but fall on the outside of -strands in the soluble form (Figure 3.2). Finally, we show 
that the recombinantly-generated AL-09 VL fibrils studied here exhibit similar global structural features to 
those of AL fibrils directly extracted from human spleen tissue (referred to as HIG), supporting both the 
physiological relevance of our SSNMR studies as well as the possibility of identifying a structural motif 
that is common to all AL fibrils. Together, these results provide detailed insight into the extensive and 
unique structure of a toxic AL fibril, thus informing on the structure-based search for improved diagnostic 






Figure 3.2. (A) Sequence alignment of AL-09 and germline ϰI O18/O8 VL domains. Highlighted residues 
indicate mutation sites; those that are non-conservative are underlined. Residues labeled in blue are site-
specifically assigned; those that are unambiguous are in bold.14 (B) Averaged secondary 13C chemical 
shifts, C, plotted for each assigned residue in AL-09 VL fibrils. Values below or above the average 
random coil chemical shift values.16 Ccoil, (i.e., C < 0 or C > 0 ppm) correspond to a -strand or α-
helix secondary structure, respectively. (C–D) Crystallographic structures of the soluble dimer forms of 
germline ϰI O18/O8 and AL-09 VL domains, respectively.11 Mutation sites in AL-09 are drawn in red. 
 
3.4. RESULTS AND DISCUSSION 
3.4.1. AL-09 VL fibrils exhibit an extensive and β-strand rich structured region. 
 Based on the resonance assignments for approximately half of the protein sequence for AL-09 VL 
fibrils (BMRB 26879) and observation of approximately 70 spin-systems (the majority of which have 
been identified at the amino acid-type specific level),14 we pursued an analysis of the corresponding 
secondary structure and dynamics. In addition to obtaining initial insight on the secondary structure 
content of the fibril species through chemical shift-based predictions of the backbone dihedral angles 
using TALOS-N15 (Figure 3.7A),14 we performed secondary 13C chemical shift (∆) calculations for 
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residues in which the 13Cα, 13C’, and/or 13Cβ chemical shifts are assigned (Figure 3.2B).16 Here we report 
the averaged value of ∆ for each residue. Collectively, these 13C ∆ values inform on the type of 
secondary structure that a protein region exhibits—values close to zero indicate random coil 
(unstructured), while positive and negative values indicate α-helical and β-strand structure predictions, 
respectively.16 As illustrated in Figure 3.2B, the large majority of uniquely assigned residues are predicted 
to exhibit β-sheet secondary structure, consistent with our refined TALOS-N predictions as well as 
findings typically observed for other fibrils.14,17 
In addition to secondary structure information, the dipolar coupling-based SSNMR 13C-13C and 
15N-13C correlation experiments report on the relative dynamics across the sequence of AL-09 VL in its 
fibril state, with cross-polarization (CP) emphasizing the rigid regions. Thus, a comparison of the relative 
CP intensities resulting from these experiments for different residues in AL-09 VL fibrils offers a 
qualitative measure of their corresponding rigidity. Here we used the relative 13Cα-15N-13C’ (CANCO) 
peak heights of assigned AL-09 VL residues to inform on the site-to-site variation of rigidity across the 
sequence of the fibril species (Figure 3.7B). Our results reveal that the majority of the assigned regions of 
AL-09 VL exhibit CP intensities greater than 50% of the maximum peak height for residues with non-
overlapping signals. These residues are spread across the majority of the AL-09 VL sequence. 
Additionally, the general increase in intensity from residue Q6 to L11 and the subsequent decrease from 
I21 to D28 suggests that Q6 is near the beginning of its associated -strand while D28 is near the end, and 
that the flanking residues may be on the periphery of the highly ordered region. 
We further assessed the relative dynamics of AL-09 VL fibrils through a series of 15N-13Cα (NCA) 
2D experiments at temperatures below, near, and above the phase transition (-30 ºC, -10 ºC, and +20 ºC) 
of the bulk water in the samples (Figures 3.3A and 3.8). It is well known from a variety of amyloid 
systems that upon freezing the bulk water, CP intensity increases for those residues in mobile regions, and 
disordered portions of the sequence exhibit broader signals at the lower temperature.18-20 The NCA 2D 
spectrum provides multiple uniquely resolved cross peaks corresponding to a wide range of residues over 
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the AL-09 VL sequence, and so these experiments allow for the temperature-dependence of fibril rigidity 
to be assessed by monitoring the changes in signal-to-noise ratio and line width of each peak. 
Accordingly, the sensitivity and resolution of 11 resolved 15N-13Cα cross peaks were measured at each 
temperature (T0, G16, D17, I21, A25, S26, S67, T85, Y96, G99, and T102). These results demonstrate a 
consistent number of resolvable peaks for all temperatures, with only slight increases in average line 
width from +20 ºC to -30 ºC (13 ± 8 Hz, 15N dimension; 8 ± 19 Hz 13Cα dimension) and decreases in 
signal-to-noise ratio (26% ± 15% lower on average). This finding indicates that the AL-09 VL fibril 
structure remains highly ordered across a wide range of temperatures, and that this order is consistently 






Figure 3.3. (A) Overlay of 15N-13Cα 2D spectra with short contact times collected at +20 ºC (red) and -30 
ºC (blue). Individual spectra are shown in Figure 3.8. (B–C) 1Hα-13Cα dipolar coupling line shapes 
obtained from 2D T-MREV experiments at +20 ºC (red), -10 ºC (black), and -30 ºC (blue) are plotted 
along ω1/(2π) from -5.0 to +5.0 kHz for integrated 13Cα regions of (B) 60–61 ppm and (C) 54–55 ppm 
(experimental, solid; simulated, dashed). Fitting simulations for the shown line shapes all demonstrated 
order parameters of S ≥ 0.95. Additional fittings are provided in Figure 3.9. 
 
To extend upon these observations and obtain a quantitative measure of the protein dynamics, we 
performed 1H-13Cα dipolar coupling measurements for 13Cα 1D regions between 50–63 ppm using the T-
MREV21,22 pulse sequence (Figures 3.3B–C and 3.9). The scaled dipolar couplings (and order parameters) 
corresponding to 1 ppm-wide integrals of the 13Cα region were determined from fitting simulations (and 
normalization to NAV). Across the 13Cα chemical shift range of 50 ppm to 63 ppm, the order parameters 
consistently demonstrated values of ≥ 0.95, supporting the presence of an extensive and highly ordered 
fibril. Furthermore, the order parameters for the 13Cα spectral region exhibited no significant dependence 
on temperature (for all fitting simulations, see Figure 3.9). Together, these dipolar coupling data provide 
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strong support for the extensive rigidity of AL-09 VL fibrils—encompassing the majority of the 108 aa 
protein sequence (~70 residues)14—as well as a low dependence on temperatures above and below the 
bulk water phase transition. It is interesting to note that this rather extensive structured region observed 
for AL-09 VL fibrils is slightly larger than the sizes of several previously determined fibril structures, 
such as amyloid-β (21–40 residues), human prion protein variant huPrP23–144 (~28 residues), and α-
synuclein fibrils (~56 residues), yet comparable in size to that observed for PI3-SH3 fibrils (75 residues) 
and the long straight fibrils of 2-microglobulin (64 residues).18,23-27  
 
3.4.2. The N- and C-terminal residues of AL-09 VL are highly ordered in the fibril structure. 
As demonstrated above, one prominent feature of AL-09 VL fibrils is that a large proportion of 
the most highly ordered residues are located near the N- and C-termini of the protein sequence (Figures 
3.2 and 3.7).14 The 15N-13Cα-13CX 3D strips in Figure 3.4A–B demonstrate the high resolution and 
sensitivity for a subset of the N- and C-terminal residues, supporting both their high rigidity and structural 
order. Furthermore, the observation of strong and well-resolved side-chain cross peaks for these residues 
provides substantial support for their adoption of a single, ordered structure in the fibril state, as the 
existence of many different conformations would cause side-chain signals arising from multiple 
magnetization transfer steps to be much weaker and broader. Additionally, these residues appear to 
exhibit a homogenous conformation, because only a single set of corresponding backbone and side-chain 
cross-peaks are observed in each 3D strip (Figure 3.4). For example, for residue V15, two unique 
chemical shifts (22.6 ppm and 20.3 ppm) are observed for the geminal side-chain methyl carbons (13C1 
and 13C2), indicating that the residue only exists in one conformation (Figure 3.4A). Collectively, these  
observations of well-defined side-chain rotamers in the termini are particularly interesting in contrast to 
previous studies of other fibrils for which the termini are highly dynamic.19,28 Given both the high rigidity 
and order of the N- and C-terminal residues, it is very likely that these two regions are major participants 
in maintaining the rigid structural integrity of the fibril state. These data further suggest that AL-09 VL 
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fibrils demonstrate a long-range structural order which may be a unique feature of AL proteins relative to 




Figure 3.4. Strip plot from the 3D NCACX spectrum of [13C,15N]-labeled AL-09 VL fibrils, 
demonstrating the backbone and side-chain atom assignments for (A) S10 to D17 (N-terminal residues) 
and (B) L94 to T102 (C-terminal residues). The sequential backbone atom connectivity of these and all 
other assigned residues is described previously.14 Data were acquired at 600 MHz with a MAS rate of 




To quantify the rigidity of the termini at a site-specific level, we performed the 3D R48318 version 
of R-symmetry sequences31 with SPC-7 13C-13C mixing32 to measure the scaled 1H-13Cα dipolar couplings 
of 14 total residues located at either the N- or C-terminus (resolved in a third dimension via the 13C). 
Specifically, these residues include S7, S12–V15, V19–I21, and A25 (N-terminus) as well as A84, T85, 
L94, P95, and T97 (C-terminus), and were chosen because they exhibited strong 13Cβ-13Cα cross-peaks in 
the first CC 2D spectral plane (i.e., those above 15 times the noise floor) from which the dipolar 
dephasing trajectories could be readily extracted (Figure 3.5A). For all cases, the simulated 1H-13Cα 
scaling factors corresponded to order parameters, S ≥ 0.95 relative to the residue exhibiting the highest 
scaling factor, I21 (Figures 3.5B–C and 3.10). Collectively, the large magnitude of these backbone 13Cα 





Figure 3.5. Site-specific 1Hα-13Cα dipolar coupling measurements for AL-09 VL fibrils. (A) First 13C-13C 
2D plane of the R48318-symmetry 3D experiment, collected with SPC-7 q42 13C-13C mixing at 20 ºC 
(black and red peaks indicate positive and negative signal intensity, respectively). Residues for which the 
1H-13Cα dipolar coupling line shapes were extracted and simulated are labeled. (B–C) A subset of the 
experimental (solid) and simulated (dashed) line shapes illustrating the site-specific rigidity of several 
residues near the N- and C-termini (B and C, respectively) of the AL-09 VL sequence. The corresponding 
order parameter, S, for each 13Cα site is indicated next the line shape (normalized to the site with the 
largest measured 1H-13Cα scaling factor). Additional fitting simulations are shown in Figure 3.10. 
 
Interestingly, as described previously on amyloidogenic/AL VL domains, a “cryptic epitope” is 
proposed to occur within the first 18 residues of the N-terminus in which the presence of a proline at 
position 8 in combination with residues 1–4 and 13–18 supports the formation of an aberrant bend within 
-strand A of the native VL domain.33 This conformational rearrangement of the N-terminus around P8 
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upon VL misfolding would be consistent with our observation of its involvement in the fibril structure, as 
the CANCO CP efficiency generally increases in either direction for residues before and after P8 (Figure 
3.7B). Furthermore, the presence of a bulge in strand G at the C-terminus of VL domains (residues 97–
108) has been implicated in serving as a protective structural motif that discourages fibril formation,34 
with a particularly prominent -bulge in kappa VL domains over lambda structures.35 It is possible that 
during fibril formation this motif undergoes a conformational change that supports an aberrant—yet 
highly ordered—conformation. Given that both the N- and C-termini of the AL-09 VL sequence contain a 
~12 aa stretch of generally intervening hydrophilic-hydrophobic residues (i.e., S10–T22 and Y96–K107), 
one entropically-favorable rearrangement that may occur could be through the interaction of these regions 
via their hydrophobic side chains. Certainly, understanding the specific orientation and interactions 
associated with the N- and C-terminal residues of AL-09 VL fibrils is fundamental to determining the 
tertiary fibril structure, and may be pursued in future SSNMR studies by the measurement of 
intramolecular distance restraints36,37 in combination with sparsely or selectively 13C-labeled 
samples.17,36,38-40 
Additional insight into the structure and formation of AL-09 VL fibrils is provided by 
consideration of the effects of mutations on the protein stability. Globular proteins undergo partial 
unfolding in order to initiate misfolding events. This is unlike unstructured peptides (A peptide) and 
intrinsically disordered proteins (-synuclein) that initiate misfolding events from an unstructured or 
unfolded state. Mutations associated to amyloid diseases—in general—decrease the conformational 
stability of the globular native fold and promote aggregation in vitro. These mutations usually influence 
the thermodynamics of the process, and may not participate in direct interactions within the fibril 
structure.41 Our mutational analyses of AL-09 VL have shown that the non-conservative mutations located 
within the dimer interface of the soluble protein structure destabilize the protein and accelerate amyloid 
formation.10 As non-conservative mutations in AL proteins may lower the energy barrier for the initial 
misfolding events to occur, we hypothesize that these effects are involved in the case of AL-09 VL during 
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the amyloid nucleation event. Accordingly, in combination with our observation of possibly reduced CP 
signal intensity and/or resolution for peaks corresponding to mutation sites, this description suggests that 
the mutations have critical influence in the early misfolding event but may not be key contributors to 
maintaining the rigid final fibril structure. Such an explanation would be consistent with the extensive 
rigidity and order we report to primarily be localized in the N- and C-terminal regions of AL-09 VL 
fibrils. 
 
3.4.3. AL-09 VL fibrils prepared in vitro exhibit structural similarities to AL extracts from human 
tissue. 
 In order to assess the physiological relevance of the AL-09 VL fibril samples studied herein, we 
investigated the structural similarities to in vivo fibrils by comparing the (1H)-13C CP 1D spectrum of AL-
09 VL fibrils (U-[15N,13C]-labeled) with that of AL fibril deposits extracted directly from post-mortem 
human spleen tissue (HIG; natural abundance) (Figure 3.6A). These ex vivo fibrils share the same ϰI 
germline gene product with AL-09 VL, which minimizes the number of amino acid differences between 
the two samples (Figure 3.6B). As illustrated in Figure 3.6A, the HIG fibrils are well structured and 
exhibit similarities in chemical shift patterns as AL-09 VL fibrils, such as with respect to the downfield 
Thr- and Ser-13Cβ chemical shifts indicative of predominantly a β-sheet secondary structure. Furthermore, 
unique glycosaminoglycan (GAG) signals are observed near 75 ppm and 183 ppm in the HIG spectrum 
(arising from the hydroxyl-containing and carboxylate carbons of GAGs, respectively), consistent with 
mass spectrometric analysis which revealed the presence of heparan sulfate proteoglycan (HSPG2) in the 
spleen tissue extract. Together, these results are in agreement with the known association of 
glycosaminoglycans with AL fibrils in vivo.42,43 Other spectral differences can be accounted for by 




Figure 3.6. Comparison of AL-09 VL fibrils with AL spleen tissue extract (HIG). (A) Overlay of 13C 1D 
SSNMR spectra (normalized to 13Cα region) for 13C natural abundance amyloid extract from postmortem 
splenic tissue (HIG; green) and AL-09 VL (black) fibrils. (B) Sequence alignment for HIG, AL-09, and κI 
O18/O8 (germline; gray) VL proteins (residues –1 and 0 are purification artifacts). Highlighted residues 
indicate mutation sites; those that are non-conservative are underlined. 
 
In addition to providing foundational insight on the structural similarities of two AL fibrils, these 
results represent the first demonstration of the feasibility of studying the molecular structures of AL 
fibrils that are pathologically relevant. Moreover, although the spectral sensitivity of ex vivo fibrils is 
limited by the lack of 13C and 15N enrichment, future structural studies of tissue fibril deposits will be 
facilitated by using the fibril material as a seed for in vitro preparations of isotopically-labeled fibril 
samples. This approach has been shown to be successful in previous SSNMR studies for Aβ1–40 fibrils 
extracted from Alzheimer’s disease afflicted brain tissue.44 These studies will be further supported by the 
ability to immediately assess the physiological relevance and structural similarity of the labeled fibrils 
using the (1H)-13C CP 1D spectrum obtained for HIG fibrils here as “fingerprint” comparison (Figure 
3.6A). 
As described earlier, one inherent challenge associated with the study of AL disease is the large 
sequence variation that can occur between patients, consequently limiting the ability to predict and 
identify early-on the occurrence of light-chain sequences with high fibril-forming propensity. 
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Interestingly, however, previous work has identified a murine monoclonal antibody that can be used to 
specifically bind light chain fibrils (as opposed to the native soluble species) irrespective of slight 
sequence variations—even between germline isotypes—so long as a proline is present at position 8 of the 
protein sequence.33,45 These observations indicate that a unique structural motif forms around P8—
previously proposed to be a β-turn—that binds specifically to the binding domain of the murine antibody. 
Given that P8 is 100% conserved among kappa light-chain sequences such as AL-09 and HIG (Figure 
3.6B) and that it exhibits structural order in AL-09 VL fibrils, it is possible that the corresponding 
structure of the N-terminal region represents this unique recognition motif. While additional structural 
studies will be necessary to confirm this, the agreement of these two structures would suggest that all AL 
fibrils containing this proline-8 would adopt the same structural motif and possibly other similar aspects 
of the structural framework of the fibril. Certainly, knowledge of whether a prevailing structural 
conformation or motif exists between different AL fibrils would provide enormous support for the 
structure-based design of potential diagnostic or therapeutic strategies, thus further emphasizing the 
importance of future structural studies on pathologically relevant AL fibrils. 
 
3.5. CONCLUSIONS 
In this study, we investigated the secondary structure and relative dynamics across the AL-09 VL 
sequence in its fibril form through the use of MAS SSNMR spectroscopy, and subsequently assessed the 
structural similarity of ex vivo AL fibrils obtained from spleen tissue with in vitro-generated AL-09 VL 
fibrils used in the study here. Overall, our data reveal that extensive regions of the AL-09 VL sequence are 
highly rigid and β-strand rich in the fibril state, encompassing the majority of the residues in the protein. 
Further, our results indicate that the residues near the N- and C-termini are especially well-ordered and 
exhibit only a single conformation in the fibril form. These measurements of fibril rigidity and relative 
order were performed at both the global sample and site-specific levels. In light of the success of previous 
work on the determination of other fibril structures, such as amyloid-β in Alzheimer’s disease and α-
synuclein in Parkinson’s disease,23,25 the results presented here on AL-09 VL fibrils are very promising 
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with respect to the feasibility of determining the corresponding three-dimensional structure. Furthermore, 
the unique structural features already observed for AL-09 VL fibrils—including the high degree of order 
for N- and C-terminal residues—relative to other fibril structures suggests that AL-09 exhibits a different 
and possibly novel type of fold or packing. Moreover, the serine-rich sequence of AL-09 VL relative to 
the generally hydrophobic-rich sequences of other amyloid fibrils46,47 may lead to the contribution of 
additional complexities to the fibril structure. 
In comparing the one-dimensional 13C spectrum of in vitro-prepared AL-09 VL fibrils with that of 
ex vivo AL fibrils obtained from human spleen tissue, our results demonstrate that both fibrils exhibit a 
high degree of rigidity and β-strand content. Importantly, these data also set the framework on which 
additional pathologically relevant AL samples may be studied, including the in vitro preparation of 
isotopically-labeled AL fibrils by the introduction of a fibril seed from the tissue extract to propagate the 
relevant structure. Indeed, given the recent identification of AL fibrils as the toxic species to 
cardiomyocytes in vitro by causing cell growth arrest,5 there is tremendous value in the delineation of the 
molecular fibril structure for benefiting the pursuit of AL therapies that are directed at the fibril species. 
Accordingly, we envision that these structural insights into AL fibrils will inform the ongoing search for 
effective treatments and biomarkers of AL disease, including small molecule inhibitors of fibril formation 
as well as monoclonal antibodies specific for insoluble light chain fibrils.4,8,9,33,48 
 
3.6. EXPERIMENTAL SECTION 
Protein Expression and Purification. Uniformly [13C,15N]-labeled AL-09 VL protein (a light-chain 
variable domain derived from a cardiac AL patient)2 was expressed and purified utilizing a modification 
of earlier methods4,49 to accommodate minimal media with 13C and 15N isotopes, as described.14 
Escherichia coli BL21 (DE3) Gold competent cells (Stratagene, La Jolla, CA), were used to express the 
AL-09 VL plasmid (pET12a) in 2xYT media (Sigma-Aldrich, Saint Louis, MO), and grown until an 
A600nm of 0.6. The culture was subsequently transferred into minimal M9 media50 (with labeled [13C]-
glucose and [15N]-ammonium chloride; 3.0 g and 1.0 g per L media, respectively) at a four-fold higher 
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cell concentration, and incubated for 1 h at 37 °C before induction with IPTG (0.8 mM). Expression was 
allowed to persist overnight at 25 °C and 100 rpm prior to harvesting. Protein purification was performed 
using osmotic shock (as described),14 followed by injection onto a HiLoad 16/60 Superdex 75 size-
exclusion column in 10 mM Tris–HCl, pH 7.4 buffer using an AKTA FPLC system (GE Healthcare; 
Piscataway, NJ). 
AL-09 VL purity and concentration were assessed by SDS-PAGE and UV absorption (extinction 
coefficient, ɛ = 13,610 cm-1 M-1), respectively. Far UV circular dichroism (CD) spectroscopy was used to 
verify native protein folding prior to the fibril formation reaction, acquiring from 200–260 nm at 4 °C 
with a Jasco Spectropolarimeter 810 (JASCO, Inc., Easton, MD) and a 0.2 cm path-length quartz cuvette. 
Percent [13C, 15N]-isotope incorporation in purified AL-09 VL was determined by MALDI-TOF to be 
approximately 99%. 
In vitro Fibril Formation. Uniformly [13C, 15N]-labeled AL-09 VL fibril samples were formed from 
purified protein monomer as described.14,51 AL-09 VL monomer was separated from any pre-formed 
aggregates by filtering the purified product through a 0.45 m membrane and subjecting the filtrate to 
ultracentrifugation (90,000 rpm, 3.3 h) at 4 ºC using a NVT-90 rotor and Optima L-100 XP centrifuge 
(Beckman Coulter, Brea, CA). Fibril-forming samples were subsequently prepared on ice from the 
monomer-containing supernatant at 20 M in Acetate Borate Citrate buffer (10 mM each, pH 2.0), 
containing 150 mM NaCl and 0.02% NaN3 in 1.5 mL low-binding microcentrifuge tubes (1.0 mL total 
volume). An additional sample was prepared for each replicate under the same conditions, but with 10 
M Thioflavin T (ThT) added for monitoring fibrillation progress. Fibril formation reactions were 
performed in triplicate in sealed (Nunc, Roskilde, Denmark), black 96-well polystyrene plates (Greiner, 
Monroe, NC) at 37 °C and 300 rpm (New Brunswick Scientific Innova40 incubator shaker), using 260 µL 
aliquots per well until fibril formation was complete based on the change in enhanced fluorescence 
intensity of ThT. The presence of fibrils was subsequently confirmed by transmission electron 
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microscopy (TEM), according to previous protocols.14 The average time for AL-09 VL fibrils to form was 
approximately two days. 
Preparation of Fibrils for SSNMR Studies. As previously described,14 completed fibril reaction 
mixtures were subjected to ultracentrifugation in polypropylene microfuge tubes using a table-top 
ultracentrifuge with a TLA-100.3 (Beckman Coulter) rotor and microfuge tube adapters for 1 h at 4 ºC 
and 55,000 rpm (~100,000 g). Pelleted fibril material was separated from the supernatant and washed 
twice with deionized water using a hand-homogenizer and repeated ultracentrifugation. Washed fibril 
pellets were dried completely under nitrogen gas until the sample mass remained unchanged. Dried AL-
09 VL fibril samples were packed into either a 3.2 mm (outer-diameter) standard-wall or thin-wall 
SSNMR MAS rotor (Agilent Technologies, Santa Clara, CA) and hydrated to a level of 50% water by 
mass. Hydration of packed samples was retained using Kel-F and rubber spacers on both ends of the 
sample in the rotor. 
AL Amyloid Extraction. Patient HIG was a male Caucasian diagnosed with multiple myeloma and 
subsequently hepatosplenic ALκ amyloidosis. The light chain component comprising the amyloid fibrils 
was shown by amino acid (aa) sequencing to be a κI protein expressed by the O18-O8 (IGKV-1-33) 
germline gene with a glycosylation site introduced at N30-N31-S32. 
Water-soluble amyloid extracts were prepared following prior protocols with some modifications.45,52 
In short, 30–40 g of freshly-frozen (-80 °C) spleen obtained postmortem from patient HIG were 
homogenized in about 300 ml pre-chilled saline solution (Virtis-Tempest; Virtis, Gardiner, NY). The 
resulting homogenate was centrifuged for 30 min at 6 °C and 15,000 g and residual saline-soluble 
material was removed by repeated cycles of homogenization and washing until the optical density (at 280 
nm) of the supernatant was less than 0.10. The pellet was then subjected to repeated rounds of 
homogenization, washing (cold, de-ionized water), and centrifugation, collecting and lyophilizing the 
amyloid-containing supernatant after each successive round. The amount of protein recovered represented 
~25% the weight of the starting material. Approximately 10 mg of the lyophilized material were 
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rehydrated to ~50% water by mass and packed into a 3.2 mm standard-wall SSNMR rotor (Agilent 
Technologies). 
Solid-State NMR Spectroscopy. MAS SSNMR data of [13C,15N]-labeled AL-09 VL were collected 
on the following spectrometers: a 600 MHz InfinityPlus wide-bore or narrow-bore spectrometer equipped 
with a 3.2 mm Balun 1H-13C-15N or T3 1H-13C-31P probe, respectively; a 500 MHz VNMRS (Varian, 
Walnut Creek, CA) spectrometer equipped with a 3.2 mm Balun 1H-13C-15N probe; and a 750 MHz 
VNMRS spectrometer equipped with a 3.2 mm Balun or BioMAS 1H-13C-15N probe (Varian, Fort Collins, 
CO). Multidimensional 15N and 13C correlation experiments were acquired using a MAS rate of 11.111 
kHz (500 MHz spectrometer), 13.333 kHz (600 MHz), or 12.500 kHz (750 MHz), and a variable-
temperature (VT) stack air flow set-point of -10 ºC, 0 ºC or 10 ºC (for sample temperatures of -5 ºC, 4 ºC 
or 12 ºC ± 3 ºC, respectively, as determined by calibration with ethylene glycol).53 A SPINAL-64 1H-
decoupling power of 65–80 kHz was applied during evolution and acquisition periods.54 One-bond 13C-
13C correlations were achieved using either dipolar-assisted rotational resonance (DARR; τmix = 25–90 
ms)55 or supercycled POST-C7 (SPC-7; τmix = 0.9–1.8 ms)32 for magnetization transfer, and one-bond 
15N-13C or 13C-15N correlations were accomplished using SPECIFIC-CP.56 Additional experimental details 
for multidimensional data acquisition (e.g., digitization settings and specific radio-frequency powers) are 
summarized previously.14 
Temperature dependent 15N-13Cα (NCA) 2D experiments were performed at -30 ºC, -10 ºC, and 20 ºC 
(VT set points, corresponding to sample temperatures of -23 ºC, -5 ºC, and 21 ºC ± 3 ºC, respectively), 
using a MAS rate of 13.333 kHz (600 MHz) and SPINAL-64 1H-decoupling power13 of 72 kHz. Short 
cross-polarization contact times of 0.1 ms and 2.0 ms were used for 1H-15N and 15N-13Cα transfers, 
respectively, to promote only intraresidue magnetization transfer (relative to other 1H-15N-13C correlation 
experiments which used times of 1.5 ms and 5.0 ms, respectively). T-MREV 1H-13C dipolar recoupling 
experiments22 were performed at the same three temperatures (VT), but using a MAS rate of 7.576 kHz 
(600 MHz) and TPPM 1H decoupling power18 of 72 kHz. Scaling factors for 1H-13C dipolar couplings of 
AL-09 VL fibrils were normalized to the 1H–13Cα scaling factor measured for crystalline [13C, 15N]-
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labeled N-acetyl-valine. R48318-symmetry 1H-13C-13C-1H 3D dipolar recoupling experiments were 
performed using a MAS rate of 13.333 kHz (600 MHz) and VT set-point of 20 ºC, with a SPINAL-64 1H-
decoupling power of 74 kHz. MAS SSNMR data for the spleen tissue AL extract sample (HIG) were 
collected on the 600 MHz narrow-bore spectrometer using a MAS rate of 10.000 kHz, a VT set-point of 
10 ºC, and a SPINAL-64 1H-decoupling power of 65 kHz. (1H)-13C CP 1D spectrum represents a total of 
61.5 h of data collection time (108,544 scans). 
Solid-State NMR Data Processing and Analysis. SSNMR data were processed using NMRPipe.57 
Multidimensional 15N and/or 13C correlation spectra were analyzed using Sparky,58 and chemical shift-
based predictions on protein secondary structure were performed using TALOS-N15 as well as 
comparison to the random coil chemical shift values presented by Zhang et al.16 T-MREV and R48318-
symmetry 1H-13C dipolar coupling dephasing curves were analyzed using an in-house fitting program 
(written in FORTRAN).22 The zero-frequency intensity present in R-symmetry spectra was excluded from 
the fitting simulations.59 
3.7. ASSOCIATED CONTENT 
3.7.1. Accession Numbers 
Backbone and side-chain (partial) 13C and 15N chemical shift assignments for AL-09 VL fibrils are 
available on the BioMagResBank (BMRB) under accession number 26879. Information on the light chain 
cDNA of AL-09 VL is available on GenBank under accession number AF490909. 
 
3.7.2. Supporting Information 
TALOS-N predicted backbone dihedral angles and relative CANCO peak heights (Figure 3.7), 
the un-overlaid set of 15N-13Cα 2D spectra at -30 ºC, -10 ºC, and 20 ºC (Figure 3.8), and the complete set 




Figure 3.7. (A) TALOS-N predicted backbone dihedral angles for AL-09 VL fibrils, plotted as a function 
of residue number (psi, closed squares; phi, open circles); error bars indicate the standard deviation of the 
averaged TALOS-N matches. (B) Normalized peak heights from the cross-peaks of the CANCO 3D 
spectrum of U-[13C,15N]-labeled AL-09 fibrils. Residue number corresponds to that of the carbonyl 
resonance; error bars correspond to the estimated spectral noise. Residues labeled with a # symbol were 
excluded due to partial peak overlap in the CANCO 3D spectrum. Highlighted residues represent 





Figure 3.8. 15N-13Cα 2D spectra of AL-09 VL fibrils with short contact times collected at +20 ºC (A; red), 





Figure 3.9. 1Hα-13Cα T-MREV experimental (solid) and simulated (dashed) fittings for a range of 1 ppm-
wide 13Cα regions (between 50–63 ppm) for AL-09 VL fibrils at (A) -30 ºC, (B) -10 ºC, and (C) +20 ºC. 
Dipolar coupling line shapes are plotted along ω1/(2π) from -5.0 to +5.0 kHz. Data were collected at 600 
MHz (1H) and a MAS rate of 7,576 Hz, and all line shapes were fit assuming a 13Cα spin-topology 
coupled to three protons (15N(H)-13Cα(H)-13Cβ(H)x). (D) 1Hα-13Cα dipolar order parameters for T-MREV 
fitting simulations of 1 ppm-wide integrated 13Cα regions between 50 ppm to 63 ppm, at -30 ºC (blue 





Figure 3.10. Site-specific 1H-(13Cβ/’)-13Cα-1H dipolar coupling line shapes (experimental, solid; 
simulated fit, dashed) obtained from 1H-13C-13C-1H R48318-symmetry 3D (SPC-7 q42 13C-13C mixing) 
data for AL-09 VL residues located near the (A) N-terminus and (B) C-terminus. The corresponding order 
parameter, S, for each 13Cα site is indicated next the line shape, and is normalized to the residue 
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CHAPTER 4: Distinct Structural Features of Light-Chain Fibrils Revealed by Four-Dimensional 
13C-Detected Solid-State NMR Spectroscopy  
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4.2. ABSTRACT 
 In this work, the structural features of light chain amyloidosis (AL) fibrils composed of the 
patient-derived protein AL-09 were investigated by the application of 13C-detected four-dimensional 
heteronuclear correlation SSNMR experiments. In addition to enabling the efficient extension and 
confirmation of 13C and 15N backbone and side-chain chemical shift assignments for the fibril structure, 
our results reveal a distinct set of backbone torsion angle restraints for the central regions of the AL-09 
variable domain (VL) sequence, which were previously unattainable by traditional three-dimensional 
methods. SSNMR data with sufficiently high resolution and sensitivity for performing detailed spectral 
analyses were obtained through the implementation of band-selective J-decoupling pulses on the indirect 
13C-dimensions in 13Ci-15Ni-13C’i-1-13CXi-1 4D type experiments in combination with non-uniform 
sampling (NUS) regimes. Overall, our data suggest the existence of a unique structural motif for the core-
forming residues of AL-09 VL fibrils, shedding light on the interplay of the terminal and central regions of 





 Light-chain (AL) amyloidosis is an aggressive systemic disease in which an over-expression of 
unstable immunoglobulin light-chain proteins in patients culminates in the formation and deposition of 
insoluble fibrils at various sites throughout the body, including the heart, kidneys, liver, and peripheral 
nerves1,2. The median survival for AL patients is 12–40 months, and becomes even more severe when the 
afflicted organ is the heart, which occurs in more than 48% of patients1-4. There is currently no known 
cure for AL, and efforts towards identifying effective diagnostic and treatment strategies, such as 
structure-based drug discovery, would largely benefit from a greater understanding of the molecular 
determinants that drive the fibril formation process as well as the structural details of the toxic fibril 
species5-8. 
Molecular-level insight into the structure of insoluble biomolecules such as protein fibrils can be 
obtained through the use of solid-state nuclear magnetic resonance (SSNMR) spectroscopy. Previous 
studies by our group and others have demonstrated the application of two- and three-dimensional SSNMR 
experiments to the study of AL fibrils, providing the first sets of high resolution details on the secondary 
structure and dynamics for two separate AL patient-derived light-chain sequences9,10. However, due to the 
observation of partial 13C and 15N chemical shift degeneracy (e.g., arising from repetitive amino acid 
motifs in the sequence) or weaker signal intensity for slightly more dynamic regions of the fibril structure, 
the ability to uniquely resolve and sequentially assign all of the structured regions of the fibrils—and thus 
arrive at a complete three-dimensional structure—has remained an inherent challenge. 
Indeed, a vast number of effective methods have been developed for addressing such limitations 
on spectral resolution in SSNMR studies of biomolecules. One of the most direct approaches that 
researchers have pursued is the use of higher-dimensional internuclear correlation experiments (e.g., 4D 
and 5D spectroscopy), which can allow the removal of chemical shift degeneracy that may be present in 
3D spectra. For example, SSNMR experiments have been developed to employ inter-residue polarization 
transfer schemes, such as the CANCOCX 4D sequence11, which can been applied to insoluble protein 
systems to yield sequential, site-specific chemical shift assignments of backbone atom correlations12. 
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Additionally, the removal of homonuclear 13C-13C J-couplings can serve as an alternative means to 
improving spectral resolution, either through the application of band-selective pulses on uniformly [13C, 
15N]-labeled samples13,14 or the preparation of sparsely 13C-labeled protein samples using [1,3-13C]- or [2-
13C]-labeled glycerol as a growth substrate15. In effect, both strategies offer substantial enhancements to 
the spectral resolution of unique internuclear cross peaks, thus relieving limitations to spectral analysis 
due to chemical shift degeneracy. 
Importantly, however, achieving the full benefit on resolution through these methods also 
typically requires substantial lengthening of the total experiment time, sometimes even on the order of 
multiple weeks. As such, the combination of these techniques with more efficient data acquisition 
schemes—particularly non-uniform sampling (NUS)—can serve as a powerful experimental strategy for 
achieving the high-resolution necessary for resolving otherwise overlapped cross peaks in a practical 
amount of time16. The use of NUS in 4D SSNMR experiments is becoming increasingly more routine 
among researchers as a strategy for effectively circumventing this time-constraint, in which a much 
smaller percentage of the multidimensional sampling grid (in some cases as little as 1%) may be acquired 
and still provide the sensitivity and resolution necessary for complete spectral analysis17. For instance, 
previous SSNMR investigations have demonstrated the utility of NUS 4D spectroscopy to obtain 1H-1H 
distance restraints through 1H-15N-15N-1H-edited 4D experiments18. Furthermore, this approach has been 
successfully applied for improving the extent of chemical shift assignments for insoluble protein systems 
by performing 1H-detected NUS 4D experiments to obtain intra- and inter-residue backbone correlations19 
as well as 13C-detected dynamic nuclear polarization (DNP) NUS 4D experiments to achieve protein side-
chain correlations20. 
Here we describe the implementation of 4D NUS 13C-detected heteronuclear correlation 
experiments in combination with selective pulses to achieve 13C-13C scalar decoupling and SPC-N mixing 
to enable the efficient acquisition of spectral data with substantial improvements in resolution and 
sensitivity. We apply this to the case of AL-09 VL fibrils to allow for the nearly complete chemical shift 
assignments of the observed structured fibril regions. Our results reveal that the central region of the 
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protein sequence exhibits distinct conformational and dynamical characteristics relative to other regions 
of the sequence, and may indicate the existence of a loop structure within the rigid fibril core that is 
primarily stabilized by the highly immobile residues of the N- and C-termini. These insights strongly 
support the hypothesis that the non-conservative mutations are responsible primarily for destabilizing the 
dimer complex and allowing misfolding to occur rather than being involved structurally in the final fibril 
form, while the N- and C-terminal residues (with partial involvement from the other central regions of the 
sequence) are integral for maintaining the structural rigidity and integrity of the AL-09 VL fibril species. 
 
4.4. RESULTS AND DISCUSSION 
4.4.1. Achieving resolution and sensitivity enhancements through J-decoupled 13C-detected 4D 
SSNMR spectroscopy. 
We present the implementation of a 4D pulse sequence that combines options for J-decoupling 
pulses and SPC-N mixing with 13C-detection, allowing for highly efficient polarization transfer for both 
13Ci-15Ni-13C’i-1-13CXi-1 (CANCOCX; i to i-1) or 13C’i-1-15Ni-13Ci-13CXi (CONCACX; i-1 to i) 
correlation pathways (Figure 4.1A). The incorporation of these elements is illustrated in the pulse 
sequence diagrams in Figures 1B-C. The sequence begins with the transfer of initial magnetization from 
1H to 13C by SPECIFIC cross-polarization (CP), followed by the first chemical shift evolution period 
(t1)21. Polarization is then transferred to 15N for the second evolution period (t2) and back to 13C for the 
third indirect dimension (t3), followed by a 13C-13C mixing period (either DARR or SPC-N)22,23 and 
finally direct detection of the resulting signal (tacq). SPECIFIC-CP is used for all heteronuclear transfer 
steps21, during which continuous-wave (CW) decoupling is applied on the 1H channel (apart from the 1H-
13C transfer step); SPINAL-64 is used for 1H decoupling during all evolution periods and acquisition24. In 
addition, band-selective (soft) pulses may be applied to both indirect 13C dimensions14,25 to provide further 
resolution and sensitivity enhancements (during which TPPM is used for 1H-decoupling)26. Last, to enable 
the efficient acquisition of 4D data sets, we digitized all three indirect dimensions according to a NUS 
regime with sampling densities of 0.5–3.7% and exponential decay rates of 4–7 Hz16,27. 
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 We evaluated the improvement in resolution and sensitivity upon additional implementation of J-
decoupling soft pulses by performing our initial experiments on the 1 immunoglobulin binding domain 
of protein G (GB1) as a protein standard. Towards this end, following the acquisition of both CANCOCA 
SPC-5 q60 (1.08 ms) and CANCOCX 50 ms 4D spectra with and without the use of soft pulses (Table 
4.1), respectively, we analyzed and compared the line widths of the indirect 13C dimensions and signal-to-
noise ratios (SNR) of all 55 13Ci-15Ni-13C’i-1-13Ci-1 peaks observed in the data sets28. Overall, this 
revealed an average improvement in line width of 45 Hz and 43 Hz ± 10 Hz for the 1 and 3 indirect 
13C-dimensions, respectively. The removal of J-couplings via application of soft pulses represents the 
primary contributor to improvements in resolution, as is supported by the analysis of changes in line 
widths observed for the 15N dimension (on which no selective pulse is applied) resulting from the use of a 
50% longer evolution time, which revealed a 7 Hz ± 10 Hz reduction line width. We also note that the use 
of slightly longer evolution times in combination with the use of soft pulses not only provides an 
additional enhancement to the resolution in the indirect 13C dimensions, but also allows for the full benefit 
of sensitivity to be achieved by removing the cos(Jt) modulation from the signal decay function for the 
indirect dimension evolution period29. Accordingly, the average sensitivity of cross peaks observed in the 
experiment with applied soft pulses remained within 8% of the average observed in the experiment 
without soft pulses. Thus, these results demonstrate the capacity of the presented CNCC 4D experiment to 
provide substantial improvements to spectral resolution while at the same time retaining maximal 





Figure 4.1. (A) Polarization transfer pathway schematic and (B–C) variety of 13C-15N-13C-13C 4D pulse 
sequence setups performed on U-13C,15N labeled AL-09 VL fibrils to obtain a diverse set of spectral 
information for enabling chemical shift and structural analyses. 
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4.4.2. Chemical shift assignments by CNCC 4D experiments reveal that central regions of the AL-
09 VL sequence are involved in the fibril core. 
We proceeded to perform several variations of these 13C-15N-13C-13C 4D experiments on U-
[13C,15N] labeled AL-09 VL fibrils, in order to provide inter-residue backbone and sidechain correlation 
information that complements the 3D data reported previously30. In particular, as detailed in Table 4.1, 
these included: a CANCOCA SPC-8 q64 (1.28 ms) 4D without J-decoupling and with modest digitization 
lengths (t1max = 5.12 ms, t2max = 10.24 ms, t3max = 5.12 ms) (Figure 4.1B); a CANCOCA SPC-8 q64 
4D with J-decoupling pulses and extended digitization times (t1max = 7.68 ms, t2max = 15.36 ms, t3max = 
10.24 ms) (Figure 4.1C); and a CANCOCX 50 ms (DARR) 4D under the same conditions (Figure 4.1D), 
allowing for the observation of i to i-1 inter-residue correlations with polarization transfer optimized for 
the emphasis of C or side-chain resonances in the 4 dimension. Subsequently, the complementary 
CONCACO SPC-8 q64 4D spectrum was acquired with similar digitization for each corresponding 
nucleus and the application of J-decoupling soft pulses to achieve i to i+1 inter-residue backbone 
connectivity. In order to enable the efficient collection of these data sets with optimal digital resolution, 
all 4D experiments were performed according to a 2.0–3.7% NUS schedule with a 4–7 Hz exponential 
decay biasing factor and digitizing out to maximum evolution times near the T2 value of the 
corresponding nucleus. For instance, 4D experiments employing soft pulses on both indirect 13C-
dimensions were collected using maximum evolution times of 7.68 ms, 15.36 ms, and 10.24 ms for 13C, 
15N, and 13C’, respectively. As the use of these digitization limits in combination with sufficiently large 
spectral widths would demand in the uniformly-sampled case approximately 10 weeks of continuous data 
collection (~68.5 days for 73,728 total rows), the execution of these experiments with only 2.0% coverage 
allowed for the experiment time to be reduced to less than 1.4 days (1472 rows). (For the CANCOCA 
SPC-8 q64 4D experiment without applied soft pulses, which used shorter digitization times and a 0.5 s 
longer pulse delay, the use of a 3.7% NUS schedule reduced the experiment time from 49 days to 1 day.) 
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 Analysis of the resulting CANCOCA/CX and CONCACO 4D spectra revealed strong and well-
resolved cross peaks with chemical shift frequencies in direct agreement with resonance assignments 
made previously with 2D and 3D spectra30. Notably, these 4D spectra revealed the presence of 
approximately 85 spin systems with high cross-peak intensity (i.e., greater than 7 times the noise floor), 
based on the number of 13Ci-15Ni-13C’i-1-13Ci-1 peaks reconstructed by SMILE31 for the CANCOCA 
3.7% NUS 4D data set. Accordingly, this signifies that the number of highly ordered residues in the AL-
09 VL fibril structure is closer to the upper limit of our estimation based on 2D and 3D spectra alone, 
which was previously reported to be 70 ± 15 residues30. This apparent increase in the number of 
structured residues for AL-09 VL fibrils may be attributed to the further removal of spin-system 
degeneracy and peak overlap that were previously observed in 3D spectra through the addition of a 
fourth-dimension.  
Subsequent analysis of the observed sets of cross peaks in the 4D spectra allowed for the 
identification and unequivocal confirmation of all 48 spin-system assignments reported in prior studies9,30, 
many of which had previously presented notable assignment challenges due to extensive chemical shift 
degeneracy. An example of the removal of this degeneracy by extending the dimensionality of our data 
sets to 4D spectra is illustrated in Figure 4.2. As portrayed along the dashed-line through the CAN(co)CX 
3D strip in Figure 4.2A, two spin-systems—V15C-N-S14C’/CX and I21C-N-T20C’/CX—share nearly 
identical 13C, 15N, and 13C’ chemical frequencies and were previously only able to be separated through 
the subsequent acquisition and analysis of other 3D spectra30. However, as shown in the 2D plane of the 
CANCOCX 50 ms 4D in Figure 4.2B (corresponding to 13C (F1) of 60.8 ppm and 15N (F2) of 129.5 
ppm), the introduction of an additional 13C’ (F3) dimension reveals a clear separation of the two spin-
systems by approximately 0.4 ppm. 
The reduction of chemical shift degeneracy observed in the 4D spectra also enabled efforts 
towards extending the backbone and side-chain resonance assignments for AL-09 VL fibrils. A clear 
demonstration of this ability can be observed for the case of P80–E81, in which the large extent of 
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degeneracy in the carbonyl region of the CAN(co)CX 3D (which prevented the identification of the 
P80C’ and C resonances previously; Figure 4.3A) is removed in the CANCOCA SPC-8 q64 4D 
spectrum, revealing a single, uniquely resolved cross peak corresponding to both the C’ and C chemical 
shifts of P80 (Figure 4.3B). Furthermore, upon the application of J-decoupling soft pulses in the two 
indirect 13C-dimensions (F1 and F3), an additional improvement to resolution is observed in the reduction 
of line width by approximately 50 Hz (Figure 4.3C).  
Collectively, our analysis of the acquired CNCC 4D spectra—combined with the augmented 
interpretation of NCACX, NCOCX, and CANcoCX 3D data sets9,30—allowed for the assignment of 
resonances for 81 residues in the AL-09 VL sequence (72 of which were identified in the 4D data alone). 
Of these 81 residues, the complete set of backbone chemical shifts were assigned for 67 residues, while 
partial backbone and/or side-chain assignments were made for an additional 14 residues (Figure 4.4). 
Importantly, along with providing a substantial improvement to the 43% of the sequence assigned 
previously30, the expanded set of of backbone assignments presented here represents more than 90% of 
the complete set of chemical shifts for the observable residues comprising the structured core of AL-09 
VL fibrils (i.e., 81 assigned residues of the approximately 85 spin systems observed in the 4D data sets). 
Furthermore, two of the additional amino acid stretches that were assigned here include those from T56–
E70 and S76–T85, both of which occur near the central region of the AL-09 VL sequence. Thus, clearly 
the use of highly digitized 4D spectra has helped us assign unique regions of the fibril core, indicating 
that the core may also involve structural contributions from some of the central regions of the protein 





Figure 4.2. Example of removing chemical shift degeneracy of the S14–V15 and T20–I21 spin-systems 
between (A) 13Ci-15Ni-(13C’)i-1-13CXi-1 3D and (B) 13Ci-15Ni-13C’i-1-13CXi-1 4D spectra, in which the S14- 
and T20-13C’ frequencies differ by only 0.4 ppm. 
 
 
Figure 4.3. Identification of new chemical shift assignments for residues P80 and E81 in AL-09 VL fibrils 
by extending (A) CAN(co)CX 25 ms 3D SSNMR experiments to (B) CANCOCA SPC-8 q64 (1.28 ms) 
4D NUS experiments. (C) The application of J-decoupling soft pulses on both indirect 13C-dimensions in 




4.4.3. Centrally-occurring residues exhibit a distinct conformation from the N- and C-terminal 
segments in AL-09 VL fibrils. 
The assignment of several previously unresolvable regions of the AL-09 VL protein sequence 
allowed for the subsequent identification of several key insights into the secondary structure of the fibril 
species as well as indications of tertiary structural components. We first investigated these details through 
an analysis of the secondary 13C chemical shift trends (13C) for all assigned residues. As shown in 
Figure 4.4, the majority of the sequence exhibits average 13C values that are consistent with a -strand 
secondary structure, as is particularly evident for residues near the N- and C-termini (with the exception 
of a few deviations observed for residues S9, D28, and Q100–T102, likely signifying the occurrence of a 
-hairpin or turn at that position of the structure). Additionally, the stretch of residues from S76–T85 
demonstrates secondary shift trends indicative of primarily -strand content. Interestingly, however, a 
notable divergence occurs for the residues spanning the central region of the sequence, T56–E70, in 
which no single secondary structure prediction is particularly dominant (Figure 4.4)32,33. Moreover, as 
may be evident by the large variability in secondary chemical shift across this region, several of the 
residues within this stretch are also observed to exhibit a relatively unique set of isotropic chemical shifts 
that may suggest the formation of a structural arrangement beyond simply random coil. For example, one 
particularly striking set of backbone chemical shifts observed are those of glycine residues in the 
sequence motif, 63SGSGSGT69 (Figure 4.5), in which G64 and G68 demonstrate downfield 15N and 
13Cchemical shifts that are 1.5–1.7 standard deviations away from the statistical mean34 (G64, 121.1 
ppm and 49.2 ppm; G68, 122.0 ppm and 48.7 ppm), whereas the intervening residue, G66, exhibits a set 
of chemical shifts that are very close to the mean (G66, 109.6 ppm and 44.2 ppm). Accordingly, although 
no specific secondary structure may be immediately evident from these absolute chemical shift values, the 
relative site-to-site variation of this short motif may suggest the presence of a less common structural 





Figure 4.4. Extent of chemical shift assignments and corresponding average secondary 13C chemical shift 
trends (13C)32 as a function of residue number for AL-09 VL fibrils. Residues labeled in blue are 




Figure 4.5. 15N-13C 2D spectrum of AL-09 VL fibrils. Cross peaks corresponding to glycine residues, 
G64, G66, and G68 are emphasized with bold labels. Regions enclosed by the dashed lines represent the 
boundaries of 1.0 and 2.0 standard deviations away from the statistical mean of glycine 15N and 13C 
chemical shifts (data obtained from the BMRB34). Spectrum was acquired at 600 MHz (1H frequency) on 
an InfinityPlus spectrometer with a MAS rate of 13.333 kHz and variable temperature set point of -10 C. 
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To further investigate the structural implications of the secondary chemical shift trends on the 
AL-09 VL fibril form, we proceeded to analyze chemical shift-based dihedral angle predictions using 
TALOS-N35, providing an extensive list of backbone and sidechain torsion angle restraints (Figure 4.6). 
The results from these predictions reveal that residues from T56–E70 exhibit a generally mixed set of 
torsion angles—consistent with our observation of the varying distribution of secondary chemical shifts in 
this region—while residues S76–T85 demonstrate torsion angles that are generally consistent with a -
strand secondary structure. TALOS-N was unable to make predictions for several of the residues in the 
T56–E70 stretch, primarily for the Gly residues; yet, we assume this is due to a combination of the 
limited number of training sets available for Gly motifs as well as the uniqueness of chemical shift values 
and amino acid pattern within the sequence. Several prior studies have identified similar shortcomings in 
the TALOS-N database for Gly residues in fibrils36-39. As such, the secondary structure of these residues 




Figure 4.6. TALOS-N35 predicted backbone torsion angles for AL-09 VL fibrils as a function of residue 
number. Blue squares and red circles indicate psi and phi torsion angles, respectively. Filled and open 
points were reported as “strong” or “generous” predictions, respectively. Angles that were reported as 




In light of this predictive limitation, we inquired on how the backbone dihedral angles of the X-
ray dimer structure of AL-09 VL (PDB: 2Q1E)40 compare to those which were able to be predicted by 
TALOS-N, in order to possibly shed light on potential similarities or differences that may inform on the 
gaps in predictions for the fibril structure of AL-09 VL (Figure 4.7). As the soluble dimer form of AL-09 
VL is known to contain a high degree of -sheet content (as is the case for all native light chain protein 
structures), many of the TALOS-N predicted angles for the fibril structure are qualitatively similar for 
regions of the sequence near the N- and C-termini. This observation may suggest that a subset of the -
strands that are present in the dimer form may also exist with similar chain lengths in the fibril state, 
although likely in a different orientation and with different intramolecular interactions given the notable 
differences observed for dihedral angles at different regions of the sequence. A relatively larger number 
of differences in torsion angles are observed for the central sequence region of T56–T69 (apart from the 
gaps in predictions discussed above), in which only two of the seven residues that were able to be 
compared demonstrated qualitative agreement in both phi and psi angles between the crystal structure and 
fibril predictions, V58 and P59. While we cannot completely eliminate the possibility of a similar 
structural motif occurring in the fibril form of AL-09 VL at this region of the sequence given the gaps in 
predicted angles, the general lack of agreement for the majority of comparable residues in the central 
region makes this possibility seem unlikely.  
One interesting detail about the X-ray dimer structure worth noting is that within the S63–T69 
stretch, residues G66 and G68 both exhibit positive phi angles of around 90; yet, both residues exist in a 
-strand in the 3D structure, which immediately leads into a turn and an adjacent -strand40. This insight 
further emphasizes the difficulty associated with accurately predicting the conformation of glycine 
residues due to the highly flexible nature of the backbone, and becomes even more challenging in the case 
of a fibril structure which comprise less than 0.05% of the number of protein structures available on the 
RCSB PDB41. As such, we decided to pursue a comparison of the AL-09 VL fibril chemical shifts with 
chemical shifts observed for other fibril structures with similar amino acid sequences. Although the 
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majority of fibril structures that have been investigated by SSNMR methods contain a high number of 
hydrophobic residues—which differ from the largely polar-containing residues in AL-09 VL fibrils—
several recent studies offer particularly suitable candidates for comparison. 
 
 
Figure 4.7. Comparison of backbone torsion angles corresponding to the X-ray crystal structure of the 
AL-09 VL dimer (PDB: 2Q1E; open symbols)40 and those determined from SSNMR-based TALOS-N 
predictions of AL-09 VL fibrils (closed symbols). Psi angles are depicted as blue squares (open or closed); 
phi angles are depicted as red circles (open or closed). 
 
The first is the case of MAK33 S20N VL fibrils, which represent another instance of AL disease-
related amyloid fibrils10. As the MAK33 VL domain is derived from the same kappa germline gene family 
as AL-09 VL, and thus shares a high sequence identity of 57% overall, including the same stretch of 
residues between P59–T6910. Interestingly, however, the chemical shifts observed for residues G64, G66, 
and G68 in AL-09 VL fibrils are largely disparate compared to those for MAK33 S20N VL fibrils, in 
which all assigned Gly residues exhibit 15N and 13C frequencies falling below 112 ppm and 47 ppm, 
respectively. Despite both AL-09 and MAK33 VL domains being derived from the kappa family of VL 
germline genes and sharing a large percentage of sequence identity, each protein appears to assume a 
rather different fibril core structure. This notable difference was originally proposed by Hora et al. 
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through their observation and assignments of primarily the central regions of the protein sequence as 
opposed to the terminal residues as observed for the case of AL-09 VL10,30.  
We also compared our chemical shift and secondary structure observations with those for the 
recently reported structure of FUS-LC fibrils, which exhibit a similarly high composition of Gly, Ser, and 
Thr residues38. Although the FUS-LC and AL-09 VL proteins essentially have no direct sequence identity, 
they both exhibit a large extent of interleaving polar and non-polar residues throughout the observable 
region of the fibril core38. Interestingly, the authors report the presence of a loop structure for a stretch of 
residues of the sequence, 74GYGSTGGYGSSQSS87, in which the polar Ser, Thr, and Tyr residues form a 
hydrogen-bonding network proposed to be responsible for holding the loop together38. In comparison to 
the T56–T69 stretch in AL-09 VL fibrils (with the sequence, 56TGVPSRFSGSGSGT69), a 
disproportionately high number of Gly, Ser, and Thr residues are observed in both cases. Furthermore, the 
authors were unable to report TALOS-N dihedral angle predictions for 8 of the residues in this stretch of 
residues for FUS-LC, including G82 which exists at the sharp turn at the edge of the loop and exhibits the 
most downfield 13C chemical shift of all observable Gly residues in the FUS-LC core of ~49 ppm38. In 
light of the similarities in chemical shift and neighboring residue identity, it thus remains highly possible 
that a similar conformation and environment is true for the case of the G64 and G68 residues in AL-09 VL 
fibrils, in which each residue forms part of a greater loop motif in the core. 
 Another very striking set of chemical shifts is presented by the nearby residue R61, in which the 
values for 13C(26.2 ppm) and 13C (32.6 ppm) are 1.7 standard deviations upfield and downfield from 
the statistical means, respectively34. Despite the occurrence of each resonance closer to the other’s 
average value (i.e., the average shifts for Arg 13Cand 13C are 30.7 ppm and 27.3 ppm, respectively), we 
were able to distinguish and unambiguously assign the appropriate chemical shift to the Cand C atoms 
of R61 through the implementation of SPC-N mixing, as this provides a sign inversion for the signal 
arising from directly coupled nuclei relative to those that are indirectly coupled (i.e., a negative peak is 
observed for C-Ccorrelations whereas a positive peak is seen for C-C correlations23. While the 
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observation of Arg 13Cchemical shifts around 26 ppm is not uncommon (~350 counts reported to the 
BMRB), the frequency of 13C shifts between 32–33 ppm is considerably lower (< 50 counts per 0.1 ppm 
interval)34. Together, these upfield and downfield chemical shift deviations for the 13Cand 13C atoms of 
the Arg side chain, respectively, may indicate the adoption of a helical conformation which is distinct 
from the primarily -sheet secondary structure observed for the other regions of the sequence, in addition 
to the formation of highly polar or electrostatic interactions with the side chains of other nearby residues. 
One example of a similarly downfield-shifted Arg 13C resonance was observed for the disulfide-
stabilized dimer structure of the XCL1 chemokine in solution, exhibiting a 13C shift of 32.9 ppm for 
residue Arg61 (referred to here as Arg61 to distinguish from R61 in AL-09 VL) (BMRB: 25693)42. The 
structure of this dimer (PDB: 2N54)42 reveals that Arg61 exists on an unstructured coil running alongside 
a-strand of predominantly polar residues, including three Thr and two Tyr residues situated within 5 Å 
across from Arg61. These features have several implications on the possible influence on the side-chain 
chemical shifts of the Arg residue. First, the presence of two aromatic rings from proximal Tyr residues 
may subject Arg61 to ring-current effects, which are well-known to induce chemical shift perturbations 
on the order of several ppm for nearby 13C resonances43,44. Second, the high number of nearby polar 
residues in the structure may induce substantial changes in the electrostatic environment surrounding the 
C and C side-chain atoms of Arg61, an effect well known to lead to large chemical shift changes45. 
In a strikingly similar fashion, R61 in AL-09 VL is positioned in a stretch of amino acids given 
by, 56TGVPSRFSGSGSGT69, in which it is immediately neighboring a polar Ser and nonpolar aromatic 
Phe residue, followed by an extensive sequence of generally intervening polar and non-polar amino acids 
(including two additional Phe residues at positions 71 and 73). Furthermore, the amino acid composition 
around R61 is rather unique relative to the other two Arg residues present in the sequence, R18 and R108, 
in which the closest aromatic residues to each are 14 and 12 aa away, respectively. Neither R18 nor R108 
demonstrate similar chemical shift deviations as observed for R61. Accordingly, both the presence of 
polar and aromatic residues near R61 may be responsible for inducing the dramatic Cand C chemical 
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shift perturbations that are observed, via a combination of ring current effects as well as contributions 
from electrostatics. Additionally, given that the Cexhibits an upfield shift relative to the average while 
the C exhibits a downfield shift, it may be possible that the ring current from F62 produces an electric 
field gradient that affects both carbon atoms differently. Interestingly, TALOS-N 1 predictions35 for the 
sidechain torsion angles of AL-09 VL fibrils suggest that the R61 N-C- C- C dihedral angle assumes a 
gauche(-) rotamer conformation, with a 1 angle of -63° ± 12°. This may represent the geometry that is 
necessary for supporting the complex interactions and electrostatic environment that are experienced by 
the R61 side chain. One final interesting similarity between the XCL1 protein and AL-09 VL, is that one 
of the main activities of the dimer form for XCL1 (as opposed to the monomer form) is the binding of 
GAG molecules42. 
Together, this set of unusual chemical shifts observed for the S60-T69 residue stretch of the AL-
09 VL sequence suggests that this region assumes a unique conformation within the fibril core relative to 
the N- and C- terminal regions. Notably, as observed by the 15N and 13C chemical shifts of the three Gly 
residues in this stretch (63SGSGSGT69), those observed for G64 and G68 are highly distinct from those of 
G66 (15N, 109.7 ppm; 13C, 44.2 ppm) despite the generally repetitive amino acid sequence. A chemical 
shift variation of this magnitude between the central residue G66 and the flanking residues G64 and G68 
may be explained the adoption of a -turn or -loop structure at this region of the AL-09 VL sequence. 
In particular, the existence of a double -turn can be rationalized through the results from previous solid-
state studies on the structure of Bombyx mori silk fibroin, formed from the repetitive sequence motif of 
(AGAGAG)10, which is presented to adopt an extended chain of repeating type-II -turns maintained by 
hydrogen bonds between the carbonyl group of Glyi with the amide hydrogen of Alai+346,47. Additionally, 
the alternating direction of each consecutive type-II -turn results in the placement of every other Gly 
residue (i.e., Glyi and Glyi+5) on the same face of the fiber chain and with an identical geometry46. Such a 
model would be consistent with the presented data for AL-09 VL fibrils, as the high similarity in 15N and 
13C chemical shifts for G64 and G68 (as opposed to G66) implies that the two residues exist in similar 
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chemical environments and orientations, and are possibly exposed to the same part of the fibril core or to 
the bulk-solvent. Further, this arrangement is also shown to support the formation of hydrogen bonds 
between stacked chains through C-O and N-H interactions48, a feature which is fundamental to the cross-
structure formed by amyloid fibrils at large49 and thus would be critical for maintaining intermolecular 
packing between AL-09 VL monomers along the fibril axis. In addition to the backbone interaction, the 
presence of both interleaving Ser and Thr residues along this region may contribute further to the 
hydrogen bonding network responsible for maintaining the structural integrity of this region of the fibril 
core. 
An alternative model would be the formation of a -loop type structure, beginning with S60 and 
ending with T69. This would place residues G64 and G68 near the base of the loop (where it begins and 
ends), and G66 would be centered at the opposite end of the loop. As the nature of the chemical 
environment and types of interactions existing between these two ends of the loop would differ, such a 
motif may account for the different set of chemical shifts observed for G64 and G68 relative to G66. 
Moreover, given the alternating pattern of polar and nonpolar residues over this stretch, the Ser and Thr 
sidechains will face toward the same direction in the three-dimensional structure. Thus, the formation of a 
loop would be supported by the positioning of the hydroxyl side chains on the inside of the loop, in which 
the polar interactions between each residue provide an additional form of structural integrity to the fibril 
core. Further, the residues just outside of the loop—namely, S60-R61-F62—may represent another sharp 
turn in the arrangement of the core, consequently lending contribution to the aberrant chemical shifts 
observed for these residues of the AL-09 VL fibril structure. 
 
4.4.4. AL-09 VL fibrils demonstrate subtle variations in dynamics throughout the extended core. 
In addition to providing structural insight on the central regions of the AL-09 VL sequence in the 
fibril core, the new assignments enabled by the four-dimensional J-decoupled CNCC experiments 
allowed for the subsequent evaluation of the corresponding dynamics relative to other segments of the 
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core. In particular, because the presented 4D experiments were performed using a dipolar-based 
polarization transfer scheme (i.e., cross-polarization) to achieve heteronuclear correlations, we first 
assessed the relative peak heights of each CANCOCA peak to gain a qualitative insight on the relative 
dynamics of different regions of the protein sequence (Figure 4.8). This analysis reveals a substantially 
reduced signal intensities measured for residues T56-E70 compared to those for the stretch from S7-I29 
(N-terminal residues), and a slight reduction in peak height relative to residues L94-R108 (C-terminal 
residues), indicating that the residues in the central region of the sequence are generally more dynamic 
(Figure 4.8). Additionally, because the 4D experiments allowed for the separation of peaks that are 
overlapped in CAN(co)CX 3D experiments, this analysis also provides a more complete and 
representative overview of the relative changes in rigidity across the AL-09 VL sequence than was able to 
be reported previously9. 
 
 
Figure 4.8. Normalized CANCOCA peak heights for assigned residues in the CANCOCA 4D spectrum 
with SPC-8 q64 (1.28 ms) mixing and no J-decoupling pulses. Data were acquired at 750 MHz with a 
3.7% NUS schedule and MAS rate of 12.500 kHz. Values correspond to the CO-CA containing residue; 




Furthermore, given the new identification of site-resolved cross peaks for multiple residues within 
the central portion of the AL-09 VL sequence, we were able to obtain more quantitative information 
reporting on the dynamics of each observed region in the AL-09 VL fibril core. This analysis was pursued 
by measuring the 1H-13C scaled dipolar couplings of several representative residues through the 
acquisition and fitting of dipolar dephasing trajectories obtained from R48318-symmetry 1H-13C-13C 3D 
experiments50. We applied this to the case of V58 because it exhibits a resolvable C-C cross peak in 
the CC 2D spectrum and provides an opportunity to compare the resulting order parameter with those of 
valine residues present in the N-terminal region of the sequence (V15 and V19). Our analysis of the 
corresponding dephasing trajectories for each Val residue reveals that V58 exhibits a slightly lower 1H-
13C order parameter (0.97) relative to both V15 and V19 (0.98 and 0.99, respectively; Figure 4.9A and 
4.10). The differences in scaled dipolar couplings between each of the three Val residues in the AL-09 VL 
sequence can be easily seen in the experimental dipolar spectra shown in Figure 4.9A, in which the V58 
dipolar splitting is clearly smaller than those of V15 and V19 (simulated fits of each are included in 
Figure 4.10). These results thus demonstrate that the backbone of V58 is partially more dynamic than V15 
and V19, supporting the existence of generally more dynamic residues near the central portion of the 
sequence relative to the terminal portions. Interestingly, in addition to the measured order parameters for 
the backbone of each valine residue, chemical shift assignments for the side-chain atoms reveal further 
support for the apparent increased dynamics of V58. Specifically, while residues V15 and V19 exhibit 
side-chain methyl chemical shifts differences of 2.2 ppm and 1.0 ppm, respectively, between the 
corresponding C1 and C2 resonances, the methyl shift difference observed for V58 is 0.4 ppm. These 
chemical shift differences can be observed in the Val methyl region of the 13C-13C 2D (Figure 4.9B), in 
which two distinct cross peaks are resolved for the C-C1 and C-C2 correlations of both V15 and 
V19, while those corresponding to V58 are severely overlapped. The existence of a relatively small 
methyl 13C chemical shift difference for V58 may be indicative of partial rotameric averaging of the C1 
and C2 chemical shifts about the C-Cbond, as can be the case for solvent-exposed side chains 
76 
 
provided that the temperature is not too low to restrict hopping between rotameric states51,52. Indeed, the 
occurrence of rotameric averaging has been observed for side-chain methyl groups (i.e., Val and Leu) in 
the solid state for highly mobile residues, a process which can be monitored through relative changes in 
dipolar-based cross-peak intensities as well as methyl chemical shift differences28. Accordingly, our 
results demonstrate that the residues in the central region of the AL-09 VL fibril core exhibit slightly 
faster dynamics than those located closer to the N- and C-termini, presenting novel insight into the 
structural components and interactions responsible for maintaining the rigid fibril assembly. 
 
 
Figure 4.9. (A) 1H-13Ca dipolar coupling trajectories and spectra for the valine residues of AL-09 VL 
fibrils, obtained from R48318-symmetry 1H-13C-13C 3D experiments. The corresponding scaling factors 
obtained from fitting simulations are shown next to the dipolar spectra (simulated fits not shown). (B) 
Expansion of Val C-C1 and -C2 region in a 13C-13C 2D spectrum collected with 25 ms DARR mixing 




Figure 4.10. Simulated fits of the 1H-13C dipolar coupling spectra for (A) V15, (B)V19, and (C) V58, 
within the AL-09 VL fibril structure (experimental, black; simulated, red). The fits reveal dipolar coupling 
scaling factors, , of 0.437, 0.440, and 0.429, which corresponds to order parameters, S, of 0.99, 0.99, and 
0.97, respectively (relative to the upper order limit as observed for I21 1H-13C, = 0.443; similarly, the 
1H-13C of NAV exhibits a scaling factor close to this limit, = 0.439). Dipolar recoupling experiments 
were performed using the R48318-symmetry sequence as the third dephasing dimension between each 13C-
13C 2D plane. 
  
4.5. CONCLUSIONS 
 In this paper, we investigated the structural and dynamical features defining the central region of 
the AL-09 VL sequence within the fibril core through the implementation of J-decoupled CANCOCX and 
CONCACO 4D SSNMR correlation experiments, which provide enhancements in both resolution and 
sensitivity for spectra of uniformly [13C, 15N]-labeled biomolecules. These data sets enabled backbone 
resonance assignments to be made for more than 90% of the observable regions of the fibril structure, and 
subsequently site-specific analysis of the corresponding structure and dynamics for the newly identified 
spin-systems. Collectively, our results reveal that centrally-occurring residues of the AL-09 VL 
sequence—notably, T56-T69—are involved in the core of the fibril structure, along with the highly 
ordered residues near the N- and C-termini that were identified previously. Interestingly, however, these 
central residues exhibit relatively higher flexibility and dynamics than the terminal-counterparts, as well 
as unique chemical shift trends suggestive of a -turn or -loop motif. These structural insights thus 
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offer several critical constraints to guide the construction of a well-supported initial model of the tertiary 
arrangement of the AL-09 VL fibril core. Accordingly, we anticipate that these methods and results will 
inform related studies on AL disease as well as other disease-related amyloid systems. 
 
4.6. MATERIALS AND METHODS 
Preparation of U-[13C,15N] AL-09 VL Fibrils. Fibril samples were prepared as described 
previously30. Following a two-week fibrillation period, AL-09 VL fibrils were then pelleted by 
ultracentrifugation, dried under a steady flow of N2 gas, packed into a 3.2 mm thin-wall SSNMR MAS 
rotor (Agilent Technologies, Santa Clara, CA), and brought to a 50% hydration level by mass. 
SSNMR Spectroscopy. Four-dimensional MAS SSNMR CANCOCA(CX) and CONCACO(CX) 
experiments on uniformly [13C, 15N]-labeled AL-09 VL fibrils and GB1 microcrystals were performed 
using a 750 MHz (1H frequency) wide-bore or 500 MHz wide-bore VNMRS spectrometer (Varian, Fort 
Collins, CO) with a 3.2 mm Balun probe in 1H-13C-15N mode or a 1.6 mm FastMAS probe in 1H-13C-15N 
mode, respectively. All 13C-detected 4D data were acquired at a MAS rate of 12.500 kHz (750 MHz) or 
22.222 kHz (500 MHz) with a variable temperature (VT) set point of 0 C. Tangent ramped cross-
polarization (CP) was used to achieve heteronuclear polarization transfer from 1H to 13C, 13C to 15N, and 
15N to 13C with contact times of 2.0 ms, 4.0 ms, and 6.0 ms, respectively21. SPINAL-64 1H-decoupling24 
was applied during all evolution and acquisition periods using an rf power of 65 kHz, and TPPM 
decoupling26 was applied during band-selective pulse elements (as indicated in Figure 4.1)14. 
Homonuclear 13C-13C polarization transfer was achieved using dipolar assisted rotational resonance 
(DARR)22 or supercycled POST-Cn (SPC-N)23 mixing schemes to promote multi- or single-bond transfer, 
respectively. Band-selective pulses were performed on each indirect 13C-dimension (1 and 3) using r-
SNOB shape elements25 and appropriately specified pulse lengths of rotor plus a half rotor periods (r), 
nr + 0.5r, for selecting the bandwidth of interest (i.e., for 13Ca or 13C’ regions)14. Additional digitization 
and acquisition details for each 4D experiment are included in Table 4.1. 
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All 4D spectra were acquired according to a non-uniform sampling (NUS) regime, with sampling 
densities of 0.5–3.7%. Sampling schedules were generated using the nus-tool application available 
through the NMRBox server53, and parameterized with the corresponding digitization limits (as specified 
in Table 4.1) as well as exponential biasing factors of 0.15–0.20 as inputs for all experiments.  
SSNMR Data Processing. All CNCC NUS 4D data presented here were processed using the 
NMRPipe software package as follows54. Varian formatted raw data were expanded with the 
nusExpand.tcl script included in NMRPipe to produce a pseudo-uniform data set in which all unsampled 
data points are filled-in with zeroes, and converted to NMRPipe format. The directly acquired dimension 
was apodized with 75 Hz line-broadening and a neutral (unsquared) sine-bell window, and subsequently 
zero-filled prior to Fourier transformation (FT). Reconstruction of the sparsely sampled indirect 
dimensions was performed using the SMILE function within NMRPipe, followed by sequential 
apodization (60 Hz line-broadening) and FT of each dimension to generate a four-dimensional frequency-
domain spectrum31. Phasing corrections for each dimension were determined by using NMRDraw to 
inspect the intermediate files from the processing output54. 
SSNMR Data Analysis. Multidimensional SSNMR data were visualized and analyzed using 
NMRFAM-SPARKY55 for performing chemical shift assignments and evaluating cross-peak line widths 
and signal-to-noise ratio values56. R48318-symmetry dipolar dephasing trajectories were extracted using 
NMRPipe and analyzed with an in-house written program for performing fitting simulations of the 
corresponding scaled 1H-13C dipolar couplings values. 
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CHAPTER 5: Towards a Robust and Streamlined Strategy for Assigning Chemical Shifts in 
Proteins Using Peak Intensity and Overlap-Weighted Scoring on NUS SSNMR Data 
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5.2. ABSTRACT 
We introduce a robust method for the computationally-aided assignment of protein chemical 
shifts in multidimensional solid-state nuclear magnetic resonance (SSNMR) data that combines peak 
intensity and frequency overlap information into a separate objective within the scoring function of the 
multi-objective search for optimal assignment solutions, and show that this offers significant 
improvement over currently available algorithms. The additional peak intensity and overlap score (PIOS) 
objective is implemented as a modification to the non-dominated sorting genetic algorithm/Monte Carlo 
programs presented previously which we refer to as PIOS/NSGA-II/MC, and alleviates several major 
limitations of the original programs, most notably the tolerance for assigning non-manually analyzed 
experimental data. In particular, rather than restricting the judgment to solely “good” or “bad” as 
previously was the case, we demonstrate how the PIOS objective provides an experimentally-based 
measure of the “goodness” of a given possible assignment, through the inclusion of cross-peak signal-to-
noise ratios. In this manner, the presented program is more readily applicable to realistic SSNMR data 
sets, which may contain a number of “data imperfections” such as noise, artifacts, spin-system 
degeneracy (and thus assignment ambiguity), as well as the presence of long or short-range inter-residue 
cross-peaks in a particular spin system. Finally, through the combination of the non-uniform sampling 
and data reconstruction methods with the SMILE algorithm, we describe (and provide the computational 
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tools for) a more streamlined strategy for the analysis of 3D and 4D SSNMR spectra and through-put into 
the PIOS/NSGA-II/MC chemical shift assignment program. 
 
5.3. INTRODUCTION 
The determination of a protein structure by magic-angle spinning (MAS) solid-state nuclear 
magnetic resonance (SSNMR) spectroscopy generally begins with the acquisition of a variety of 
multidimensional homo- and heteronuclear correlation spectra to obtain the 13C and 15N chemical shift 
information of the biomolecule of interest1. In addition to providing initial insight on the secondary 
structure of the protein through correlation of the secondary chemical shifts with empirical trends2,3, 
having knowledge of the specific atoms to which various cross peaks correspond can enable a qualitative 
assessment of dynamics based on differences in cross-peak intensity resulting from dipolar coupling-
based polarization transfer experiments. Most importantly, these chemical shift assignments are necessary 
for performing subsequent structural and dynamics measurements on the molecule, including the 
determination of internuclear distance restraints4,5, backbone order parameters6, side-chain motions7, as 
well as the investigation of how chemical shift perturbations relate to specific biomolecular activities or 
interactions8. Ultimately, these pieces of information can be combined into simulated annealing 
calculations for obtaining a final three-dimensional protein structure9. 
 The process of assigning chemical shifts in protein SSNMR data typically involves (at minimum) 
the acquisition and analysis of several 15N and 13C 3D correlation experiments, including a 15Ni-13Ci-
13CXi (NCACX), a 15Ni-13C’i-1-13CXi-1 (NCOCX), and a 13Ci-15Ni-(13C’i-1)-13CXi-1 (CAN(co)CX), which 
together provide the backbone connectivity information necessary for enabling the step-wise assignment 
of chemical shifts for each residue along the protein sequence10,11. This general assignment strategy is 
known as a “backbone-walk1.” The collection of four-dimensional heteronuclear correlation spectra can 
provide an additional set of chemical shift information by further removing chemical shift degeneracy to 
resolve cross peaks that may be overlapped in 3D experiments12, as well as offer another way of obtaining 
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a set of distance restraints for structure determination13. As such, this strategy is particularly useful for 
large or complex biomolecular systems that may exhibit substantial signal overlap or degeneracy, and is 
becoming routinely used in SSNMR studies with the availability of more efficient data acquisition and 
processing methods such as non-uniform sampling (NUS)14,15 combined with the use of the reconstruction 
algorithm, SMILE16. 
While these established methods collectively provide a generalized and robust strategy for the 
assignment of chemical shifts in solid biomolecules, due to the amount of time and manual effort required 
to perform each of these tasks—in addition to the inherent challenges that are unique to the specific 
protein under study—this process can often be the most rate-limiting step in a structural pursuit. 
Challenges at this stage may arise due to a variety of experimental and technical factors, including 
extensive chemical shift degeneracy and peak overlap, low inherent sensitivity, the existence of multiple 
protein conformations within the sample, the absence of cross-peak intensity for highly dynamic regions 
along the backbone (and thus an impediment to the backbone walk procedure), as well as the practical 
limits of analyzing highly complex multidimensional data by manual means. These complications 
naturally become further exacerbated with increasing size of the molecule, as this leads to a higher extent 
of spectral congestion as well as greater uncertainty with respect to the unique spin system to which a 
peak corresponds. As such, despite having the technical advantage and potential to study insoluble 
proteins of any size, the feasibility and efficiency of assigning chemical shifts to such large systems still 
remains a major pressing factor in SSNMR studies. 
A tremendous amount of research effort has focused on addressing this challenge by improving 
the computational tools and software that are currently available for assigning chemical shifts of protein 
SSSNMR data. In addition to the development and active support of freely-available software packages 
for visualizing and analyzing multidimensional NMR data17,18, concerted efforts have been directed 
toward design of fast and accurate programs for computationally aiding the assignment process of protein 
chemical shifts. In particular, MCASSIGN19 and its successor, MCASSIGN220, introduced by Tycko et al. 
and Hu et al., respectively, uses a Monte Carlo and simulated annealing (MC/SA) approach to the 
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assignment problem by randomly sampling the combination of spin systems from a set of given lists (e.g., 
an organized list of peak groups from a NCACX or NCOCX spectrum, in which all peaks sharing the 
same 15N and 13C or 13C’ frequencies are listed together), and assesses a specific set of possible 
connections (specified by the user) between the two spin systems to determine if the connection is 
“good,” “bad,” or falls on the boundary of an assignment (“edge”). These values are totaled for each 
given combination of spin systems (i.e., an assignment solution) and are combined with increasing weight 
upon each full program iteration (the simulated annealing component) to give a final score that is used to 
determine if the assignment should be kept or rejected. Indeed, this program offers a straightforward way 
of sampling all of the possible connections of a given list of spin systems to eventually arrive at a solution 
with the most number of “used” and “good” connections but fewest number of penalties (“bad” and 
“edge” connections).  
The MCASSIGN2 method was later adopted by Yang et al.21, in which they introduced a non-
dominated sorting genetic algorithm (NSGA-II)22 into the MC/SA program as a way to fully harness the 
multi-objective aspect of the assignment method and reduce the time spent on sampling redundant 
assignment solutions. Through the function of the NSGA-II routine, the program sorts each group of 
assignment solutions (i.e. a “generation”) based on how well each individual dominates the others with 
respect to each objective (i.e., “good,” “bad,” “edge,” and “used”), and retains only the best solutions to 
generate an “offspring” population that inherits a subset of the assignments from the parent generation. 
This continuous process of sorting the group of individuals by their objectives ultimately produces a set 
of rankings in which those solutions which dominate in at least one objective are proscribed a “Pareto 
order” of 1, and are otherwise known as Pareto-frontier solutions. Thus, rather than relying solely on the 
random sampling and scoring of assignment solutions by a Monte Carlo approach, the addition of this 
genetic algorithm allows for optimal solutions to be identified in a much more directed and efficient 
manner. Further, although one general concern for the use of such an algorithm is the high tendency to 
drive the solutions into a local minimum, the author’s decision to integrate this with the MC/SA algorithm 
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offers a powerful way to obtain the optimal solution while still allowing for enough random sampling 
potentially escape these wells21. 
While the MCASSIGN2 and combined NSGA-II/MC programs each establish an adaptable and 
highly functional approach to the assignment of protein chemical shifts given any variety of 
multidimensional SSNMR spectra, they both still suffer from a number of shortcomings that can lead to 
severe errors in the assignment simulation. One of these limitations is the “all-or-nothing” manner by 
which the connection between a given set of spin systems is declared as either “good” or “bad”, based on 
the occurrence of a single matching or non-matching of frequencies. As a result, even solutions that 
exhibit all matching connections except one (e.g., due to the presence of an additional peak in the spin 
system) will be penalized and may be excluded later from the list by restricted sorting steps, as both 
programs were designed to remove any assignment solutions with bad connections near the end of the 
calculation20,21. While such a tactic works reasonably well for properly analyzed data sets in which no 
mistakes are included in the preparation of input spin-system lists, the penalization of an entire spin 
system based on a single misaligned connection restricts the program to only being able to tolerate “error-
free” data. 
Recently, Murray et al. report the use of a modified form of the MCASSIGN2 program (referred 
to as mcassign2c), in which the quantity of “good” is scaled between entirely good and entirely bad based 
on the amount of separation between the two frequencies being connected23. We believe this modification 
represents an important step towards properly accounting for the quality of a “good” connection without 
giving it an equal score as another solution that may exhibit slightly closer spin-system alignment. This is 
especially important for instances of spin-system degeneracy, as two residues exhibiting very similar 
chemical shifts in two or three dimensions may both be considered equally good based on the original 
“all-or-nothing” approach, even if one of the spin systems matches slightly better than the other. 
However, the continued treatment of “bad” connections as a penalty to the assignment process still leaves 
open the possibility of excluding possibly valid assignments that contain a small number of non-matching 
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connections (e.g., due to the additional inclusion of an artifact peak, inter-residue correlation, or 
degenerate spin-system peak within a single spin-system).  
Here, we present a highly robust adaptation of the previous programs which combines the peak 
intensity and frequency overlap of a given spin-system comparison as a way of scoring the quality of the 
connection. In order to build upon the MC and genetic algorithm functionalities offered by the previous 
programs, we implemented this peak intensity and overlap score (PIOS) as a new objective within the 
combined PIOS-weighted NSGA-II/MC program. We apply this method to the 1 immunoglobulin 
binding domain of protein G (GB1) as a test case, and demonstrate the improvement that it offers relative 
to the previous programs, which becomes most revealing for cases involving imperfect and unanalyzed 
data sets. Furthermore, we describe a strategy for streamlining the workflow between data acquisition by 
NUS and protein chemical shift assignments by PIOS/NSGA-II/MC, in which we string together several 
SSNMR methods and tools through the use of Python scripting, and we demonstrate the success of this 
automated process for fibril form of the amyloidogenic light-chain protein, AL-09 VL. 
 
5.4. METHODS 
5.4.1. Overview of modified PIOS-weighted NSGA-II/MC algorithm. 
The PIOS-weighted NSGA-II/MC assignment program that we present here for computationally-
aiding the chemical shift assignment process is based on the NSGA-II/MC program previously introduced 
by Yang et al.21, which combines the MCASSIGN2 algorithm20 with a multi-objective genetic algorithm 
for more efficient searching of optimal assignment solutions. As such, the general flow of logic and 
program structure remain very similar, but with the addition of several modifications at the scoring step of 
the algorithm as well as the treatment of bad assignments, which we describe in the following section and 
Supplemental Materials 5.7.1. The source code is written in Fortran 95 (provided upon request) and may 
readily be compiled on Linux, OSX, or Windows operating systems using the freely-available PGI 
Community Edition compiler. 
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 A flowchart illustrating each of the key steps in the program is provided in Figure 5.1. The initial 
input files include: (1) the amino acid sequence of the protein (in one-letter code); (2) a list of spin 
systems obtained from each spectrum being used, containing the chemical shift frequencies and 
corresponding SNR values for each peak in the spin system as well as a header line specifying the 
estimated uncertainty in peak position of each atom type for all spin systems; (3) a connection file 
specifying the connectivity and relation of each frequency within one spin-system list with another; and 
last (4) a control file that points to each of the input and desired output file locations and contains the list 
of user-specifiable run options, including the number of individuals to form the initial group of 
assignments (and thus the number of resulting solutions from the calculation), the number of full program 
steps as well as the number of MC and NSGA-II attempts to perform at each iteration, the probability of 
the program forming a null mutation, additional NSGA-II-specific settings such as the gene pool size as 
well as crossover and mutation rates for controlling the diversity of offspring from the parent generation, 
and finally MC/SA-related weighting factor value limits to use for each objective (w1, “good”; w2, “bad”; 
w3, “edge”; w4, “used”; and w5, PIOS) in calculating the score of the individual assignment, which are 





Figure 5.1. Flowchart of the control logic scheme followed by the PIOS-weighted NSGA-II/MC 
chemical shift assignment program. 
 
 Upon initialization of the calculation with a specified or clock time-based seed number, the 
program generates a starting group of individuals (i.e., complete sets of assignments) by randomly 
selecting spin systems from the input lists which have amino acid type guesses that are consistent with the 
corresponding residue in the protein sequence. If desired, it is also possible to provide the output file from 
a previous calculation to form the starting group individuals for a new calculation; however, the size of 
the group as well as the number and type of spin-system lists used must remain the same. The initial 
group is then evaluated for the overall fitness of the individuals by Pareto ordering, and is subsequently 
directed into the MC/SA procedure. 
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For each MC attempt, nmc, specified in the control file, the algorithm begins with one of the 
individuals of the group and calls a mutation subroutine which randomly either changes one of the spin 
systems in the current set of assignments to another spin system (without violating the amino acid type or 
degeneracy of the given spin system) or sets it to a null spin system (based on the null probability 
specified at input). Within this process, all five objectives (Ngood, Nbad, Nedge, Nused, and QPIO) are 
determined for the given assignment by looping over each possible connection of frequencies between 
each spin-system list for every residue in the sequence, and tabulating the number of good, bad, and edge 
connections that are made, the number of spin systems used, and the quality score based on the PIOS 
calculation described in the next section. The overall score, S, of the individual both before and after the 
mutation is calculated from the combination of the quantities for each objective, scaled by the 
corresponding weighting factor, w, as follows: 
 𝑆 = 𝑤1𝑁good − 𝑤2𝑁bad − 𝑤3𝑁edge + 𝑤4𝑁used + 𝑤5𝑄PIO
𝑇𝑜𝑡,†
, (1) 
where Ngood, Nbad, and Nedge, represent the number of good, bad, and edge connections respectively, Nused, 
represents the number of used spin systems, and 𝑄PIO
𝑇𝑜𝑡,†
 represents the total quality score based on peak 
intensity and overlap of all connections (†indicates that this value is divided by 100 for this scoring 
calculation, because it is scaled up by 100 when tabulated to keep it in integer form). After a new 
assignment has been made (e.g., through the change of a single spin-system assignment for a random 
residue in the sequence), the change in score is calculated as the difference of the two independent scores 
from each assignment,  
 ∆𝑆 = 𝑆new − 𝑆old. (2) 
Last the MC/SA component uses Metropolis’ criterion to decide whether the new assignment should be 
retained by choosing a random number, xrand, and determining if the following inequality holds true: 
 𝑥rand ≤ 𝑒
∆𝑆.   (3) 
If the condition is not met, then the program discards the new assignment and reverts back to the previous 
assignment before cycling back for the next MC attempt. This process continues until all MC attempts, 
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NMC, have been completed for all individuals of the group, all of which are then carried over to the 
NSGA-II component to use as the initial group of assignments. Upon the next round of MC attempts (i.e., 
after a full calculation cycle of the program has been completed, in which the number of steps, ns, 
increases by 1), the weighting factors for each objective are incremented according to the specified 
minimum and maximum weight values and number of total steps of the program. In this manner, this 
gradual incrementation of objective weighting constitutes the simulated annealing aspect of the MC/SA 
algorithm19. 
 The program then proceeds onto the NSGA-II component of the calculation for the total number 
of specified attempts, NGA, starting with the resulting set of assignments from the MC/SA process above 
onto the first attempt, nga = 1. The NSGA-II process begins with the determination of objective values for 
each individual of the given group of assignments and subsequently subjects this group to a series of 
mutation and crossover events (described in detail by Yang et al.21) in order to form an initial parent 
generation to use for producing a set of offspring assignments. The algorithm then cycles through the new 
generation and performs a second series of mutations in order to produce a completely diverse set of 
individuals, and removes any identical assignments. The final set of parent and offspring assignments are 
evaluated based on their Pareto order ranking and the most fit individuals are selected to move onto the 
next NSGA-II attempt, which repeats until nga = NGA. After the cycle of attempts completes, the program 
returns back to the MC/SA component with the final group assignments resulting from the NSGA-II 
component. 
 
5.4.2. Identification of a suitable scoring function to account for peak intensity and overlap. 
In the presented PIOS-weighted NSGA-II/MC program described here, we have incorporated an 
additional weight to the algorithm that uses the peak intensity and extent of chemical shift overlap to 
provide a better measure (or score) of the quality of a tested connection, hence our referral to this 
augmented method as PIOS-weighted NSGA-II/MC. As depicted in the flowchart shown in Figure 5.2, 
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the calculation of the intensity and overlap objective score begins with the comparison of a set of 
frequencies from two separate spin-system lists in a given connection test, in which three quantities are 
calculated. First, the intensity of each peak is scored as a function of SNR according to Equations 4–5, 
providing a value between 0 to 1 for each peak (Iscore,1 and Iscore,2). The generalized equation that we 
determined to most suitably account for the influence of a peak intensity on the quality of a particular 
connection is a sigmoidal curve in the form of a Gompertz function, as follows: 
 𝑓(𝑥) = 𝑎𝑒−𝑏𝑒
−𝑐𝑥
, (4) 
where the independent variable x represents the peak intensity, a and c are factors that define the 
maximum scaling and growth of the curve along the y-axis, respectively, and b is the displacement factor 
along the x-axis. Because we wanted to normalize our scoring function to 1 to simplify the calculation 
process, we set a to 1, and subsequently adjusted the values of b and c such that a SNR, x, of 5 provides a 
score close to 0.25, while a SNR of 15 provides a score close to 1. Accordingly, the final form of the 
implemented intensity scoring function is written: 
 𝐼score = 𝑒
−10𝑒−0.4∙𝑆𝑁𝑅 . (5) 
 Our rationale behind selecting these specific scaling and growth factors was to identify a function 
that changes most across the range of SNR values in which the uncertainty of peak position, spin-system 
belonging, and authenticity (i.e., whether it is noise or not) is highest. Beyond a noise threshold of 15  
(i.e., 15 times the noise-floor), most observed peaks can be considered to be “true peaks” in moderately 
signal-averaged multidimensional MAS SSNMR spectra (e.g.., several hours to a day for 2D spectra, or 
one to several days for higher-dimensional experiments). Further, based on negative control simulations 
in which the SNR of non-representative peaks within a given spin system were adjusted relative to true 
peaks within the spin system, the negative influence of SNR on the success of assignment solutions was 
found to become most severe below values of 10 for truly-representative peaks (with non-representative 
peak SNR values set to 30) (Figure 5.11). Although we have not included the option for users to adjust 
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these constants through the settings in the input control file for the PIOS-weighted NSGA-II/MC 
program, this may be easily changed in the program code directly if desired. 
Next, the extent of overlap of the two frequencies is scored based on the chemical shifts and user-
specified peak position uncertainties (1 and 2) of each frequency, normalized to 2*min(1,2) of the peak 
with the narrower uncertainty range to give a value between 0 and 1, Oscore, as follows:  
 𝑂score =
Overlap of peaks 1 and 2 within range of 1 and 2
2*min(1,2)
. (6) 
Subsequently, all three quantities are multiplied together to yield a product that represents the 
PIOS (or quality score) of the tested connection: 
  𝑄PIO = 𝐼score, peak 1 ∗ 𝐼score, peak 2 ∗ 𝑂score, (7) 
which provides a value of QPIO between 0 and 1, which is then scaled by 100† and rounded up to the 
nearest integer in order to meet the compatibility requirements in the program code (†however, the final 
quality score is scaled back down by 100 during the overall objective scoring calculation in Equation 1). 
This quality score is calculated for every possible combination of frequencies specified in the connection 
table (Nrows), for every spin system in the given assignment (Nseq), and is tabulated for every ith possible 
connection (Nconnect) throughout this process to provide a final total quality score for the entire assignment 
given by, 
 𝑄PIO
𝑇𝑜𝑡 = ∑ 𝑄PIO,𝑖 ∗ 100
𝑁𝑐𝑜𝑛𝑛𝑒𝑐𝑡
𝑖=1 ,  
 where, 𝑁𝑐𝑜𝑛𝑛𝑒𝑐𝑡 = 𝑁𝑠𝑒𝑞 ∗ 𝑁𝑠𝑝𝑒𝑐𝑡𝑟𝑎 ∗ 𝑁𝑟𝑜𝑤𝑠, (8) 
Accordingly, our method effectively provides a way of scaling the quality of a given set of connections, 
as opposed to assigning them as either “entirely good” or “entirely bad,” but still remains separate from 
the tabulation of the number of good connections. In this manner, in the event that a final set of 
assignment solutions exhibit the same number of good connections, one may still be able to assess the 






Figure 5.2. Calculation workflow for scoring the quality value of a given connection based on the SNR of 
each peak as well as the extent of overlap. 
 
5.4.3. Implementation of PIOS-weighted function within the NSGA-II/MC program. 
The interest in introducing the PIO-weighted score into the assignment program was to augment 
the robustness and performance of the previously expanded NSGA-II/MC algorithm, by incorporating 
valuable spectral information into an additional objective through which the program can propagate good 
assignments versus those that are considered bad in a more informed manner. This strategy functions in 
itself to help alleviate complications arising from the presence of additional peaks in a residue’s list of 
frequencies due to spin system degeneracy or weak inter-residue correlations (e.g., > i ± 1) in the SSNMR 
spectra through its scoring of the quality of the connection in a non-binary manner, and using peak 
intensity data combined with frequency alignment to inform on the extent to which the assignment “fits” 
(Figure 5.3). In this way, the PIOS-weighted NSGA-II/MC algorithm is highly tolerable of accepting 
generally less refined data sets that have not been extensively analyzed manually, since it indirectly 
accounts for the possible presence of a bad connection by giving the assignment a slightly lower score. 
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Accordingly, an important feature distinguishing this strategy from the combined NSGA-II/MC or 
standalone MCASSIGN2 methods is that here, final solutions that still contain a number of “bad 
connections” do not need to be—and should not be in many cases—completely eliminated in the assisted 
assignment process, which is a general requirement of the other programs20,21. The way in which the PIO 
scoring function is implemented in the program is what allows for it to do this. 
 
 
Figure 5.3. (A) 2D strip and corresponding 1D slice from a US NCACX 50 ms 3D spectrum illustrating 
the spin system of residue G9 in GB1 without any inter-residue correlations observed. (B) The same strip 
and slice of a separate NCACX 50 ms 3D (22% NUS) spectrum, which illustrates the additional presence 
of inter-residue peaks within the G9 spin system of GB1. Both spectra were collected with a MAS rate of 
12.500 kHz at 750 MHz (1H frequency) and 0 C for approximately 14 hours total. 
 
In deciding how to incorporate the scoring function into the NSGA-II/MC algorithm, we 
considered and tested several options before choosing to implement it as an additional objective involved 
in the Pareto ordering process. An alternative route by which we also added the function was through the 
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direct inclusion as part of the “good” objective, as a way to simply scale the overall “goodness” of each 
assignment. However, because we recognized that different connections will provide different magnitudes 
of PIOS depending on the strength of the SNR for the given connection, and as such may suppress the 
retention of assignment solutions which exhibit a higher number of good connections but which may be 
slightly weaker or fewer. For instance, there may be a situation in which one assignment solution has only 
one half of the total number of possible good connections but a very high PIOS objective quantity due to 
the alignment of many strong peaks between multiple connections, while another solution has 75% of the 
total number of good connections but only a modest PIOS quantity due to the corresponding spin systems 
having either very low intensity or few frequencies to overlap. In such an event, the combination of the 
PIOS quantity into the number of good connections would result in the suppression of the second possible 
solution. As such, by instead implementing the PIO score as a separate objective, assignment solutions 
with higher good connections but lower PIO-score, or vice-versa, would both be presented as valid 
solutions with different maximized objectives, rather than losing one under the control of the other.  
As we have emphasized, one additional benefit to adding the PIOS objective into the assignment 
algorithm is that the score is not penalized for making a weak connection or not making any connection at 
all, but rather either receives a lower quality score or no score at all, respectively. As this scaling of the 
score offers an indirect way of judging whether a connection is “good” or “bad”, for the majority of the 
simulations that we run here were performed with the tabulation of bad connections turned off. Although 
the continued tabulation of bad connections would not be an issue for cases of near-ideal data sets—
particularly for those in which the chemical shifts are listed in a specific order based on the knowledge of 
the specific atom type—in situations where the atom type of a particular chemical shift cannot be 
confidently identified, let alone whether the peak truly belongs in the given spin system, the number of 
tabulated bad connections can become exceedingly large and cause disruption to the sorting process even 
if the weights on bad are set to zero. Moreover, for nearly all of the calculations described below (which 
were performed using spin-system lists generated from minimally analyzed data sets) we use a connection 
list which specifies the possible connection between every possible 3 frequency of one spectrum with 
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every possible 3 frequency of another, with up to six 3 frequencies present in each spin system. This 
was intentionally done as way to further test the robustness of the presented algorithm for instances in 
which the atom type to which a specific chemical shift column corresponds does not need to be known in 
advance of performing the assignment simulation. Yet, as a consequence of forcing the program to 
sample all of the possible good and bad connections between each spin system, this incidentally can result 
in the tabulation of a large quantity of bad (or simply, “mismatched”) connections as well, which may 
lead to substantial complications at the sorting/ranking step further downstream in the program. 
Accordingly, the calculations described below avoid the tabulation of bad connections all together, 
allowing us to directly assess the influence of the added PIOS objective function as well as the robustness 
of the PIOS-weighted NSGA-II/MC program as a whole. 
 
5.4.4. Strategies for streamlining the analysis of NUS 3D and 4D data by the PIOS-weighted 
NSGA-II/MC algorithm. 
In the overarching interest of arriving at a fully automated approach for the assignment of 
chemical shifts in SSNMR spectra of proteins, we have developed and combined a collection of 
computational tools for streamlining the procedure involved in the translation of minimally analyzed 
NMR data sets into unbiased and pre-formatted spin-system lists that can be directly used as input to PIO-
weighted NSGA-II/MC calculations. Our work towards this goal was aimed at addressing three major 
rate-limiting steps in the typical process of preparing signal lists for program input: (1) the manual 
picking and grouping of peaks into separate spin systems; (2) the process of determining amino acid 
guesses for each of the corresponding spin systems; and (3) finally organizing these spin-system lists into 
a readable format for the assignment algorithm. These steps previously required a substantial amount of 
manual effort by the user and thus not only partially defeat the purpose of establishing a robust automated 
assignment algorithm, but also increase the susceptibility of overall process to user-bias and error. An 





Figure 5.4. Streamlined workflow for the generation of input files for PIOS/NSGA-II/MC using raw peak 
lists generated from either the reconstruction of spectra using SMILE or peak picking in Sparky. 
 
The first time-consuming step we address involves the picking and grouping of peaks in 3D 
and/or 4D spectra into separate spin-system lists. Typically, this requires the user to manually work 
through each spectrum, pick the observed cross peaks at different noise-threshold cutoffs, and then group 
these peaks into unassigned spin systems. While for some non-congested or highly resolved 3D SSNMR 
spectra this step may be done fairly effortlessly, it becomes a much greater difficulty in cases where there 
is significant peak overlap, spin-system degeneracy, or the presence of additional cross-peaks within a 
particular spin system arising from inter-residue correlations, as this can obscure what peaks truly belong 
to the same spin system and thus require a number of subjective decisions from the user (Figure 5.3). 
Indeed, several available NMR data analysis packages offer tools for expediting this process, such as 
through the use of automated peak-picking extensions and assignment guessing options, such as in 
Sparky17,18, CcpNmr24, NMRView25, and NMRDraw26. Further, some of these programs already offer 
means of automatically assigning solution NMR data through the integration of other assignment 
software, such as the PINE plugin27 within the NMRFAM-SPARKY package18. However, a generalized 
solution for the generation spin-system lists from peak lists for SSNMR data and the corresponding 
automation of their assignment remains largely limited. 
To address this limitation, we have assembled an in-house script to process the output from 
Sparky, group the peaks into spin systems based on user-defined tolerances and convert them into a 
compatible format for the PIOS-weighted NSGA-II/MC program, as illustrated by the work flow in 
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Figure 5.5. Additionally, to further extend this utility to the case of NUS 3D and 4D SSNMR spectra, we 
have also incorporated the capability of the script to directly read in the log file output from SMILE16 
reconstructed NUS spectra (as made available through the NMRPipe software package)26, which contains 
a list of chemical shift and data height information for all of the reconstructed peaks in the corresponding 
spectrum. In this manner, we are able to bypass the manual interaction with the fully processed 
multidimensional data set entirely (although it remains critical that the spectrum is processed correctly, 
including phasing specifications in the SMILE function). Together, the immense reduction in time 
required to acquire 3D and 4D SSNMR data by means of NUS, reconstruct the spectrum and immediately 
obtain a list of spin-systems that can be incorporated into the PIOS-weighted NSGA-II/MC assignment 
program offers a tremendous advantage over the manual effort required by standard methods. Thus, to 
validate the effectiveness and success of the proposed streamlined strategy for chemical shift assignment 
analysis, the majority of the results presented below were obtained using spin-system lists generated 
through the application of this peak-grouping script to either SMILE or Sparky peak lists, requiring very 
little to no manual analysis of the resulting spin-system lists. We employ this method both for the test 
case of GB1 as well as a much more challenging case of AL-09 VL fibrils, and describe the specific types 
of spectra used and how the peak lists for each were produced. The Python code for the peak-grouping 
script may be obtained upon request (which can be applied to NCACX, NCOCX, and CANcoCX 3D 
spectra as well as CANCOCX and CONCACO 4D spectra), and a detailed overview of the steps involved 





Figure 5.5. Flowchart for the peak grouping script used to generate spin-system lists from SMILE log 
files for input into the PIOS NSGAII/MC program. Asterisks indicate that the step can be controlled by 
user-defined input settings. 
 
Last, we also present a script to facilitate the process of determining amino acid guesses for each 
spin system by throughput into the PLUQ program developed by Fritzsching et al.28. Accordingly, this 
functions to simply take the output of the peak-grouping script above, and depending on the type of 
spectrum for which the spin-system list represents, extracts specific columns of frequencies and submits 
them to PLUQ. The output of the amino acid queries is then read back in and appended to the end of each 
spin-system list, while retaining the proper formatting of the list for input into the PIOS-weighted NSGA-
II/MC program. One additional feature that we have included in this step as a way of further assessing the 
robustness of the presented algorithm is the subsequent expansion of each set of amino acid guesses for 
each spin-system such that groups of amino acids which exhibit similar chemical shifts will be added onto 
the given set of guesses (e.g., if a Glu guess is present, guesses for Asp, Gln, and Asn will be included as 
well if not already present). This serves to increase the likelihood that the correct amino acid guess is 
included for each spin system, as the exclusion of the correct guess will prevent the spin system from 
being tested for that particular assignment. Overall, our intent in providing these alternative strategies to 
the assisted assignment process is to help streamline the tasks that otherwise become more cumbersome 
to perform, especially when the user is required to also manage and organize the corresponding intensity 
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information associated with each peak, retain a specific order of frequencies in the final input list for 
connection purposes, as well as repeat this process for a large number of different input files obtained 
from spectra processed using a variety of apodization parameters. This PLUQ throughput script is written 
in Python and may be obtained upon request; a description of the functions performed by the script can be 
found in the Supplemental Materials 5.7.1.3. 
 
5.5. RESULTS AND DISCUSSION 
5.5.1. Validating and assessing the performance of the PIOS-weighted NSGA-II/MC algorithm 
relative to other methods. 
Prior to performing our assignment calculations using the PIOS-weighted NSGA-II/MC program, 
we carried out a set of control experiments using the input spin-system lists and NSGA-II/MC program 
published previously21. In particular, we applied the original NSGA-II/MC program to the three cases of 
incomplete GB1 NCACX and NCOCX data sets in which spin systems from each list were deleted in a 
consecutive, random, or random and independent manner. These lists were prepared artificially with the 
intent of testing the program’s ability to correctly assign the provided regions of the protein sequence 
despite the possible absence of cross peaks for highly dynamic portions of the protein structure, as can 
often be the case in other protein systems. In all cases, the NSGA-II/MC program consistently reproduced 
the successful results previously reported (data not shown). Subsequently, we performed all three tests 
using the PIOS-weighted NSGA-II/MC program with same input spin-system lists but setting the global 
chemical shift uncertainties to the average of the corresponding frequency from the provided lists and 
setting the SNR for all peaks to a moderate value of 10. Our results revealed similarly accurate chemical 
shift assignments for the regions of the protein sequence which were retained in the input spin-system 
lists (Figure 5.10), demonstrating that the replacement of the “bad” objective with the PIOS objective 




While this test provides a strong validation of the program’s ability to assign only the residues 
which exhibit cross-peak intensity, one limitation that it faces is the use of spin-system lists containing 
fewer than the number of residues present in the protein sequence. As such, an important alternative test 
of this capacity is to provide the program with spin-system list containing more than the number of 
residues in the protein sequence, in order to determine if the program will still be able to correctly assign 
the correct residues despite the additional presence of possible noise, artifacts, or spin-systems arising 
from the existence of multiple conformations for a single residue. One indirect way of testing this is 
through the provision of GB1 spin-system lists containing more than the number of expected spin systems 
(i.e., 56 for GB1) without prior knowledge of whether the all of the truly representative spin systems of 
the protein are included, as would occur in the case of generating lists by automated means rather than 
manual analysis. 
To pursue this investigation, we proceeded to compare the ability of the PIOS-weighted NSGA-
II/MC algorithm relative to the previous NSGA-II/MC program to assign the chemical shifts of GB1 from 
spin-system lists generated by the streamlined workflow described in the previous section (Figures 3 and 
4). Specifically, the peak lists obtained from the SMILE reconstruction of NCACX 50 ms (22% NUS) 
and NCOCX 50 ms (17% NUS) 3D data as well as CANCOCX 50ms (4% NUS) 4D data were provided 
as input to the peak grouping script to generate a list of spin systems for which amino acid typing could 
be performed using the PLUQ throughput script and manual inspection of the results, providing a final 
spin-system list for each spectrum for input to the PIOS-weighted NSGA-II/MC program. The final set of 
spin-system lists for all three spectra are included in the Supplemental Materials 5.7.3, which also include 
the SNR information corresponding to all peaks within each spin system. One notable detail that can be 
observed in the GB1 input lists is that several of the spin systems contain more than the number of 
expected frequencies for a particular residue type, particularly among several glycine spin systems 
(recognized by the unique CA chemical shift frequency). These additional frequencies are the apparent 
consequence of one or more inter-residue cross peaks occurring within a given spin system and/or may 
represent the presence of spin-system degeneracy between two separate residues containing similar 
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frequencies in the 1 and 2 dimension for 3D spectra. As we are interested in establishing a more robust 
program that can successfully handle spin-system lists in which the identification of particular atom types 
for each frequency is not required (i.e., requiring the user to know in advance what type of side-chain 
atom a particular frequency corresponds to and thus place in a specific column order for connecting to the 
other signal lists), the order of 3 frequencies for each input list that we used for our tests is simply based 
on decreasing SNR value and does not necessarily reflect the atom type to which each frequency 
corresponds. Nonetheless, the value of including the SNR value for each frequency becomes most 
apparent in cases of such spin-system degeneracy or inter-residue correlations, as the intensity of these 
indirectly associated cross-peak correlations is notably lower than those corresponding directly to the 
spin-system or residue of interest. Accordingly, the PIOS-weighted NSGA-II/MC program is far less 
susceptible of being negatively impacted by the presence of such additional frequency information than 
the previous program which does not account for the relative extent of peak intensity and overlap.  
Our initial performance tests were carried out in ten replicates (each with a different input seed 
number) using only the MC component of the algorithm (5 x 105 attempts) over 30 total steps with an 
initial group size of 50. Minimum and maximum weights for good, edge, used, and PIOS objectives were 
set to 0–5, 0–1, 0–1, and 0–2, respectively, while no weight was placed on bad connections in order to 
avoid penalizing the overall score for each assignment due to the presence of non-representative chemical 
shifts in several of the spin systems as described above. Additionally, as all possible combinations of 
connections between all 3 frequencies of one spin-system list with those of the other spin-system were 
specified as test connections in the connection file, the inclusion of weight on bad connections can 
interfere with the program’s ability to identify the optimal solution. The input control file containing all 
details for the runs as well as the expanded connection file are included in the Supplemental Materials 
5.7.4 and 5.7.5. Overall, as shown in Figure 5.6A, the PIOS-weighted NSGA-II/MC program performed 
consistently well over the course of all ten runs, providing accurate chemical shift assignments for the 
entire GB1 sequence, including the 13C chemical shifts for residue M1 (the N-terminal 15N chemical shift 
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is folded in the 1 dimension of the NCACX experiment and thus exhibits the incorrect frequency in the 
final output, as it was not unfolded during the generation of spin-system lists). To assess how these results 
compare to those obtained from the exclusion of the PIOS objective, we performed ten independent runs 
using the original NSGA-II/MC program under the same calculation settings21, and removing the 
additional SNR information from the spin-system lists. The percentage of times each residue was 
assigned correctly across all ten runs for the NSGA-II/MC program is plotted in Figure 5.6B. Notably, the 
PIOS-weighted program was found to perform statistically better than the original NSGA-II/MC program 
when provided with the same input spin-system and connection files.  
 
Figure 5.6. Average assignment accuracy as a function of residue number over ten independent 
simulations on GB1 spin-system lists generated from the grouped output of SMILE reconstructed 
NCACX 50 ms and NCOCX 50 ms 3D NUS spectra and CANCOCX 50ms 4D NUS data, using only MC 
steps with the (A) the PIOS/NSGA-II/MC or (B) NSGA-II/MC assignment program. (C) Results over ten 
runs from the PIOS/NSGA-II/MC program using both MC and NSGA-II attempts. Spin-system lists and 





This result provides a clear demonstration of one benefit from including the additional PIOS 
weight into the computationally-aided assignment process, as the deficiencies of the original program 
may be attributed to its dependence on high quality input spin-system lists which do not contain any 
overlapping or non-representative frequencies within a single spin-system. Additionally, the general 
dependence of the previous programs on being provided input lists in which the atom types are already 
known and placed in a specific column order accordingly prevents them from being able to handle more 
realistic data sets in which the atom types are not known. This restriction arises from the program placing 
equal weight on all frequencies within a given spin system regardless of the identity of the corresponding 
atom type or the residue to which it belongs (and even for noise peaks), thus becoming highly susceptible 
to assignment errors caused such as a false positive. This limitation is addressed through the PIOS 
objective by providing a way to scale the quality of a connection based on the SNR corresponding to each 
frequency and working under the assumption that overlapping inter-residue peaks within a spin system 
will exhibit a lower intensity than those that directly belong to the spin system.   
Another clear benefit offered through the addition of the PIOS objective is related to the “all-
good” or “all-bad” decision making in the original program. Similar to the case described above, if an 
additional resonance is present in a particular spin system (e.g., the inter-residue correlation of the i+1 
13C chemical shift), the NSGA-II/MC program will identify this as a bad connection and thus assign a 
lower Pareto order to the given assignment. However, in the case of the PIOS-weighted NSGA-II/MC 
program, such a connection will either simply be ignored (if no other frequency in the connected spin 
system overlaps with the inter-residue correlation frequency) or given a relatively lower PIOS value as 
opposed declaring the connection as being “entirely good” (under the assumption that the inter-residue 
peak will exhibit a weaker signal intensity relative to an intra-residue correlation). As such, the heavy 
dependence on an either all-or-nothing objective is alleviated by the inclusion of the PIOS objective, thus 
preventing the possible elimination of a large number possibly valid solutions resulting from the 
identification of a single bad connection, as can occur under the design of the original programs. 
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We also performed a similar set of simulations with the addition of the NSGA-II component as 
well (5 x 103 NSGA-II attempts; 5 x 105 MC attempts; 15 SA iterations; max w1, w2, w3, w4, and w5 of 2.5, 
0.0, 0.5, 0.5, and 1.25, respectively; see Supplemental Materials 5.7.4 for control file). The results from 
the simulations performed with the PIOS-weighted NSGA-II/MC program demonstrated nearly perfect 
results for all runs with the exception of four residues which were assigned correctly for 9 of the 10 
simulations (Figure 5.6C). We also performed these simulations using the original NSGA-II/MC program 
for comparison to the presented program; however, due to the inability to turn off the tabulation of bad 
connections in the previous program, we recognized that this caused severe complications in the sorting 
algorithm in the NSGA-II attempts and thus led to significant deficiencies in the results (even with the w3 
weight for bad connections set to zero), and thus we have excluded this comparison.  
Another noteworthy observation is that in nearly all runs of GB1, the solutions with the highest 
PIO score represented the one with the most accurate number assignments, even between other Pareto-
order-1 solutions that with the same number of “good” connections. Thus, the addition of the PIOS 
objective provides a valuable complement to the “good” objective and others, as it can offer and 
additional standard by which the quality of a solution can be assessed. We have found this trend to be 
particularly useful for tracking the progress and success of an assignment calculation, as it can provide 
indirect insight on whether—and at what step—the sampling of the program has fallen into a local 
minimum. Importantly, however, in light of this observation we would also like to point out that due to 
the way the PIOS objective must be calculated in the program, the overall quantity can become 
exceptionally large relative to the other objectives, often adding up into the range of tens of thousands 
(though which is divided by 100 at the scoring step), which can very easily drive the calculation in to a 
local minimum if the corresponding weighting factor is not set properly. Provided this, we have found the 
use of 0 as an initial weighting factor and maximum values between 20 to 500 times lower than the 
number of total steps (e.g., for 50 steps, we would use a w5max of 0.5 to 1.25), but should be adjusted and 




5.5.2. Evaluating the robustness of the PIOS-weighted NSGA-II/MC program with unanalyzed 
and computationally generated spin-system lists. 
We next aimed to investigate the robustness of the PIOS-weighted NSGA-II/MC algorithm by 
providing it with more challenging spin-system lists. While the lists provided for the earlier tests were 
observed to contain several inter-residue correlations for a few spin systems, those lists were generated 
using a high sigma level in the processing of the data with SMILE and as such does not contain many of 
the relatively weaker peaks that are still present in the data. As such, we reprocessed the NCACX 50 ms 
and NCOCX 50 ms 3D NUS data sets using a lower sigma threshold of 10, and provided the output log 
files and input to the peak-grouping script work flow. This provided us with two new NCACX and 
NCOCX spin-system lists that contained 95 spin systems and 73 spin systems, respectively. Further, in 
order to avoid the possibility of excluding the correct amino acid guesses for the relevant spin systems of 
GB1, we specified in the PLUQ throughput script to include all amino acids of the following groups if 
one is present in the set of guesses for a given spin system: (1) I, V, and T; (2) D, N, E, and Q; (3) K, L, 
and I; and (4) F, W and Y. 
Subsequently, we performed a series of 5 independent runs using these lists in combination with 
the CANCOCX list used for the previous simulations, with different initial control files settings. The first 
set of simulations were performed using only MC attempts and over 30 full program (SA) iterations. As 
shown in Figure 5.7A, nearly all of the residues of GB1 were assigned correctly in the majority of the 
simulations. We next performed a similar set of 5 independent runs using both MC and NSGA-II 
attempts, but with only 15 total SA iterations. Interestingly, the results from these simulations 
demonstrated significantly lower agreement with the correct GB1 chemical shift assignments (Figure 
5.7B). Yet, as we describe in the results on AL-09 VL fibrils in one of the following sections, the NSGA-
II component does not necessarily consistently lead to lower quality results and may only have been a 
consequence of the use of fewer simulated annealing steps here. Alternatively, it may be possible that the 
NSGA-II algorithm performs less optimally when provided such complicated data sets (i.e., those 
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containing many non-representative frequencies within a given spin-system). Nonetheless, we have found 
both the MC/SA as well as the NSGA-II methods to offer their own benefit to the assignment results in a 
variety of other cases, and recognize them each as valid algorithms to the assignment process. 
 
 
Figure 5.7. Accuracy and precision of PIOS-weighted NSGA-II/MC assignments of GB1 as a function of 
residue number over five independent simulations using NCACX, NCOCX, and CANCOCX spin-system 
lists in which many inter-residue correlations are present. (A) Assignment simulations run using only MC 
attempts (5 x 105) over 30 steps with a group size of 50. (B) Simulations run using both MC attempts (5 x 
105) and NSGA-II attempts (5 x 103) over 15 steps. NCACX 50 ms and NCOCX 50 ms NUS 3D lists 
were generated directly from SMILE reconstructed peak lists (processed using a relatively lower nSigma 
value of 10 and time domain limits of 0.1 to 1.0) and PLUQ throughput, followed by automated addition 
of similar amino acid types. 
 
One particularly interesting example of the success of robustness for the PIOS-weighted 
algorithm can be seen in the assignment of glycine 9, in which multiple inter-residue correlations are 
observed in the single spin system. As illustrated in Figure 5.3, the 13C resonances for both the i-1 and 
i+1 residues are present within the spin system. Despite this, the assignment program was still able to 
successfully assign this residue in every simulation with only MC attempts (Figure 5.7A), and for the 
majority of runs with both MC and NSGA-II attempts (Figure 5.7B). Intriguingly, after reviewing the 
assignment solution resulting from one of the fully accurate simulations, we observed that the spin 
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systems of N8 and K10 in the NCACX list likewise contain the 13C frequency corresponding to G9 
(44.8 ppm). Although the connection file that we used did not specify the comparison of frequency 
column #2 (13C for the NCACX list) with any 3 frequencies in the other lists—and thus preventing the 
connection of this frequency with its presence as an inter-residue correlation in another spin system—this 
raises the consideration of whether doing so might also be of value, as the observation of such 
neighboring correlations when analyzing data manually is typically used as a valuable way to confirm the 
accuracy of an assignment. Certainly, an investigation on the added value of including potential inter-
residue correlations into the connection list is an interest we intend to pursue in future studies. Overall, 
the results that we have obtained through this method show clear improvement relative to the original 
NSGA2/MC program, and demonstrate that even if the input spin-system lists contained inter-residue 
correlations, the PIOS-weighted program is still able to correctly assign the residue for the primary 1 and 
2-containing spin system. 
 
5.5.3. Sequential chemical shift assignments using a single four-dimensional CANCOCX NUS 
spectrum. 
 In addition to analyzing the overall robustness of the PIOS-weighted NSGA-II/MC algorithm, we 
were also interested in assessing the capacity of the program to perform sequential chemical shift 
assignments with as minimal data as possible. Towards this, we acquired a CANCOCX 50 ms 4% NUS 
4D spectrum and a CANCOCA SPC-7 q56 (1.28 ms) 4% NUS 4D spectrum on GB1 and generated a 
corresponding spin-system list for the data set through the SMILE reconstruction and peak-grouping 
workflow. At the amino acid guessing step, however, we decided to use the single spin-system list input 
to generate two separate outputs from the PLUQ processing script—one in which amino acid guesses 
were made based on the CA and N chemical shifts (1 and 2), and another based on the CO and CX 
chemical shifts (3 and 4). Additionally, we prepared a new connection file in which we could relate the 
two separate spin-system lists by the matching CA and CX frequencies of 1 and 4. Upon inputting these 
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files into the PIOS-weighted NSGA-II/MC assignment program and analyzing the results, we found that 
all but two residues of the protein sequence were assigned correctly (Figure 5.8). Surprisingly, the only 
residues that were misassigned (N8 and A20) are not notably degenerate spin-systems out of the list of 
GB1 assignments, and thus the program’s inability to correctly assign these residues in particular was not 
expected. Nonetheless, the ability to assign nearly all other residues with only a single, unanalyzed NUS 
4D spectrum raises tremendous interest in the possibility of applying this to more difficult systems and 




Figure 5.8. PIOS/NSGA-II/MC assignment results for GB1 using a single spin-system list generated 
from the combined grouping of peaks reconstructed by SMILE for a CANCOCX 50 ms NUS 4D 




5.5.4. Augmenting chemical shift assignments of AL-09 VL fibrils with PIOS-weighted NSGA-
II/MC. 
After validating the success and robustness of the PIOS-weighted NSGA-II/MC assignment 
program using the test case of minimally edited SSNMR data of GB1, we proceeded to extend our 
approach to more challenging protein systems which exhibit a higher extent of spin-system degeneracy, 
peak overlap, as well as spectral congestion for proteins of larger size. One representative example of this 
is exhibited by the case of AL-09 VL fibrils, for which we have recently reported the backbone and side-
chain chemical shifts as well as insight on the secondary structure and dynamics of different regions of 
the fibril29,30. The protein sequence for AL-09 VL is 110 amino acids, and exhibits a disproportionately 
high number of serine and threonine residues (14 Ser and 12 Thr) relative to other amino acid types, and 
the presence of which we have observed to contribute to partial peak overlap due to similarities in 
backbone and side-chain chemical shifts. Several other notable features of the AL-09 VL protein sequence 
that present substantial assignment challenges are the occurrence of repetitive amino acid motifs (e.g., 
63SGSGSGT69), as well as the presence of 8 proline residues throughout the sequence. While proline spin 
system generally consists of a set of rather unique chemical shift frequencies relative to other amino acids 
(e.g., a 15N shift typically ≥ 130 ppm and 13C shift ~60 ppm), it poses a notable challenging case in 15N-
13C correlation SSNMR spectra, as the lack of an amide proton results in a poor overall signal for the 
proline spin system in (1H)-15N-13C-13C type experiments that rely upon 1H-15N polarization transfer for 
the initial signal.  
 The spin-system lists used for performing the automated assignment program on AL09 were 
prepared in the following manners: (1) an NCACX spin-system list was obtained by combining the 
SMILE output peak lists from a NCACBCO SPC-10 q64 (25% NUS) 3D spectrum reconstructed using 
nSigma values of 6 and 8; (2) NCOCX spin-system list assembled from the combination of several 
manually analyzed NCOCX and NCOCA 3D spectra; and (3) a CANCOCX spin-system list prepared 
from the combination of SMILE reconstructed peak lists for a CANCOCX 50ms 4D (2% NUS) spectrum 
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and CANCOCA SPC-8 q64 4D (4% NUS) spectrum, using an nSigma value of 4. All three of these 
grouped spin-system lists were then provided as input to the PLUQ throughput script to obtain an initial 
set of amino acid type guesses for each spin system. 
 Using these spin-system lists as input the PIOS-weighted NSGA-II/MC program, we performed 
50 independent simulations using either only MC attempts (50,000) or both MC and NSGA-II attempts 
(50,000 and 5,000, respectively), and all runs were performed using 30 total steps, a group size of 50, 
gene pool size of 40, minimum SA weights of 0, and maximum weights of 5, 0, 1, 1, 1.25 for good, bad, 
edge, used, and PIOS, respectively. The results from the simulations are plotted in Figure 5.9 for the MC-
only (blue) as well as the combined MC and NSGA-II (red) runs as a histogram of the number of times a 
residue was assigned correctly out of all 50 runs (i.e., matching with manual assignments) as a function of 
residue number. Interestingly, both initial calculation setups performed with very similar success on 
average, which was unexpected in light of the previous test of GB1 earlier, in which the combined MC 
and NSGA-II simulations produced much lower quality results than the MC only simulations. As such, it 
is possible that the reason for lower success for GB1 may have been due to the use of an insufficient 
number of total SA steps, as for the case here the same number (30 steps) was used in both cases. 
Certainly, this is an additional test we will perform briefly. Beyond the similarity of MC and MC with 
NSGA-II outputs, one noteworthy consistency between the two is that in both simulation setups, the N- 
and C-terminal residues are observed to be assigned correctly more frequently than the other residues, 
which further augments our previous chemical shift assignments as well as our observations of highly 
ordered and resolved spin systems for residues within these regions29,30.  
One interesting observation in the results shown in Figure 5.9 is that several of the residues were 
not assigned correctly in any of the total 100 simulations, specifically: Q3–M4, P8, C23, V58–P59, R61–
F62, and F98. While at initial glance this may appear to be signify a deficiency in the PIOS-weighted 
NSGA-II/MC program, re-inspection of the generated input lists revealed that most of these residues were 
reconstructed by SMILE and grouped accordingly into the input spin-system lists; however, the limiting 
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factor in this situation was most often the absence of the accurate amino acid guess predicted for the given 
set of chemical shifts by PLUQ. Nonetheless, one way of addressing this shortcoming would be to 
perform multiple variations of the simulations using several different versions of grouped spin-system 
lists (e.g., using different SMILE parameters, using different peak-grouping tolerances, as well as 
different types of spectra), which is a general recommendation we make when performing 
computationally-assisted assignments. Indeed, in using a variety of spectra types and processing 
parameters—in combination with the use of the streamlined approach we describe and apply here—one 
may be much more easily able to recognize the benefit of inputting ample (though perhaps not “perfect”) 






Figure 5.9. Comparison of the consistency of PIOS/NSGA-II/MC results between 50 different 
simulations with manual assignments of AL-09 VL fibrils, using either only MC attempts (5 x 105; blue) 
or using both MC and NSGA-II attempts (5 x 105 and 5 x 103; red). NCACX and CANCOX spin-system 
lists generated from grouping of the reconstructed peak list output from SMILE as well as a NCOCX 
spin-system list generated from manual assignments in Sparky. Reconstructed NCACX and CANCOCX 
spectra include a 25% NUS NCA(CB)CO 3D spectrum with SPC-10 q60 mixing, a 4% NUS CANCOCA 
4D spectrum with SPC-8 q64 mixing, and a 4% CANCOCX 50ms 4D with J-decoupling soft pulses in 
both indirect 13C-dimensions. Hash-mark symbols (#) indicate that no manual assignment has been made 





We present and demonstrate the improved performance of a robust assignment program that uses 
peak intensity and frequency overlap information for scoring the quality of set of given assignments, 
which we call the PIOS objective. In addition to showing that this method functions with consistently 
high accuracy for assigning the chemical shifts for the test case of GB1, we demonstrate that the PIOS-
weighted NSGA-II/MC program can produce similarly successful results for input data sets containing a 
high number of inter-residue correlations, and does not rely upon any specific ordering of chemical shifts 
in the input files. To this end, we apply this algorithm to a streamlined workflow in which no manual 
analysis of the data is required. In addition to showing success with GB1, we also demonstrate 
appreciable assignment accuracy for more challenging cases of AL-09 VL fibrils which exhibit a higher 
degree of spin-system degeneracy and peak overlap. Overall, the presented PIOS-weighted NSGA-II/MC 
algorithm is demonstrated to offer substantial improvement relative to the previously reported algorithms 
which do not take into account the peak intensity information as a way to guide the assignment process. 
 
5.7. SUPPLEMENTAL MATERIALS 
5.7.1. Supplemental information 
5.7.1.1. Notes on the modifications implemented in PIOS-weighted NSGA-II/MC program source code 
The source code for the PIOS-weighted NSGAII/MC program is written in Fortran 95, and is an 
extension of the NSGA-II/MC code written by Yang et al.21 as well as the MCASSIGN2 code from Hu et 
al.20, respectively. The corresponding Fortran 95 files for generating the PIOS-weighted NSGA-II/MC 
executable as well as a template Makefile are may be obtained upon request. In the implementation of the 
PIOS objective into the program, several modifications to the previous code were necessary in order to 
accommodate the additional quality score calculation in addition to several other minor changes. Of these 
minor modifications includes our decision to change the declaration of connections that fall outside the 
limits of the protein sequence (e.g., an NCOCX spin system assigned to the C-terminal residue) from bad 
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connections to be edge assignments instead, since we believe this better represents the meaning of the 
connection and that an impossible assignment of this type should not be penalized with a higher weight 
(as w2 is typically set to be higher than w3).  
Other small changes were generally gated around addressing Fortran compilation issues, through 
which we have now made the program fully compatible with the freely-available PGI community edition 
compiler. This compiler is available for download on the PGI website for OS X, Unix, and Windows 
operating systems, so long as the system requirements for installing the compiler are met. We have 
confirmed that the PIOS-weighted NSGAII/MC program compiles and runs successfully on Mac OS X 
10.10, Ubuntu 16.04, and CentOS Linux 7.3 working environments. The executable used here was 
generated using an optimization level of 2, with the added debugging option flag, ‘-g’. 
 
5.7.1.2. Description of the functionality and logic of the peak-filtering and grouping script  
The peak filtering and grouping script is written in Python and may be provided upon request. It 
can be run simply through the command line and requires only the installation of the NumPy module. The 
script functions by first reading in a Sparky peak list file or SMILE log file generated from the processing 
of a NCACX, NCOCX, or CANcoCX 3D spectrum or CANCOCX 4D spectrum using SMILE 
reconstruction on either NUS or US data (with the ‘-report 2’ flag, for a detailed log file), and extracting 
out all of the peak information as well as the thermal noise level. Additionally, depending on the settings 
specified by the user, the script will serve as a filtering function at this step by either retaining or 
excluding negative cross-peak signals, as well as peaks that fall outside certain indirect dimension 
chemical shift ranges (e.g., we retained peaks within 15N ranges of 95–150 ppm, 13CA ranges of 38–70 
ppm, and 13C’ ranges of 165–185 ppm). We chose to exclude negative peaks from data sets acquired with 
DARR mixing as they did not represent peaks of interest, but they were retained for experiments 
performed using SPC-N dipolar recoupling schemes, which result in negative cross-peak intensities for 
directly coupled 13C-13C correlations.  
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Next, peaks with similar chemical shift frequencies in the indirect dimensions (i.e., w1 and w2 for 
3Ds; or w1-w3 for 4Ds) are grouped together based on user-defined tolerances (in ppm), forming an 
initial set of spin systems. Typical tolerances used for the spin system lists generated here were 0.25 ppm 
for 15N dimensions and 0.15 ppm for 13C dimensions, which were chosen to cover the full range of 
chemical shifts within the standard deviations of the average shift value often observed for the 
corresponding nucleus type in SSNMR spectra (i.e., 0.5 ppm for 15N; 0.3 ppm for 13C). As this grouping 
process can lead to the generation of redundant spin systems (e.g., peaks A and B will be grouped, as will 
peaks B and A separately, in the format by which it is currently implemented), these duplicates are 
removed; yet, it is also worth noting that while peaks A and B are grouped based on the indirect 
dimension frequencies of A, there may be an event where peak B is later grouped with both A as well as 
additional peaks C, D, etc. In such an event, both spin systems are retained in the final output signal list, 
even though they may differ by only one frequency, or by the averaged shift of one of the frequencies. 
Although this may be undesirable in some situations—becoming most problematic at the assisted-
assignment stage due to increasingly longer calculations—we believe this presents as a highly suitable 
solution to the question of possible spin-system degeneracy. In other words, rather than requiring the user 
to assess whether a particular spin system should be given a degeneracy value greater than 1, the 
generation of multiple, similar—yet slightly different—sets of spin systems can serve as an alternative 
approach to the decision-making process, and as such the script by default assigns a degeneracy value of 1 
to every generated spin system in the final output list. This of course can be modified later by the user, if 
desired. Another added and interesting benefit to the possibility of redundant spin-system grouping is that 
the PIOS-weighted algorithm will, in the end, identify the spin system which agrees best with the other 
spin-system lists based on the slight differences in chemical shift frequencies (as this is accounted for in 
the overlap score) as well as SNR values of the corresponding peaks selected to be grouped in each spin 
system. As such, for the assignment calculations performed in our work here, all of the spin systems 
generated by the grouping script were retained to provide the algorithm with the complete set of data to 
use for assignments, rather than unintentionally excluding solutions that may be more optimal. 
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Following the initial filtering and grouping steps, all of the indirect dimension frequencies are 
separately averaged within each spin-system group, providing a single average chemical shift value for 
the 1 and 2 frequencies of the spin system (and 3 for 4Ds). Further, as peaks occurring at the 
diagonal in a 3D or 4D spectrum will exhibit nearly the same chemical shift value in both the direct 
dimension and one of the indirect dimensions (e.g., an N-CA-CA correlation), the script will average the 
direct dimension chemical shift into the corresponding indirect dimension based on a separate user-
defined tolerance range (we used 0.15 ppm for 13C shifts, which represent the only nucleus for which a 
diagonal was present in the data analyzed here). Subsequently, a similar averaging process is performed 
for all direct dimension chemical shifts within another user-defined ppm range, as we observed that in 
some instances (based on the settings used in the data processing step), SMILE can overrepresent certain 
peaks as multiple signals and thus lead to the presence of many very similar chemical shifts within a 
single spin system. During this process, a decision is made on how to handle the SNR values 
corresponding to the two peaks for which the direct dimension chemical shift will be averaged, in which 
the script will average the two SNR values if the value of the weaker peak is within 50% of that of the 
stronger peak; otherwise, the stronger SNR is retained to correspond to the averaged chemical shift. 
Related to this, as the final output list must contain a SNR value corresponding to each chemical shift 
frequency in the spin system in order to be read in properly by the PIOS-weighted NSGAII/MC program, 
there must be an SNR assigned to the indirect dimension frequencies as well. Thus, we decided the most 
appropriate way to address this is to use the max SNR value from within each spin system to represent the 
SNR of the indirect dimensions. 
Last, the script sorts the grouped spin systems based on the 15N chemical shift frequency, in 
addition to sorting the direct dimension chemical shifts within each spin system based on the strength of 
each frequency’s corresponding SNR, before outputting the list as a new text file. This ordering of direct 
dimension shifts is generally trivial, but is done so that the subsequent PLUQ throughput script will select 
the stronger frequencies to use as input for amino acid querying, as only the first five frequencies are used 
for each query. The final output signal list contains a header line at the top specifying the number of 
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grouped spin systems present in the file as well as the number of frequencies included within each spin 
system (we used maximum sizes of 9 frequencies per spin system; however, this can be specified by the 
user when running the script), followed on the next line by the estimated chemical shift uncertainties (in 
ppm) for each corresponding frequency (calculated as 2*tolerance of each nucleus type as specified by 
the user in the grouping script). The remaining rows of the file represent the grouped spin systems, and 
are printed out in the following column-order (for n frequencies): 
 
15N (ppm) | 13CA (ppm) | 13C’/13CX1–n | SNR 15N | SNR 13CA | SNR 13C/CX1–n | Degeneracy | AAs 
 
We note here that the output spin-system list from this script will be formatted properly for the 
PIOS NSGAII/MC program, but by default will contain the full list of possible AAs for each spin system 
(i.e., all 20 amino acid letter codes will be filled into the “AAs” column field). This is done primarily to 
serve as a placeholder for until the frequencies from each spin system in the list can be run through 
PLUQ. Because the process of filtering and grouping the peak list is a much faster computational task 
than the I/O involved in querying a long list of spin systems, we decided to make the PLUQ throughput 
script as a separate step than incorporating it into the grouping job. This allows the user to assess and 
review the resulting spin system list before running it through PLUQ, and make any changes to the 
tolerances or indirect dimension window limits (or to the final list itself) that they wish to make without 
having to wait several seconds to a few minutes (depending on the length of the list) between each 
change. 
 
5.7.1.3. Description of the functionality of the PLUQ throughput script 
Once the user is satisfied with the resulting list of spin systems for the particular spectrum of 
interest, this list may be used as input for a separate PLUQ28 throughput script, to obtain the top amino 
acid guesses for each spin system. This script works by using user-specified chemical shift columns from 
each spin-system list as frequencies to input into the PLUQ program, and essentially concatenating the 
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input command lines to PLUQ, which are then submitted to the terminal and the terminal output is saved 
to a separate file. The script then reads in the results from PLUQ, converts all amino acids to single letter 
type, and then appends the guesses to the end of each spin system prior to final output to the proper 
format for running in the PIOS NSGAII/MC program. This script only requires that the user has PLUQ 
installed on their system, and specifies the path to the PLUQ directory within in the Python throughput 
script. This PLUQ throughput script, as well as the peak filtering and grouping script, may be obtained 
upon request. 
In this manner, by streamlining the steps involved in generating input files for the PIOS 
NSGAII/MC program, our intent is to give the user the ability to explore another frontier in the realm of 
possible assignment solutions—that of processing-dependent variations in reconstructed data. As such, 
we suggest that the user process the data in multiple different ways, as well as filtering and grouping the 
script with several different tolerance settings, so that they have multiple slightly different versions of 
spin-system lists from the same data set to use in the PIOS NSGA-II/MC program. As the top scoring 
solutions will receive Pareto-order 1 ranking, one may compare the results from each of these and assess 
which chemical shifts are identified most frequently for each residue. 
 
5.7.1.4. Description of the functionality of the PIOS-weighted NSGA-II/MC post-processing script 
To facilitate the analysis of results from the PIOS-weighted NSGA-II/MC program, we also 
provide a Python script for averaging the chemical shifts for the top scoring solutions, and is essentially a 
direct re-write of the MATLAB scripts provided by Yang et al.21. This can be provided upon request. One 
caveat to be aware of when using this script, however, is that if a connection file involving multiple CX to 
CX connections is used, the results from this script may likely represent averages of non-similar chemical 
shifts. For example, the CX1 shift of the NCACX list may be averaged with the CX2 of the NCOCX list, 
if the connection file specified the possible connection between the CX1 and CX2 between the two lists, 
as this script uses the information in the connection file to determine which chemical shifts to average 
among the tops scoring solutions. Nonetheless, so long as no degenerate connections are specified for the 
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15N and 13CA chemical shifts (as we have avoided in our connection lists), the average chemical shift 
values for these resonances should be represented properly. 
 
5.7.2. Supplemental figures 
 
Figure 5.10. Validation of the ability of the PIOS-weighted NSGA-II/MC program to provide 
consistently accurate chemical shift assignments as the NSGA-II/MC program in the case of GB1 for 
which 20% of the NCACX and NCOCX spin-system lists provided as input are deleted (A) 
consecutively, (B) randomly, and (C) randomly and independently. The input files used for these 
calculations were prepared from the example data provided by Yang et al.21, in which the only minor 
changes were made to adapt them to the formatting requirements of the PIOS-weighted NSGA-II/MC 
program. The SNR for all frequencies was set to 10, and the global chemical shift uncertainties for each 
frequency column were set to the average of the uncertainties reported for each individual spin system in 





Figure 5.11. Assessing the influence of SNR values and the presence of inter-residue correlations on 
PIOS-weighted NSGA-II/MC assignment success. Simulations were performed over 5 independent runs 
using (A) the original NCACX, NCOCX, and CANCOCX spin-system lists, which contain many inter-
residue correlations, (B) the same lists with all SNR values set to 30 for all spin-systems, (C) with the 
SNR values corresponding to the first three frequencies of the ith residue (i.e., those with a shift index of 
0 in the connection table) set to 10 and all others set to 30, and (D) with the SNR values corresponding to 
shifts 1–3 in the NCACX and NCOCX set to 5, shift 4 in the NCOCX set to 10, and shifts 1–3 in the 
CANCOCX set to 5, 5, and 3, respectively, while all others were set to 30.  
 
5.7.3. Supplemental tables: NCACX, NCOCX and CANCOCX spin-system lists for GB1, without 
extensive inter-residue correlations. Lists were generated from output peak lists from SMILE 
reconstruction of NCACX 50 ms (22% NUS) and NOCX 50 ms (17% NUS) 3D data as well as 




5.7.3.1. NCACX List 
67 9 
                  0.5 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
           104.071 69.866 21.607 2000 2000 2000 2000 2000 2000 19 19 19 0 0 0 0 0 0 1 TVI 
104.081 60.448 21.566 69.898 175.518 2000 2000 2000 2000 65 65 65 57 42 0 0 0 0 1 ITV 
105.534 45.057 171.074 2000 2000 2000 2000 2000 2000 70 70 55 0 0 0 0 0 0 1 G 
106.328 62.016 69.42 22.571 173.055 2000 2000 2000 2000 46 46 41 41 35 0 0 0 0 1 TVI 
108.099 45.253 172.46 2000 2000 2000 2000 2000 2000 92 92 68 0 0 0 0 0 0 1 G 
108.341 46.931 173.765 61.871 21.886 2000 2000 2000 2000 90 90 64 17 16 0 0 0 0 1 G 
109.016 61.015 21.085 73.057 173.683 2000 2000 2000 2000 38 38 37 35 29 0 0 0 0 1 ITV 
109.45 44.777 172.926 2000 2000 2000 2000 2000 2000 68 68 51 0 0 0 0 0 0 1 G 
112.002 62.581 21.342 71.548 174.146 175.34 2000 2000 2000 52 52 52 48 37 16 0 0 0 1 ITV 
112.048 60.423 171.953 20.939 71.706 2000 2000 2000 2000 41 41 32 28 17 0 0 0 0 1 TVI 
114.879 60.25 171.819 70.492 20.06 174.057 2000 2000 2000 85 85 53 52 41 19 0 0 0 1 TVI 
114.894 53.631 174.036 176.833 40.23 2000 2000 2000 2000 58 58 40 37 36 0 0 0 0 1 DNLEQKI 
115.359 52.596 179.774 174.958 42.184 2000 2000 2000 2000 41 41 35 30 26 0 0 0 0 1 DLNEQKI 
116.02 63.685 174.825 31.942 21.201 2000 2000 2000 2000 49 49 36 30 15 0 0 0 0 1 PVIKL 
116.178 61.446 18.932 70.771 171.054 2000 2000 2000 2000 52 52 45 43 39 0 0 0 0 1 ITVS 
116.233 59.215 29.047 35.485 181.486 177.605 2000 2000 2000 44 44 37 32 31 30 0 0 0 1 HQVKREIDNL 
116.239 60.451 174.114 72.489 21.792 2000 2000 2000 2000 44 44 38 34 32 0 0 0 0 1 ITV 
117.208 60.325 32.716 178.821 26.347 30.012 2000 2000 2000 71 71 53 37 36 26 0 0 0 1 MREQKDNLI 
117.236 67.464 21.401 175.645 2000 2000 2000 2000 2000 59 59 51 31 0 0 0 0 0 1 TVIKL 
118.085 57.156 175.997 39.201 179.288 2000 2000 2000 2000 75 75 60 56 49 0 0 0 0 1 YDLFNEQKIW 
118.141 58.558 21.82 19.725 172.404 32.687 2000 2000 2000 39 39 39 35 30 25 0 0 0 1 CITVKL 
118.491 57.623 37.602 178.825 2000 2000 2000 2000 2000 17 17 17 16 0 0 0 0 0 1 DKFNILEYVTQW 
118.515 57.685 37.602 178.825 2000 2000 2000 2000 2000 38 38 17 16 0 0 0 0 0 1 DQKFEILNYVTW 
118.567 57.791 171.619 42.666 178.825 2000 2000 2000 2000 38 38 19 19 16 0 0 0 0 1 DQKFLEYNIW 
118.588 57.817 171.619 42.666 2000 2000 2000 2000 2000 38 38 19 19 0 0 0 0 0 1 DFILYVNEQKW 
118.881 54.104 19.014 179.379 2000 2000 2000 2000 2000 100 100 100 49 0 0 0 0 0 1 DKALRENQI 
119.003 66.387 21.013 31.841 22.158 178.602 2000 2000 2000 59 59 59 51 47 36 0 0 0 1 IVKL 
119.226 55.332 31.518 177.621 36.187 45.22 172.582 2000 2000 76 76 47 38 29 14 13 0 0 1 MREKDNQLI 
119.469 55.616 28.065 175.191 24.333 43.28 2000 2000 2000 33 33 33 31 25 15 0 0 0 1 HQKLREDNI 
119.494 55.663 24.333 175.191 28.065 43.28 2000 2000 2000 33 33 33 31 25 15 0 0 0 1 HKLQRDNEI 
119.498 55.675 175.191 24.333 43.28 2000 2000 2000 2000 31 31 31 25 15 0 0 0 0 1 DLFNEQKIWY 
120.482 54.622 18.2 181.173 2000 2000 2000 2000 2000 123 123 123 45 0 0 0 0 0 1 DKALRENQI 
120.498 60.188 31.63 179.413 27.331 29.397 2000 2000 2000 47 47 35 30 29 14 0 0 0 1 MREQKDNLI 
120.75 61.524 178.408 38.678 2000 2000 2000 2000 2000 27 27 25 21 0 0 0 0 0 1 IKFELNYVDQW 
120.786 54.011 34.236 173.966 2000 2000 2000 2000 2000 59 59 45 41 0 0 0 0 0 1 REQKDNLI 
120.911 59.332 32.762 178.888 25.689 173.007 29.124 2000 2000 75 75 66 42 41 18 15 0 0 1 MREQKDNLI 
121.007 56.053 175.962 38.23 177.66 2000 2000 2000 2000 58 58 42 40 33 0 0 0 0 1 DKNILEYVTQFW 
121.118 58.918 28.842 34.03 177.324 179.731 2000 2000 2000 51 51 51 41 34 26 0 0 0 1 REQKDNLI 
121.623 61.845 21.904 174.947 31.922 46.92 173.72 2000 2000 96 96 96 40 39 17 14 0 0 1 PVKIL 
122.146 54.334 30.139 32.362 171.155 2000 2000 2000 2000 44 44 44 43 39 0 0 0 0 1 MREQKDNLI 
122.456 56.13 18.005 179.388 2000 2000 2000 2000 2000 93 93 93 43 0 0 0 0 0 1 DKALRENQI 
122.563 54.611 18.256 179.549 174.774 2000 2000 2000 2000 131 131 88 54 18 0 0 0 0 1 DKNLAEQI 
122.749 54.891 36.155 25.516 28.852 173.067 2000 2000 2000 38 38 38 35 26 15 0 0 0 1 EKDNQLI 
123.06 53.434 38.784 175.55 26.004 29.697 2000 2000 2000 45 45 35 32 27 14 0 0 0 1 DNILVEQK 
123.135 57.109 174.638 43.393 2000 2000 2000 2000 2000 29 29 28 18 0 0 0 0 0 1 DKFILEYVNQW 
123.328 54.674 42.973 179.635 2000 2000 2000 2000 2000 39 39 39 13 0 0 0 0 0 1 DLFNEQKIWY 
123.368 42.963 179.65 2000 2000 2000 2000 2000 2000 15 15 14 0 0 0 0 0 0 1 G 
123.695 55.07 17.606 177.082 2000 2000 2000 2000 2000 80 80 71 48 0 0 0 0 0 1 KEDLANQI 
123.705 55.09 17.477 177.082 2000 2000 2000 2000 2000 80 80 72 48 0 0 0 0 0 1 KEDLANQI 
123.726 55.111 17.477 2000 2000 2000 2000 2000 2000 80 80 72 0 0 0 0 0 0 1 DQKLRENI 
123.981 61.389 21.439 72.013 173.857 2000 2000 2000 2000 53 53 49 45 40 0 0 0 0 1 ITVKL 
124.903 57.571 177.024 33.246 112.339 127.113 2000 2000 2000 33 33 25 21 16 14 0 0 0 1 QEVKIDNLW 
124.904 50.826 176.303 38.266 2000 2000 2000 2000 2000 46 46 46 39 0 0 0 0 0 1 LDINVEQK 
125.103 55.905 30.352 174.742 35.204 171.172 2000 2000 2000 66 66 50 45 23 15 0 0 0 1 REQKDNLI 
125.238 54.452 175.668 30.832 35.931 171.095 2000 2000 2000 67 67 51 43 20 15 0 0 0 1 REQKDNLI 
125.431 50.867 23.575 177.437 2000 2000 2000 2000 2000 89 89 80 45 0 0 0 0 0 1 NDLIAVTEQK 
126.067 60.058 17.516 27.345 37.838 175.023 12.717 2000 2000 49 49 49 38 34 30 24 0 0 1 IVKL 
126.243 51.105 42.71 180.18 176.144 2000 2000 2000 2000 39 39 39 33 26 0 0 0 0 1 NDLFEQKIWY 
126.89 54.808 174.793 25.097 27.032 2000 2000 2000 2000 28 28 28 27 26 0 0 0 0 1 LRKI 
126.952 53.041 24.98 27.293 25.777 174.546 42.502 2000 2000 32 32 25 24 23 23 14 0 0 1 LKI 
127.314 54.606 26.02 43.144 2000 2000 2000 2000 2000 48 48 33 33 0 0 0 0 0 1 LRKI 
127.359 54.583 43.144 26.02 173.699 2000 2000 2000 2000 48 48 33 33 30 0 0 0 0 1 DKLRNEQI 
127.436 54.557 43.144 26.02 173.699 27.843 23.064 2000 2000 48 48 33 33 30 29 23 0 0 1 KLFRIWY 
127.479 54.549 43.144 173.699 27.843 23.064 2000 2000 2000 48 48 33 30 29 23 0 0 0 1 DLFRNEQKIWY 
129.992 56.625 175.434 43.256 2000 2000 2000 2000 2000 27 27 18 14 0 0 0 0 0 1 DKFLEYNQIW 
130.777 57.656 180.279 33.289 38.734 183.119 2000 2000 2000 67 67 60 56 37 28 0 0 0 1 DQKFLENIWY 





5.7.3.2. NCOCX List 
67 9 
                  0.5 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 
           104.09 54.155 179.389 19.017 2000 2000 2000 2000 2000 67 49 67 57 0 0 0 0 0 1 DKTALNIVEQ 
105.538 53.467 175.593 38.816 26.011 2000 2000 2000 2000 43 36 43 24 21 0 0 0 0 1 DNLEQKI 
106.351 59.404 178.926 32.83 173.016 25.726 2000 2000 2000 62 40 62 35 22 16 0 0 0 1 MRQVKIDNE 
108.096 52.937 174.83 41.712 180.78 2000 2000 2000 2000 61 37 61 26 25 0 0 0 0 1 DLNEQKI 
108.332 53.657 174.079 40.274 176.885 46.958 173.652 2000 2000 59 47 59 28 25 20 14 0 0 1 DLNEQKI 
109.015 57.628 177.041 33.251 2000 2000 2000 2000 2000 33 27 33 18 0 0 0 0 0 1 MEQKDNLIW 
109.445 50.858 176.144 38.275 2000 2000 2000 2000 2000 45 32 45 25 0 0 0 0 0 1 DNIAVEQKL 
110.615 50.879 176.568 38.274 2000 2000 2000 2000 2000 44 21 44 21 0 0 0 0 0 1 DANIYVEQKLFW 
112.009 55.718 175.212 28.007 24.357 43.322 2000 2000 2000 49 29 49 28 19 15 0 0 0 1 LKI 
112.015 56.633 175.584 2000 2000 2000 2000 2000 2000 18 18 18 0 0 0 0 0 0 1 HSQKFNREYIVTDLW 
113.036 57.179 176.018 39.253 2000 2000 2000 2000 2000 45 15 45 23 0 0 0 0 0 1 DFILNYVEQKW 
114.161 40.285 176.835 53.633 174.071 2000 2000 2000 2000 47 35 47 31 21 0 0 0 0 1 DNLEQKI 
114.2 40.285 176.885 53.633 174.071 2000 2000 2000 2000 47 35 47 31 21 0 0 0 0 1 DNLEQKI 
114.23 40.285 176.947 174.071 2000 2000 2000 2000 2000 35 35 35 21 0 0 0 0 0 1 LDNIFVEQKWY 
114.889 54.049 174.002 34.266 60.277 2000 2000 2000 2000 64 47 64 34 16 0 0 0 0 1 QREVKIDNL 
114.909 56.106 175.968 38.298 177.656 2000 2000 2000 2000 64 45 64 30 25 0 0 0 0 1 YDNFLEQKIW 
115.361 63.722 174.846 31.989 2000 2000 2000 2000 2000 48 43 48 27 0 0 0 0 0 1 PVEIDNQK 
115.514 2000 179.803 34.057 28.869 2000 2000 2000 2000 78 0 78 19 13 0 0 0 0 1 EQKDNLI 
116.056 50.889 177.485 23.581 2000 2000 2000 2000 2000 40 32 40 40 0 0 0 0 0 1 DPALRNEQKI 
116.162 60.471 174.15 72.513 21.82 2000 2000 2000 2000 51 51 51 37 26 0 0 0 0 1 ITVK 
116.219 55.133 177.067 17.514 2000 2000 2000 2000 2000 44 37 44 44 0 0 0 0 0 1 KDLNAEQI 
116.283 60.314 171.831 70.565 20.121 174.077 2000 2000 2000 47 47 47 37 26 17 0 0 0 1 PITVK 
117.238 59.222 177.629 29.011 181.529 35.483 2000 2000 2000 29 29 29 24 20 16 0 0 0 1 HQKRWEDNIFY 
117.245 54.628 181.208 18.219 2000 2000 2000 2000 2000 44 33 44 44 0 0 0 0 0 1 DVPTAEYINQKLFW 
118.085 56.143 179.421 18.088 2000 2000 2000 2000 2000 41 38 41 41 0 0 0 0 0 1 DTAMILRNVEQK 
118.129 60.485 171.987 20.985 71.761 2000 2000 2000 2000 38 36 38 24 20 0 0 0 0 1 ITVK 
118.544 66.426 178.558 31.839 20.988 2000 2000 2000 2000 33 33 33 25 23 0 0 0 0 1 PVKI 
118.552 61.044 173.699 73.076 21.158 2000 2000 2000 2000 46 40 46 41 39 0 0 0 0 1 ITVK 
118.565 66.426 178.578 22.2 31.839 20.988 2000 2000 2000 33 33 33 25 23 21 0 0 0 1 PTVKI 
118.658 66.426 178.672 31.839 20.988 22.2 2000 2000 2000 53 33 53 25 23 21 0 0 0 1 PTVKI 
118.885 54.549 177.232 179.611 42.957 2000 2000 2000 2000 40 39 40 38 32 0 0 0 0 1 DLANEQKI 
118.895 60.323 178.78 32.739 22.2 26.378 2000 2000 2000 53 40 53 30 21 15 0 0 0 1 PRVKI 
118.957 60.323 178.799 32.739 26.378 2000 2000 2000 2000 53 40 53 30 15 0 0 0 0 1 QKPMREDNI 
119.221 45.271 172.478 2000 2000 2000 2000 2000 2000 71 64 71 0 0 0 0 0 0 1 G 
119.496 60.498 175.511 69.901 21.574 2000 2000 2000 2000 50 43 50 42 36 0 0 0 0 1 ITVK 
120.483 57.626 178.867 37.579 2000 2000 2000 2000 2000 27 18 27 13 0 0 0 0 0 1 DKFNILEYVQW 
120.512 54.613 179.533 18.313 2000 2000 2000 2000 2000 64 51 64 64 0 0 0 0 0 1 DNMLAEQKI 
120.76 58.989 177.35 28.862 34.086 179.638 2000 2000 2000 42 38 42 32 25 22 0 0 0 1 REQKDNLI 
120.816 45.112 171.111 2000 2000 2000 2000 2000 2000 66 56 66 0 0 0 0 0 0 1 G 
120.912 44.803 172.978 2000 2000 2000 2000 2000 2000 55 45 55 0 0 0 0 0 0 1 G 
121.033 57.167 179.338 176.015 39.271 27.173 56.12 2000 2000 93 40 93 40 31 16 15 0 0 1 DLIRVNEQK 
121.034 57.167 179.303 176.015 39.271 56.12 2000 2000 2000 40 40 40 40 31 16 0 0 0 1 YDLFNEQKIW 
121.045 57.167 179.387 176.015 39.271 60.252 31.674 56.12 27.173 93 40 93 40 31 30 25 16 14 1 DFILEYVNQKW 
121.045 57.167 179.359 176.015 39.271 60.252 31.674 27.173 56.12 93 40 93 40 31 30 25 16 15 1 DFILEYVNQKW 
121.051 60.252 179.395 176.015 39.271 31.674 56.12 27.173 2000 93 30 93 40 31 25 16 14 0 1 IVKPFREYDNQW 
121.629 46.986 173.796 61.859 21.856 2000 2000 2000 2000 68 61 68 15 13 0 0 0 0 1 G 
122.473 61.538 178.469 38.78 18.09 2000 2000 2000 2000 29 27 29 20 15 0 0 0 0 1 EIYFAVDNQKW 
122.54 52.646 175 179.743 42.207 2000 2000 2000 2000 34 34 34 32 22 0 0 0 0 1 DLNEQKI 
122.83 57.144 174.694 43.43 2000 2000 2000 2000 2000 78 32 78 16 0 0 0 0 0 1 DFILYVNEQKW 
122.996 55.911 174.739 30.335 57.144 43.43 171.192 35.461 2000 78 43 78 33 32 16 15 14 0 1 HQKFREYDNLIW 
123.074 54.53 173.723 26.056 23.077 27.915 43.231 2000 2000 47 23 47 33 20 20 14 0 0 1 LKI 
123.079 55.911 174.772 30.335 171.192 35.461 2000 2000 2000 78 43 78 33 15 14 0 0 0 1 RHEQKDNLI 
123.333 42.746 176.186 51.097 180.225 2000 2000 2000 2000 34 30 34 28 22 0 0 0 0 1 DALFNEQKIWY 
123.754 67.621 175.657 21.456 54.944 17.521 2000 2000 2000 58 58 58 35 16 15 0 0 0 1 DVKTAEINQ 
123.993 58.592 172.453 19.728 21.811 32.697 2000 2000 2000 39 33 39 30 30 22 0 0 0 1 TVKIL 
124.913 54.755 174.836 43.017 27.061 2000 2000 2000 2000 30 27 30 17 15 0 0 0 0 1 LRKI 
124.947 55.341 177.713 31.568 36.237 2000 2000 2000 2000 38 35 38 27 14 0 0 0 0 1 MEQKDNLI 
125.178 54.398 171.142 61.491 70.827 32.395 30.205 18.927 174.733 96 59 96 48 44 43 43 37 15 1 VQKTMEIDNL 
125.466 54.539 175.688 30.874 2000 2000 2000 2000 2000 65 46 65 28 0 0 0 0 0 1 KEQRDNLI 
126.061 53.053 174.633 27.316 25.073 2000 2000 2000 2000 24 22 24 16 14 0 0 0 0 1 LKI 
126.256 57.89 171.652 42.721 2000 2000 2000 2000 2000 40 33 40 26 0 0 0 0 0 1 IFDLYVNEQKW 
126.894 60.283 175.099 37.84 17.59 27.409 59.87 2000 2000 37 37 37 25 24 22 17 0 0 1 IVK 
126.974 54.918 173.087 36.215 25.582 2000 2000 2000 2000 41 41 41 29 17 0 0 0 0 1 QKNMREYDLIFW 
127.595 62.065 173.078 69.426 22.569 2000 2000 2000 2000 40 40 40 38 32 0 0 0 0 1 TVIK 
129.988 62.597 174.147 71.636 21.301 175.325 2000 2000 2000 45 42 45 37 37 15 0 0 0 1 PTVIK 
130.791 61.409 173.878 72.075 21.458 2000 2000 2000 2000 59 55 59 50 43 0 0 0 0 1 PITVK 
130.9 61.857 174.958 21.969 31.933 173.758 2000 2000 2000 60 40 60 60 30 17 0 0 0 1 PTVIK 




5.7.3.3. CANCOCX List 
67 9 
                  0.5 0.4 0.4 0.35 0.35 0.35 0.35 0.35 0.35 
           104.096 60.467 179.388 18.999 54.145 2000 2000 2000 2000 27 27 27 27 27 0 0 0 0 1 TV 
105.543 45.078 175.623 53.438 38.756 26.016 2000 2000 2000 17 17 17 17 13 9 0 0 0 1 G 
106.382 62.01 178.923 59.335 32.794 2000 2000 2000 2000 19 19 19 19 16 0 0 0 0 1 TV 
108.037 45.284 174.824 52.897 41.687 2000 2000 2000 2000 17 17 17 17 14 0 0 0 0 1 GT 
108.05 45.282 174.823 52.897 41.687 2000 2000 2000 2000 17 17 17 17 14 0 0 0 0 1 GT 
108.271 46.974 174.08 53.648 40.328 2000 2000 2000 2000 21 21 21 21 13 0 0 0 0 1 G 
108.275 46.965 174.07 53.648 40.328 2000 2000 2000 2000 21 21 21 21 13 0 0 0 0 1 G 
108.98 61.061 177.052 57.57 33.214 2000 2000 2000 2000 13 13 13 13 9 0 0 0 0 1 TVS 
109.43 44.846 176.161 50.825 38.236 2000 2000 2000 2000 17 17 17 17 13 0 0 0 0 1 G 
112.037 62.595 175.201 55.659 28.094 24.409 2000 2000 2000 14 14 14 14 14 9 0 0 0 1 SVT 
112.134 60.443 175.534 56.6 2000 2000 2000 2000 2000 9 9 9 9 0 0 0 0 0 1 CPTVS 
114.84 53.672 175.951 56.059 38.306 2000 2000 2000 2000 20 20 20 20 15 0 0 0 0 1 DQFELRANKI 
114.852 60.263 173.989 54.048 34.261 2000 2000 2000 2000 29 29 29 29 17 0 0 0 0 1 ISVKTRYL 
115.314 52.614 174.841 63.734 31.989 2000 2000 2000 2000 20 20 20 20 14 0 0 0 0 1 LDNQREKI 
116.018 63.694 177.475 23.541 50.842 2000 2000 2000 2000 22 22 22 22 17 0 0 0 0 1 CISVTKL 
116.098 61.426 174.155 60.441 72.514 21.841 2000 2000 2000 26 26 26 26 18 16 0 0 0 1 SVTFEYDNQ 
116.212 59.229 177.078 55.104 17.488 2000 2000 2000 2000 22 22 22 22 19 0 0 0 0 1 HSQKTRVEDNLI 
116.271 60.451 171.85 70.522 20.057 2000 2000 2000 2000 26 26 26 20 11 0 0 0 0 1 CHSVKQTEDNLI 
117.167 67.545 181.187 18.212 54.651 2000 2000 2000 2000 33 33 33 33 32 0 0 0 0 1 ITVSKL 
117.174 60.31 177.633 59.2 29.032 35.537 2000 2000 2000 17 17 17 17 13 11 0 0 0 1 HSVKTFREDNQLI 
118.09 57.145 179.423 18.045 56.108 2000 2000 2000 2000 24 24 24 24 22 0 0 0 0 1 DSQKMLEYNI 
118.229 58.583 172.024 60.451 21.008 71.718 2000 2000 2000 22 22 22 22 16 15 0 0 0 1 CSQKMLRVEYDNI 
118.502 57.616 178.553 66.394 31.883 22.213 21.037 2000 2000 12 12 12 12 11 9 9 0 0 1 DSQKLREYNIF 
118.566 57.852 173.693 61.053 21.192 73.065 2000 2000 2000 18 18 18 18 14 13 0 0 0 1 DSQKMLRENIY 
118.951 66.409 178.799 60.325 32.675 26.369 2000 2000 2000 22 22 22 22 18 10 0 0 0 1 ISVKTFEDNQL 
118.952 54.11 177.244 54.642 42.99 2000 2000 2000 2000 23 23 23 23 19 0 0 0 0 1 DQKNLRAEI 
118.953 54.109 177.242 54.642 42.99 2000 2000 2000 2000 23 23 23 23 19 0 0 0 0 1 DQKNLRAEI 
119.309 55.347 172.5 45.266 2000 2000 2000 2000 2000 39 39 39 39 0 0 0 0 0 1 DQKAHLENI 
119.543 55.612 175.519 60.48 69.866 21.591 2000 2000 2000 21 21 21 21 19 19 0 0 0 1 HQKNAMLEDI 
120.437 54.636 179.531 18.265 2000 2000 2000 2000 2000 35 35 35 35 0 0 0 0 0 1 DQKALRENI 
120.581 60.209 178.959 57.581 2000 2000 2000 2000 2000 12 12 12 12 0 0 0 0 0 1 IQVKFHREDNL 
120.684 61.577 177.34 58.951 28.835 34.047 2000 2000 2000 16 16 16 16 13 12 0 0 0 1 IVTFWYKL 
120.747 54.103 171.099 45.106 2000 2000 2000 2000 2000 34 34 34 34 0 0 0 0 0 1 DKNLAEQI 
120.898 59.386 173.022 44.794 2000 2000 2000 2000 2000 31 31 31 31 0 0 0 0 0 1 IVQKLREYDN 
120.906 59.385 173.021 44.794 2000 2000 2000 2000 2000 31 31 31 31 0 0 0 0 0 1 IVQKLREYDN 
121.026 56.099 179.353 57.133 39.204 2000 2000 2000 2000 18 18 18 18 13 0 0 0 0 1 DQKFALRENI 
121.071 58.946 179.448 60.191 31.673 27.174 2000 2000 2000 18 18 18 18 13 9 0 0 0 1 IVQKLREYDN 
121.591 61.901 173.789 46.932 46.572 21.901 2000 2000 2000 38 38 38 38 9 9 0 0 0 1 IVTFWYKL 
122.439 56.148 178.504 61.501 38.763 2000 2000 2000 2000 15 15 15 15 12 0 0 0 0 1 DQKFAMLRENI 
122.449 54.586 175.013 52.628 42.278 2000 2000 2000 2000 23 23 23 23 17 0 0 0 0 1 DQKALENI 
122.451 54.588 175.012 52.628 42.278 2000 2000 2000 2000 23 23 23 23 17 0 0 0 0 1 DQKAMLENI 
122.729 54.762 174.7 43.246 2000 2000 2000 2000 2000 9 9 9 9 0 0 0 0 0 1 DKALRENQI 
122.732 54.96 174.6 57.119 2000 2000 2000 2000 2000 14 14 14 14 0 0 0 0 0 1 DKALRENQI 
123.003 53.489 173.768 54.491 43.196 27.878 2000 2000 2000 15 15 15 15 13 10 0 0 0 1 DKALRENQI 
123.007 53.479 173.77 54.491 43.196 27.878 2000 2000 2000 15 15 15 15 13 10 0 0 0 1 DKALRENQI 
123.084 57.138 174.76 55.872 30.363 2000 2000 2000 2000 20 20 20 20 16 0 0 0 0 1 DSKFILEYNQ 
123.392 54.687 176.147 42.728 51.047 2000 2000 2000 2000 16 16 16 16 16 0 0 0 0 1 DQKALRENI 
123.427 54.683 176.147 51.047 42.728 2000 2000 2000 2000 16 16 16 16 16 0 0 0 0 1 DQKALRENI 
123.7 55.09 175.651 67.627 21.439 67.229 2000 2000 2000 30 30 30 30 21 16 0 0 0 1 QKALREDNI 
124.043 61.446 172.481 58.585 21.735 19.754 32.667 2000 2000 16 16 16 16 15 12 11 0 0 1 ISVKTFYL 
124.876 50.867 174.848 54.802 2000 2000 2000 2000 2000 13 13 13 13 0 0 0 0 0 1 CDAHLNEQKI 
124.959 57.611 177.677 55.317 31.579 2000 2000 2000 2000 17 17 17 17 13 0 0 0 0 1 CDSQKFILEYNW 
125.043 55.924 171.227 54.34 32.371 30.175 53.83 2000 2000 29 29 29 29 22 21 8 0 0 1 QKFALREYDNI 
125.149 50.807 174.82 27.032 2000 2000 2000 2000 2000 9 9 9 9 0 0 0 0 0 1 DQPALNEKI 
125.179 54.467 171.129 61.44 70.809 18.985 2000 2000 2000 24 24 24 24 21 18 0 0 0 1 DKAMHLRENQI 
125.37 50.866 175.662 54.53 30.896 2000 2000 2000 2000 26 26 26 26 16 0 0 0 0 1 DQPAHLNEKI 
126.041 60.112 174.655 53.033 25.78 25.022 42.645 2000 2000 14 14 14 14 9 9 9 0 0 1 CIQVKWEDNL 
126.073 60.112 174.675 25.78 25.022 53.033 27.28 42.645 2000 14 14 14 14 10 9 9 9 0 1 CIVQKEDNL 
126.14 60.126 174.714 27.28 25.78 25.022 2000 2000 2000 10 10 10 10 9 9 0 0 0 1 CIVKWEDNQL 
126.21 51.108 171.68 57.848 42.719 2000 2000 2000 2000 13 13 13 13 11 0 0 0 0 1 LDNFAEQKI 
126.221 51.1 171.68 57.848 42.719 2000 2000 2000 2000 13 13 13 13 11 0 0 0 0 1 LDNFAEQKI 
126.89 54.782 175.083 60.18 27.364 37.883 17.549 2000 2000 17 17 17 17 15 12 12 0 0 1 DQKALRENI 
126.982 53.072 173.098 54.923 36.19 25.541 2000 2000 2000 18 18 18 18 16 11 0 0 0 1 DKALRNEQI 
127.443 54.52 173.092 61.992 22.613 69.444 2000 2000 2000 20 20 20 20 16 14 0 0 0 1 DKELRANQI 
129.947 56.638 174.155 62.581 71.624 21.341 2000 2000 2000 18 18 18 18 17 15 0 0 0 1 CKFLRWEYDNQI 
130.798 52.891 174.941 21.908 61.875 31.954 2000 2000 2000 26 26 26 26 19 13 0 0 0 1 HDLRANEQKI 





5.7.4. Example input control file 
NSGA2_MC_ASSIGN input 
!***************************************************** 
GB1_seq.txt         !sequence file 
3                   !number of spectra 
NCACX_50ms.txt      !spectrum 1 
NCOCX_50ms.txt      !spectrum 2 
CANCOCX_50ms_4D.txt !spectrum 3 
Conn_ncacx_ncocx_cancocx_expanded.txt !connection table 
NULL          !initial data file 
outdata.txt   !output file(data) 
outtab        !output files(table) 
!***************************************************** 
50     !group size 
40     !gene pool size 
15     !number of steps 
5000   !number of NSGA-ii attempts 
500000 !number of MC attempts 
15     !number of free steps 
0.8    !mutation rate 
0.6    !additional mutation rate 
0.2    !crossover rate 
0.3    !null probability 
0.0    !minimum w1 (good, for MC step) 
0.0    !minimum w2 (bad, for MC step) 
0.0    !minimum w3 (edge, for MC step) 
0.0    !minimum w4 (used, for MC step) 
0.0    !minimum w5 (PIOS weight for MC step) 
2.5    !maximum w1 (good, for MC step) 
0.0    !maximum w2 (bad, for MC step) 
0.5    !maximum w3 (edge, for MC step) 
0.5    !maximum w4 (used, for MC step) 





5.7.5. Example connection file for (1) NCACX,  (2) NCOCX, and (3) CANcoCX spin-system lists 
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1 3 6 3 0 -1 
1 2 1 1 0 1 
 
1 3 6 4 0 -1 
1 3 1 1 0 0 
 
1 3 6 5 0 -1 
2 3 1 1 1 0 
 
1 3 6 6 0 -1 
1 2 2 2 0 0 
 
1 3 6 7 0 -1 
1 3 2 2 0 0 
 
1 3 6 8 0 -1 
2 3 2 2 0 0 
 
1 3 6 9 0 -1 
1 2 3 3 0 0 
 
1 3 7 3 0 -1 
1 2 3 4 0 0 
 
1 3 7 4 0 -1 
1 2 3 5 0 0 
 
1 3 7 5 0 -1 
1 2 3 6 0 0 
 
1 3 7 6 0 -1 
1 2 3 7 0 0 
 
1 3 7 7 0 -1 
1 2 3 8 0 0 
 
1 3 7 8 0 -1 
1 2 3 9 0 0 
 
1 3 7 9 0 -1 
1 2 4 3 0 0 
 
1 3 8 3 0 -1 
1 2 4 4 0 0 
 
1 3 8 4 0 -1 
1 2 4 5 0 0 
 
1 3 8 5 0 -1 
1 2 4 6 0 0 
 
1 3 8 6 0 -1 
1 2 4 7 0 0 
 
1 3 8 7 0 -1 
1 2 4 8 0 0 
 
1 3 8 8 0 -1 
1 2 4 9 0 0 
 
1 3 8 9 0 -1 
1 2 5 3 0 0 
 
1 3 9 3 0 -1 
1 2 5 4 0 0 
 
1 3 9 4 0 -1 
1 2 5 5 0 0 
 
1 3 9 5 0 -1 
1 2 5 6 0 0 
 
1 3 9 6 0 -1 
1 2 5 7 0 0 
 
1 3 9 7 0 -1 
1 2 5 8 0 0 
 
1 3 9 8 0 -1 
1 2 5 9 0 0 
 
1 3 9 9 0 -1 
1 2 6 3 0 0 
 
2 3 3 3 0 -1 
1 2 6 4 0 0 
 
2 3 3 4 0 -1 
1 2 6 5 0 0 
 
2 3 3 5 0 -1 
1 2 6 6 0 0 
 
2 3 3 6 0 -1 
1 2 6 7 0 0 
 
2 3 3 7 0 -1 
1 2 6 8 0 0 
 
2 3 3 8 0 -1 
1 2 6 9 0 0 
 
2 3 3 9 0 -1 
1 2 7 3 0 0 
 
2 3 4 3 0 -1 
1 2 7 4 0 0 
 
2 3 4 4 0 -1 
1 2 7 5 0 0 
 
2 3 4 5 0 -1 
1 2 7 6 0 0 
 
2 3 4 6 0 -1 
1 2 7 7 0 0 
 
2 3 4 7 0 -1 
1 2 7 8 0 0 
 
2 3 4 8 0 -1 
1 2 7 9 0 0 
 
2 3 4 9 0 -1 
1 2 8 3 0 0 
 
2 3 5 3 0 -1 
1 2 8 4 0 0 
 
2 3 5 4 0 -1 
1 2 8 5 0 0 
 
2 3 5 5 0 -1 
1 2 8 6 0 0 
 
2 3 5 6 0 -1 
1 2 8 7 0 0 
 
2 3 5 7 0 -1 
1 2 8 8 0 0 
 
2 3 5 8 0 -1 
1 2 8 9 0 0 
 
2 3 5 9 0 -1 
1 2 9 3 0 0 
 
2 3 6 3 0 -1 
1 2 9 4 0 0 
 
2 3 6 4 0 -1 
1 2 9 5 0 0 
 
2 3 6 5 0 -1 
1 2 9 6 0 0 
 
2 3 6 6 0 -1 
1 2 9 7 0 0 
 
2 3 6 7 0 -1 
1 2 9 8 0 0 
 
2 3 6 8 0 -1 
1 2 9 9 0 0 
 
2 3 6 9 0 -1 
1 3 3 3 0 -1 
 
2 3 7 3 0 -1 
1 3 3 4 0 -1 
 
2 3 7 4 0 -1 
1 3 3 5 0 -1 
 
2 3 7 5 0 -1 
1 3 3 6 0 -1 
 
2 3 7 6 0 -1 
1 3 3 7 0 -1 
 
2 3 7 7 0 -1 
1 3 3 8 0 -1 
 
2 3 7 8 0 -1 
1 3 3 9 0 -1 
 
2 3 7 9 0 -1 
1 3 4 3 0 -1 
 
2 3 8 3 0 -1 
1 3 4 4 0 -1 
 
2 3 8 4 0 -1 
1 3 4 5 0 -1 
 
2 3 8 5 0 -1 
1 3 4 6 0 -1 
 
2 3 8 6 0 -1 
1 3 4 7 0 -1 
 
2 3 8 7 0 -1 
1 3 4 8 0 -1 
 
2 3 8 8 0 -1 
1 3 4 9 0 -1 
 
2 3 8 9 0 -1 
1 3 5 3 0 -1 
 
2 3 9 3 0 -1 
1 3 5 4 0 -1 
 
2 3 9 4 0 -1 
1 3 5 5 0 -1 
 
2 3 9 5 0 -1 
1 3 5 6 0 -1 
 
2 3 9 6 0 -1 
1 3 5 7 0 -1 
 
2 3 9 7 0 -1 
1 3 5 8 0 -1 
 
2 3 9 8 0 -1 
1 3 5 9 0 -1 
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CHAPTER 6: CONCLUSIONS AND OUTLOOK 
6.1. CONCLUSIONS 
In this work, I presented the collection of investigations we have performed that are directed at 
understanding the structural determinants of cardiac light-chain amyloidosis, through the application of 
MAS SSNMR spectroscopy to the case of AL-09 VL fibrils. Overall, our results demonstrate that the 
majority of the 108 amino acid sequence of AL-09 VL is highly rigid in the fibril structure and that the N- 
and C- termini in particular exhibit a substantial extent of order relative to the other regions of the protein 
sequence1,2. Furthermore, recent insights described in Chapter 4 reveal that several of the centrally-
occurring residues in the sequence also exhibit a moderate degree of order in addition to a set of distinct 
chemical shift frequencies that may indicate the adoption of a unique conformational arrangement relative 
to the surrounding topology of the fibril core. Collectively, these results and conclusions offer several of 
the first key insights into the molecular structure and dynamics involved in AL disease fibrils, and 
importantly place the project at a highly optimal position to pursue the measurement of distance restraints 
and subsequent simulated annealing calculations for the determination of the first three-dimensional AL 
fibril structure to be reported.  
In light of the multitude of AL protein sequences that can form fibrils between patients, there 
remains a large urgency for the elucidation of a fibril structure at the molecular-level, as this may serve as 
a model on which the variety of other AL fibrils may be studied. Indeed, several structurally-based 
investigations on disease-related amyloid fibrils have yielded a variety of molecules with potentially 
therapeutic and diagnostic significance, particularly in the case of Alzheimer’s disease3,4. These studies 
are enabled by the availability of the three-dimensional structure of the corresponding fibril system3. 
Accordingly, the future determination of the structure of AL fibrils may fuel similar studies. Nonetheless, 
despite the current absence of a full three-dimensional picture for the AL fibril species, several studies 
have reported the identification of a murine monoclonal antibody that can specifically bind the fibril form 
of the protein, but not the soluble form5,6. Thus, there exists a great amount of potential for not only 
extending these findings into diagnostic applications, but also for providing model framework through 
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which we may probe these fibril-specific binding interactions to inform subsequent research on the 
rational design of other molecules that may participate in similar binding interactions.  
 
6.2. OUTLOOK 
As described above, there remains a large demand for obtaining a complete description of the 
atomic-resolution structure of AL fibrils. Towards this interest, the results and conclusions provided in 
the preceding chapters place us at a particularly opportune position for achieving this objective in the case 
of AL-09 VL fibrils. Specifically, our knowledge of the chemical shifts for approximately 90% of the 
structurally-rigid AL-09 VL protein backbone will enable us to perform the final set of experiments 
necessary for determining a comprehensive list of distance restraints, which we may subsequently 
incorporate into simulated annealing structure calculations7. Moreover, as we now also have access to an 
extensive list of backbone torsion angle predictions (as well as for side-chain 1 angles) determined from 
TALOS-N8, these may be supplied as additional structural restraints into the calculations. 
In considering the various experimental strategies that can be pursued to obtain a valuable set of 
distance restraints, several in particular have been demonstrated to provide success in the case of fibril 
systems—both through the results of previous studies9-12 as well as ongoing research efforts in our 
group—and differ depending on the type of internuclear distance to be measured (i.e., intra- or 
intermolecular) as well as the labeling pattern of the sample13. For the case of uniformly [13C, 15N]-labeled 
samples, which represents the labeling scheme of all AL-09 VL fibril preparations thus far, one can 
employ homonuclear dipolar-recoupling pulse sequence techniques such as proton assisted recoupling 
(PAR)14,15, dipolar assisted rotational-recoupling (DARR)16, and proton-driven spin-diffusion (PDSD)17 to 
enable the measurement of short-, medium-, and long-range distances between 13C–13C (PAR, DARR, 
and PDSD) or 15N–15N (PDSD18 and PAR19) spin pairs. Furthermore, heteronuclear dipolar-recoupling 
experiments such as proton assisted insensitive nuclei cross polarization (PAIN-CP)20 or rotational-echo 
double-resonance (REDOR)21 can be performed to obtain 13C–15N distance restraints, using U-[13C, 15N] 
samples that are fully labeled22,23 or diluted in natural abundance material24, respectively. Accordingly, in 
138 
 
light of the current availability of solely U-[13C, 15N]-labeled AL-09 VL fibrils, the application of these 
techniques (particularly, PAR and PAIN-CP) would provide a direct route to obtaining the first set of 
intramolecular distances for the fibril structure.  
Additionally, the preparation of sparsely 13C-labeled samples offers another powerful approach to 
the determination of unambiguous medium- and long-range distance restraints for both intra- and 
intermolecular correlations. While there are a variety of possible sparse-labeling schemes that can be 
prepared, a few that are more commonly used and likely most valuable for the case of AL-09 VL fibrils 
include [1,3-13C]- or [2-13C]-glycerol25 as well as [1-13C]- or [2-13C]-glucose26, which are provided as the 
growth substrate to the cellular culture during protein expression (with or without 15NH3, depending on 
the type of distance desired). The study of these samples through the similar application of the techniques 
above—namely, REDOR and the related transferred-echo double-resonance (TEDOR)27—can enable for 
a significant improvement to the number of intramolecular restraints obtained from the uniformly-labeled 
samples alone, as the sparse-labeling reduces spectral congestion. Furthermore, by combining these 
sparsely 13C-labeled samples with solely 15N-labeled material (prior to fibril formation), one can enable to 
additional determination of unambiguous intermolecular distances. Collectively, these experiments can be 
used to obtain a large variety of distance restraints for the fibril sample of interest, and are the most 
beneficial when all of the chemical shifts for the protein are known, as this allows for the unambiguous 
identification of the residues corresponding to long-range cross-peak correlations. Thus, the extension of 
these investigations to the case of AL-09 VL fibrils should be a relatively straightforward task following 
the necessary sample preparation, which is currently underway. 
The distance restraint information obtained from the above experiments may be further 
complemented by backbone torsion angle measurements for specific sites along the protein sequence, in 
order to provide an augmented list of dihedral angle restraints. A variety of experiments have been 
developed to perform these measurements in the solid state, including the T-MREV28,29 and BARE30 pulse 
sequences. The application of these experiments to AL-09 VL fibrils would be particularly valuable for 
investigating the regions of the sequence for which TALOS-N was unable to make accurate predictions of 
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the corresponding angles, such as the stretch of residues from T56–T69 (as described in Chapter 4). 
Moreover, the success of this approach has been demonstrated by Murray et al. in the case of FUS-LC 
fibrils, in which 15N-BARE measurements were performed to obtain restraints for multiple residues 
within the -loop structure of the fibril core12. Notably, as discussed in Chapter 4, this -loop structure 
also exhibits several similarities in sequence and chemical shift as the T56–T69 stretch in AL-09 VL, and 
thus represents one of the proposed structural models for this region of the fibril core. 
Together, the structural restraints that we obtain from each of these methods can be incorporated 
into simulated annealing calculations using the XPLOR-NIH software package7. Ultimately, the iterative 
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